{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 160382, "items": [{"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T05:03:24Z", "timestamp": 1574485404201}, "reference-count": 19, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2011, 2, 1]], "date-time": "2011-02-01T00:00:00Z", "timestamp": 1296518400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Urology"], "published-print": {"date-parts": [[2011, 2]]}, "DOI": "10.1016/j.juro.2010.09.077", "type": "journal-article", "created": {"date-parts": [[2010, 12, 20]], "date-time": "2010-12-20T09:05:16Z", "timestamp": 1292835916000}, "page": "706-711", "source": "Crossref", "is-referenced-by-count": 48, "title": ["Sarcosine in Prostate Cancer Tissue is Not a Differential Metabolite for Prostate Cancer Aggressiveness and Biochemical Progression"], "prefix": "10.1097", "volume": "185", "author": [{"given": "Florian", "family": "Jentzmik", "sequence": "first", "affiliation": [{"name": "Department of Urology, University Hospital Charit\u00e9, University Medicine, Berlin, Germany"}]}, {"given": "Carsten", "family": "Stephan", "sequence": "additional", "affiliation": [{"name": "Department of Urology, University Hospital Charit\u00e9, University Medicine, Berlin, Germany"}, {"name": "Berlin Institute for Urologic Research, Berlin, Germany"}]}, {"given": "Michael", "family": "Lein", "sequence": "additional", "affiliation": [{"name": "Department of Urology, University Hospital Charit\u00e9, University Medicine, Berlin, Germany"}, {"name": "Berlin Institute for Urologic Research, Berlin, Germany"}]}, {"given": "Kurt", "family": "Miller", "sequence": "additional", "affiliation": [{"name": "Department of Urology, University Hospital Charit\u00e9, University Medicine, Berlin, Germany"}]}, {"given": "Beate", "family": "Kamlage", "sequence": "additional", "affiliation": [{"name": "Metanomics GmbH, Berlin, Germany"}]}, {"given": "Bianca", "family": "Bethan", "sequence": "additional", "affiliation": [{"name": "Metanomics GmbH, Berlin, Germany"}]}, {"given": "Glen", "family": "Kristiansen", "sequence": "additional", "affiliation": [{"name": "Department of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland"}]}, {"given": "Klaus", "family": "Jung", "sequence": "additional", "affiliation": [{"name": "Department of Urology, University Hospital Charit\u00e9, University Medicine, Berlin, Germany"}, {"name": "Berlin Institute for Urologic Research, Berlin, Germany"}]}], "member": "276", "container-title": ["Journal of Urology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0022534710047105?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0022534710047105?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 17]], "date-time": "2019-06-17T14:48:05Z", "timestamp": 1560782885000}, "score": 71.466156, "issued": {"date-parts": [[2011, 2]]}, "references-count": 19, "journal-issue": {"published-print": {"date-parts": [[2011, 2]]}, "issue": "2"}, "alternative-id": ["10.1016/j.juro.2010.09.077"], "URL": "http://dx.doi.org/10.1016/j.juro.2010.09.077", "ISSN": ["0022-5347", "1527-3792"], "issn-type": [{"value": "0022-5347", "type": "print"}, {"value": "1527-3792", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T12:47:05Z", "timestamp": 1574513225491}, "reference-count": 0, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "4S", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2011, 4, 1]], "date-time": "2011-04-01T00:00:00Z", "timestamp": 1301616000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Urology"], "published-print": {"date-parts": [[2011, 4]]}, "DOI": "10.1016/j.juro.2011.02.204", "type": "journal-article", "created": {"date-parts": [[2011, 5, 20]], "date-time": "2011-05-20T09:22:50Z", "timestamp": 1305883370000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["137 SARCOSINE IN PROSTATE TISSUE IS NOT A DIFFERENTIAL METABOLITE FOR PROSTATE CANCER AGGRESSIVENESS AND BIOCHEMICAL PROGRESSION"], "prefix": "10.1097", "volume": "185", "author": [{"given": "Florian", "family": "Jentzmik", "sequence": "first", "affiliation": [{"name": "Ulm, Germany"}]}, {"given": "Carsten", "family": "Stephan", "sequence": "additional", "affiliation": [{"name": "Berlin, Germany"}]}, {"given": "Michael", "family": "Lein", "sequence": "additional", "affiliation": [{"name": "Berlin, Germany"}]}, {"given": "Kurt", "family": "Miller", "sequence": "additional", "affiliation": [{"name": "Berlin, Germany"}]}, {"given": "Beate", "family": "Kamlage", "sequence": "additional", "affiliation": [{"name": "Berlin, Germany"}]}, {"given": "Bianca", "family": "Bethan", "sequence": "additional", "affiliation": [{"name": "Berlin, Germany"}]}, {"given": "Glen", "family": "Kristiansen", "sequence": "additional", "affiliation": [{"name": "Z\u00fcrich, Switzerland"}]}, {"given": "Klaus", "family": "Jung", "sequence": "additional", "affiliation": [{"name": "Berlin, Germany"}]}], "member": "276", "container-title": ["Journal of Urology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0022534711004526?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0022534711004526?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 17]], "date-time": "2019-06-17T16:39:45Z", "timestamp": 1560789585000}, "score": 68.44731, "issued": {"date-parts": [[2011, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2011, 4]]}, "issue": "4S"}, "alternative-id": ["10.1016/j.juro.2011.02.204"], "URL": "http://dx.doi.org/10.1016/j.juro.2011.02.204", "ISSN": ["0022-5347", "1527-3792"], "issn-type": [{"value": "0022-5347", "type": "print"}, {"value": "1527-3792", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T11:50:36Z", "timestamp": 1574769036739}, "reference-count": 0, "publisher": "Impact Journals, LLC", "issue": "29", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Oncotarget"], "published-print": {"date-parts": [[2017, 7, 18]]}, "DOI": "10.18632/oncotarget.16943", "type": "journal-article", "created": {"date-parts": [[2017, 4, 8]], "date-time": "2017-04-08T04:43:43Z", "timestamp": 1491626623000}, "source": "Crossref", "is-referenced-by-count": 10, "title": ["Influence of serum cholesterol level and statin treatment on prostate cancer aggressiveness"], "prefix": "10.18632", "volume": "8", "author": [{"given": "Thomas J.", "family": "Schnoeller", "sequence": "first", "affiliation": []}, {"given": "Florian", "family": "Jentzmik", "sequence": "additional", "affiliation": []}, {"given": "Andres J.", "family": "Schrader", "sequence": "additional", "affiliation": []}, {"given": "Julie", "family": "Steinestel", "sequence": "additional", "affiliation": []}], "member": "7892", "published-online": {"date-parts": [[2017, 4, 8]]}, "container-title": ["Oncotarget"], "language": "en", "link": [{"URL": "http://www.oncotarget.com/fulltext/16943", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 1, 15]], "date-time": "2018-01-15T17:57:23Z", "timestamp": 1516039043000}, "score": 40.82322, "issued": {"date-parts": [[2017, 4, 8]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2017, 7, 18]]}, "issue": "29"}, "alternative-id": ["16943"], "URL": "http://dx.doi.org/10.18632/oncotarget.16943", "ISSN": ["1949-2553"], "issn-type": [{"value": "1949-2553", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T16:59:25Z", "timestamp": 1575305965537}, "reference-count": 58, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2005, 6, 1]], "date-time": "2005-06-01T00:00:00Z", "timestamp": 1117584000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Prostate Cancer"], "published-print": {"date-parts": [[2005, 6]]}, "DOI": "10.3816/cgc.2005.n.010", "type": "journal-article", "created": {"date-parts": [[2008, 9, 11]], "date-time": "2008-09-11T01:07:44Z", "timestamp": 1221095264000}, "page": "38-44", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Treating the Biochemical Recurrence of Prostate Cancer After Definitive Primary Therapy"], "prefix": "10.3816", "volume": "4", "author": [{"given": "John F.", "family": "Ward", "sequence": "first", "affiliation": []}, {"given": "Judd W.", "family": "Moul", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Clinical Prostate Cancer"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S154003521170097X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S154003521170097X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 5, 13]], "date-time": "2019-05-13T23:00:04Z", "timestamp": 1557788404000}, "score": 39.922283, "issued": {"date-parts": [[2005, 6]]}, "references-count": 58, "journal-issue": {"published-print": {"date-parts": [[2005, 6]]}, "issue": "1"}, "alternative-id": ["S154003521170097X"], "URL": "http://dx.doi.org/10.3816/cgc.2005.n.010", "ISSN": ["1540-0352"], "issn-type": [{"value": "1540-0352", "type": "print"}], "subject": ["Urology", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T16:23:44Z", "timestamp": 1574785424259}, "reference-count": 13, "publisher": "Wiley", "issue": "18", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2017, 5, 23]], "date-time": "2017-05-23T00:00:00Z", "timestamp": 1495497600000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://onlinelibrary.wiley.com/termsAndConditions#vor", "start": {"date-parts": [[2017, 5, 23]], "date-time": "2017-05-23T00:00:00Z", "timestamp": 1495497600000}, "delay-in-days": 0, "content-version": "vor"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer"], "published-print": {"date-parts": [[2017, 9, 15]]}, "DOI": "10.1002/cncr.30779", "type": "journal-article", "created": {"date-parts": [[2017, 5, 24]], "date-time": "2017-05-24T01:06:18Z", "timestamp": 1495587978000}, "page": "3447-3449", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Understanding temporal trends in medical costs associated with progression to metastatic prostate cancer"], "prefix": "10.1002", "volume": "123", "author": [{"ORCID": "http://orcid.org/0000-0002-3571-6610", "authenticated-orcid": false, "given": "Daniel M.", "family": "Frendl", "sequence": "first", "affiliation": [{"name": "Department of Urology, Massachusetts General Hospital; Harvard Medical School; Boston Massachusetts"}]}, {"given": "Aria F.", "family": "Olumi", "sequence": "additional", "affiliation": [{"name": "Department of Urology, Massachusetts General Hospital; Harvard Medical School; Boston Massachusetts"}]}], "member": "311", "published-online": {"date-parts": [[2017, 5, 23]]}, "reference": [{"key": "10.1002/cncr.30779-BIB0001|cncr30779-cit-0001", "unstructured": "Surveillance, Epidemiology, and End Results Program Cancer stat facts: prostate cancer https://seer.cancer.gov/statfacts/html/prost.html 2017"}, {"key": "10.1002/cncr.30779-BIB0002|cncr30779-cit-0002", "doi-asserted-by": "crossref", "first-page": "320", "DOI": "10.1634/theoncologist.2015-0327", "article-title": "The clinical and economic impacts of skeletal-related events among Medicare enrollees with prostate cancer metastatic to bone", "volume": "21", "author": "McDougall", "year": "2016", "journal-title": "Oncologist."}, {"key": "10.1002/cncr.30779-BIB0003|cncr30779-cit-0003", "doi-asserted-by": "crossref", "first-page": "579", "DOI": "10.1093/annonc/mdi122", "article-title": "The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer", "volume": "16", "author": "Weinfurt", "year": "2005", "journal-title": "Ann Oncol."}, {"key": "10.1002/cncr.30779-BIB0004|cncr30779-cit-0004", "doi-asserted-by": "crossref", "first-page": "307", "DOI": "10.1002/pon.572", "article-title": "Prostate cancer and health-related quality of life", "volume": "11", "author": "Eton", "year": "2002", "journal-title": "Psychooncology."}, {"key": "10.1002/cncr.30779-BIB0005|cncr30779-cit-0005", "doi-asserted-by": "crossref", "first-page": "467", "DOI": "10.1016/j.eururo.2013.11.002", "article-title": "EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer", "volume": "65", "author": "Heidenreich", "year": "2014", "journal-title": "Eur Urol."}, {"key": "10.1002/cncr.30779-BIB0006|cncr30779-cit-0006", "doi-asserted-by": "crossref", "first-page": "1028", "DOI": "10.1016/j.eururo.2014.09.032", "article-title": "Survival with newly diagnosed metastatic prostate cancer in the \u201cdocetaxel era\u201d: data from 917 patients in the control arm of the STAMPEDE trial", "volume": "67", "author": "James", "year": "2015", "journal-title": "Eur Urol."}, {"key": "10.1002/cncr.30779-BIB0007|cncr30779-cit-0007", "doi-asserted-by": "crossref", "first-page": "1415", "DOI": "10.1056/NEJMoa1606220", "article-title": "10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer", "volume": "275", "author": "Hamdy", "year": "2016", "journal-title": "N Engl J Med."}, {"key": "10.1002/cncr.30779-BIB0008|cncr30779-cit-0008", "doi-asserted-by": "crossref", "first-page": "2054", "DOI": "10.1001/jama.2015.14905", "article-title": "Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations", "volume": "314", "author": "Jemal", "year": "2016", "journal-title": "JAMA."}, {"key": "10.1002/cncr.30779-BIB0009|cncr30779-cit-0009", "doi-asserted-by": "crossref", "first-page": "26", "DOI": "10.1038/nrurol.2016.251", "article-title": "The effect of the USPSTF PSA screening recommendation on prostate cancer incidence patterns in the USA", "volume": "14", "author": "Fleshner", "year": "2016", "journal-title": "Nat Rev Urol."}, {"key": "10.1002/cncr.30779-BIB0010|cncr30779-cit-0010", "doi-asserted-by": "crossref", "first-page": "120", "DOI": "10.7326/0003-4819-157-2-201207170-00459", "article-title": "Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement", "volume": "157", "author": "Moyer", "year": "2012", "journal-title": "Ann Intern Med."}, {"key": "10.1002/cncr.30779-BIB0011|cncr30779-cit-0011", "doi-asserted-by": "crossref", "first-page": "3591", "DOI": "10.1002/cncr.30784", "article-title": "Impact of subsequent metastases on costs and medical resource use for prostate cancer patients initially diagnosed with localized disease", "volume": "123", "author": "Li", "year": "2017", "journal-title": "Cancer."}, {"key": "10.1002/cncr.30779-BIB0012|cncr30779-cit-0012", "doi-asserted-by": "crossref", "first-page": "80", "DOI": "10.1001/jama.2015.6036", "article-title": "Trends in management for patients with localized prostate cancer, 1990-2013", "volume": "314", "author": "Cooperberg", "year": "2015", "journal-title": "JAMA."}, {"key": "10.1002/cncr.30779-BIB0013|cncr30779-cit-0013", "doi-asserted-by": "crossref", "first-page": "890", "DOI": "10.1001/jamaoncol.2015.6275", "article-title": "Economic analysis of prostate-specific antigen screening and selective treatment strategies", "volume": "2", "author": "Roth", "year": "2017", "journal-title": "JAMA Oncol."}], "container-title": ["Cancer"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.30779", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.30779", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 6]], "date-time": "2018-08-06T04:18:22Z", "timestamp": 1533529102000}, "score": 39.554337, "subtitle": ["Trends in Medical Costs for Prostate Cancer"], "issued": {"date-parts": [[2017, 5, 23]]}, "references-count": 13, "journal-issue": {"published-print": {"date-parts": [[2017, 9, 15]]}, "issue": "18"}, "URL": "http://dx.doi.org/10.1002/cncr.30779", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0008-543X"], "issn-type": [{"value": "0008-543X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T10:16:35Z", "timestamp": 1574417795836}, "reference-count": 10, "publisher": "Elsevier BV", "issue": "1", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2010, 7, 1]], "date-time": "2010-07-01T00:00:00Z", "timestamp": 1277942400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Urology"], "published-print": {"date-parts": [[2010, 7]]}, "DOI": "10.1016/j.eururo.2010.03.004", "type": "journal-article", "created": {"date-parts": [[2010, 3, 15]], "date-time": "2010-03-15T09:43:45Z", "timestamp": 1268646225000}, "page": "20-21", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Reply from Authors re: Jack A. Schalken. Is Urinary Sarcosine Useful to Identify Patients With Significant Prostate Cancer? The Trials and Tribulations of Biomarker Development. Eur Urol 2010;58:19\u201320"], "prefix": "10.1016", "volume": "58", "author": [{"given": "Carsten", "family": "Stephan", "sequence": "first", "affiliation": []}, {"given": "Florian", "family": "Jentzmik", "sequence": "additional", "affiliation": []}, {"given": "Klaus", "family": "Jung", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Urology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0302283810002228?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0302283810002228?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 12]], "date-time": "2018-12-12T16:24:46Z", "timestamp": 1544631886000}, "score": 38.319473, "issued": {"date-parts": [[2010, 7]]}, "references-count": 10, "journal-issue": {"published-print": {"date-parts": [[2010, 7]]}, "issue": "1"}, "alternative-id": ["S0302283810002228"], "URL": "http://dx.doi.org/10.1016/j.eururo.2010.03.004", "ISSN": ["0302-2838"], "issn-type": [{"value": "0302-2838", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T20:20:34Z", "timestamp": 1574454034176}, "reference-count": 10, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2010, 10, 1]], "date-time": "2010-10-01T00:00:00Z", "timestamp": 1285891200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Urology"], "published-print": {"date-parts": [[2010, 10]]}, "DOI": "10.1016/j.eururo.2010.07.032", "type": "journal-article", "created": {"date-parts": [[2010, 8, 7]], "date-time": "2010-08-07T08:44:16Z", "timestamp": 1281170656000}, "page": "e41-e42", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Reply to Amitha K Hewavitharana\u2019s Letter to the Editor re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in Urine After Digital Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours. Eur Urol 2010;58:12\u20138"], "prefix": "10.1016", "volume": "58", "author": [{"given": "Florian", "family": "Jentzmik", "sequence": "first", "affiliation": []}, {"given": "Carsten", "family": "Stephan", "sequence": "additional", "affiliation": []}, {"given": "Klaus", "family": "Jung", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Urology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0302283810006950?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0302283810006950?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 9]], "date-time": "2018-12-09T00:25:49Z", "timestamp": 1544315149000}, "score": 38.319473, "issued": {"date-parts": [[2010, 10]]}, "references-count": 10, "journal-issue": {"published-print": {"date-parts": [[2010, 10]]}, "issue": "4"}, "alternative-id": ["S0302283810006950"], "URL": "http://dx.doi.org/10.1016/j.eururo.2010.07.032", "ISSN": ["0302-2838"], "issn-type": [{"value": "0302-2838", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T15:21:11Z", "timestamp": 1574868071056}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2017, 11, 15]]}, "DOI": "10.1158/1538-7445.newfront17-ia22", "type": "proceedings-article", "created": {"date-parts": [[2017, 12, 1]], "date-time": "2017-12-01T14:38:08Z", "timestamp": 1512139088000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Abstract IA22: Emerging signaling pathways in prostate cancer therapy"], "prefix": "10.1158", "author": [{"given": "Luiz F.", "family": "Zerbini", "sequence": "first", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2017, 11, 14]]}, "event": {"name": "Abstracts: AACR International Conference: New Frontiers in Cancer Research; January 18-22, 2017; Cape Town, South Africa"}, "container-title": ["Prostate Cancer"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.NEWFRONT17-IA22", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T17:58:22Z", "timestamp": 1558202302000}, "score": 37.940212, "issued": {"date-parts": [[2017, 11, 14]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.NEWFRONT17-IA22"], "URL": "http://dx.doi.org/10.1158/1538-7445.newfront17-ia22"}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T19:42:45Z", "timestamp": 1575229365507}, "publisher-location": "Berlin, Boston", "reference-count": 0, "publisher": "DE GRUYTER", "isbn-type": [{"value": "9783110807271", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1515/9783110807271.31", "type": "book-chapter", "created": {"date-parts": [[2013, 5, 30]], "date-time": "2013-05-30T20:45:14Z", "timestamp": 1369946714000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Tumour suppressor genes in prostate cancer"], "prefix": "10.1515", "author": [{"given": "S. F.", "family": "Brewster", "sequence": "first", "affiliation": []}], "member": "374", "container-title": ["Molecular Biology of Prostate Cancer"], "link": [{"URL": "https://www.degruyter.com/view/books/9783110807271/9783110807271.31/9783110807271.31.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 5, 16]], "date-time": "2017-05-16T20:35:11Z", "timestamp": 1494966911000}, "score": 37.940212, "issued": {"date-parts": [[null]]}, "ISBN": ["9783110807271"], "references-count": 0, "URL": "http://dx.doi.org/10.1515/9783110807271.31"}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T19:14:46Z", "timestamp": 1575141286632}, "reference-count": 27, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Current Opinion in Urology"], "published-print": {"date-parts": [[2005, 5]]}, "DOI": "10.1097/01.mou.0000165552.79416.11", "type": "journal-article", "created": {"date-parts": [[2005, 4, 6]], "date-time": "2005-04-06T14:23:31Z", "timestamp": 1112797411000}, "page": "181-186", "source": "Crossref", "is-referenced-by-count": 25, "title": ["Biochemical recurrence after definitive prostate cancer therapy. Part I: Defining and localizing biochemical recurrence of prostate cancer*"], "prefix": "10.1097", "volume": "15", "author": [{"given": "John F", "family": "Ward", "sequence": "first", "affiliation": []}, {"given": "Judd W", "family": "Moul", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Current Opinion in Urology"], "language": "en", "deposited": {"date-parts": [[2019, 2, 10]], "date-time": "2019-02-10T00:19:27Z", "timestamp": 1549757967000}, "score": 37.670727, "subtitle": [""], "issued": {"date-parts": [[2005, 5]]}, "references-count": 27, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.1097/01.mou.0000165552.79416.11", "ISSN": ["0963-0643"], "issn-type": [{"value": "0963-0643", "type": "print"}], "subject": ["Urology"]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T19:14:46Z", "timestamp": 1575141286960}, "reference-count": 59, "publisher": "Ovid Technologies (Wolters Kluwer Health)", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Current Opinion in Urology"], "published-print": {"date-parts": [[2005, 5]]}, "DOI": "10.1097/01.mou.0000165553.17534.e3", "type": "journal-article", "created": {"date-parts": [[2005, 4, 6]], "date-time": "2005-04-06T14:23:31Z", "timestamp": 1112797411000}, "page": "187-195", "source": "Crossref", "is-referenced-by-count": 18, "title": ["Biochemical recurrence after definitive prostate cancer therapy. Part II: Treatment strategies for biochemical recurrence of prostate cancer*"], "prefix": "10.1097", "volume": "15", "author": [{"given": "John F", "family": "Ward", "sequence": "first", "affiliation": []}, {"given": "Judd W", "family": "Moul", "sequence": "additional", "affiliation": []}], "member": "276", "container-title": ["Current Opinion in Urology"], "language": "en", "deposited": {"date-parts": [[2019, 2, 10]], "date-time": "2019-02-10T00:19:50Z", "timestamp": 1549757990000}, "score": 37.670727, "subtitle": [""], "issued": {"date-parts": [[2005, 5]]}, "references-count": 59, "journal-issue": {"issue": "3"}, "URL": "http://dx.doi.org/10.1097/01.mou.0000165553.17534.e3", "ISSN": ["0963-0643"], "issn-type": [{"value": "0963-0643", "type": "print"}], "subject": ["Urology"]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T07:31:18Z", "timestamp": 1574753478798}, "reference-count": 48, "publisher": "Wiley", "issue": "5", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"name": "The Scientific and Technological Research Council of Turkey (TUBITAK)", "award": ["108S051"]}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Prostate"], "published-print": {"date-parts": [[2016, 4]]}, "DOI": "10.1002/pros.23137", "type": "journal-article", "created": {"date-parts": [[2015, 12, 28]], "date-time": "2015-12-28T10:14:37Z", "timestamp": 1451297677000}, "page": "434-444", "source": "Crossref", "is-referenced-by-count": 11, "title": ["The role of ATP-binding cassette transporter genes in the progression of prostate cancer"], "prefix": "10.1002", "volume": "76", "author": [{"given": "Omer F.", "family": "Karatas", "sequence": "first", "affiliation": [{"name": "Department of Molecular Biology and Genetics; Erzurum Technical University; Erzurum Turkey"}]}, {"given": "Esra", "family": "Guzel", "sequence": "additional", "affiliation": [{"name": "Department of Medical Genetics, Cerrahpasa Medical School; Istanbul University; Istanbul Turkey"}, {"name": "Department of Molecular Biology and Genetics; Biruni University; Istanbul Turkey"}]}, {"given": "Mehmet B.", "family": "Duz", "sequence": "additional", "affiliation": [{"name": "Department of Medical Genetics, Cerrahpasa Medical School; Istanbul University; Istanbul Turkey"}]}, {"given": "Michael", "family": "Ittmann", "sequence": "additional", "affiliation": [{"name": "Department of Pathology and Immunology; Baylor College of Medicine; Houston Texas"}, {"name": "Michael E. DeBakey VAMC; Houston Texas"}]}, {"given": "Mustafa", "family": "Ozen", "sequence": "additional", "affiliation": [{"name": "Department of Medical Genetics, Cerrahpasa Medical School; Istanbul University; Istanbul Turkey"}, {"name": "Department of Molecular Biology and Genetics; Biruni University; Istanbul Turkey"}, {"name": "Department of Pathology and Immunology; Baylor College of Medicine; Houston Texas"}]}], "member": "311", "published-online": {"date-parts": [[2015, 12, 28]]}, "reference": [{"issue": "1", "key": "10.1002/pros.23137-BIB0001|pros23137-cit-0001", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.3322/caac.21208", "article-title": "Cancer statistics, 2014", "volume": "64", "author": "Siegel", "year": "2014", "journal-title": "CA Cancer J Clin"}, {"issue": "2", "key": "10.1002/pros.23137-BIB0002|pros23137-cit-0002", "doi-asserted-by": "crossref", "first-page": "162", "DOI": "10.1046/j.1464-410X.2002.2822.x", "article-title": "Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: International comparisons", "volume": "90", "author": "Quinn", "year": "2002", "journal-title": "BJU Int"}, {"issue": "2", "key": "10.1002/pros.23137-BIB0003|pros23137-cit-0003", "doi-asserted-by": "crossref", "first-page": "69", "DOI": "10.3322/caac.20107", "article-title": "Global cancer statistics", "volume": "61", "author": "Jemal", "year": "2011", "journal-title": "CA Cancer J Clin"}, {"issue": "5", "key": "10.1002/pros.23137-BIB0004|pros23137-cit-0004", "doi-asserted-by": "crossref", "first-page": "496", "DOI": "10.1016/j.ejso.2014.02.221", "article-title": "Defining prostate cancer risk after radical prostatectomy", "volume": "40", "author": "Adamis", "year": "2014", "journal-title": "Eur J Surg Oncol"}, {"issue": "4", "key": "10.1002/pros.23137-BIB0005|pros23137-cit-0005", "doi-asserted-by": "crossref", "first-page": "1320", "DOI": "10.1097/01.ju.0000049200.30192.d1", "article-title": "Pretreatment predictors of time to cancer specific death after prostate specific antigen failure", "volume": "169", "author": "D'Amico", "year": "2003", "journal-title": "J Urol"}, {"key": "10.1002/pros.23137-BIB0006|pros23137-cit-0006", "doi-asserted-by": "crossref", "first-page": "146170", "DOI": "10.1155/2014/146170", "article-title": "MicroRNA as new tools for prostate cancer risk assessment and therapeutic intervention: Results from clinical data set and patients' samples", "volume": "2014", "author": "Cannistraci", "year": "2014", "journal-title": "Biomed Res Int"}, {"issue": "2", "key": "10.1002/pros.23137-BIB0007|pros23137-cit-0007", "doi-asserted-by": "crossref", "first-page": "517", "DOI": "10.1016/S0022-5347(05)63946-8", "article-title": "Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer", "volume": "169", "author": "Han", "year": "2003", "journal-title": "J Urol"}, {"issue": "15", "key": "10.1002/pros.23137-BIB0008|pros23137-cit-0008", "doi-asserted-by": "crossref", "first-page": "1498", "DOI": "10.1002/pros.22867", "article-title": "Differential expression of stem cell markers and ABCG2 in recurrent prostate cancer", "volume": "74", "author": "Guzel", "year": "2014", "journal-title": "Prostate"}, {"issue": "6", "key": "10.1002/pros.23137-BIB0009|pros23137-cit-0009", "doi-asserted-by": "crossref", "first-page": "e98675", "DOI": "10.1371/journal.pone.0098675", "article-title": "MiR-1 and miR-133b are differentially expressed in patients with recurrent prostate cancer", "volume": "9", "author": "Karatas", "year": "2014", "journal-title": "PLoS ONE"}, {"issue": "5", "key": "10.1002/pros.23137-BIB0010|pros23137-cit-0010", "doi-asserted-by": "crossref", "first-page": "515", "DOI": "10.2217/pgs.13.26", "article-title": "The expression profile of ATP-binding cassette transporter genes in breast carcinoma", "volume": "14", "author": "Hlavac", "year": "2013", "journal-title": "Pharmacogenomics"}, {"key": "10.1002/pros.23137-BIB0011|pros23137-cit-0011", "doi-asserted-by": "crossref", "first-page": "409", "DOI": "10.1016/S0076-6879(05)00024-8", "article-title": "The genetics of ATP-binding cassette transporters", "volume": "400", "author": "Dean", "year": "2005", "journal-title": "Methods Enzymol"}, {"issue": "9", "key": "10.1002/pros.23137-BIB0012|pros23137-cit-0012", "doi-asserted-by": "crossref", "first-page": "1387", "DOI": "10.1016/j.bbadis.2012.02.009", "article-title": "Peroxisomal ABC transporters: Structure, function and role in disease", "volume": "1822", "author": "Morita", "year": "2012", "journal-title": "Biochim Biophys Acta"}, {"issue": "2", "key": "10.1002/pros.23137-BIB0013|pros23137-cit-0013", "doi-asserted-by": "crossref", "first-page": "147", "DOI": "10.1038/nrc2789", "article-title": "ABC transporters in cancer: More than just drug efflux pumps", "volume": "10", "author": "Fletcher", "year": "2010", "journal-title": "Nat Rev Cancer"}, {"key": "10.1002/pros.23137-BIB0014|pros23137-cit-0014", "doi-asserted-by": "crossref", "first-page": "941876", "DOI": "10.1155/2011/941876", "article-title": "Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis", "volume": "2011", "author": "Morrison", "year": "2011", "journal-title": "J Oncol"}, {"issue": "16", "key": "10.1002/pros.23137-BIB0015|pros23137-cit-0015", "doi-asserted-by": "crossref", "first-page": "1236", "DOI": "10.1093/jnci/djr256", "article-title": "ABCC multidrug transporters in childhood neuroblastoma: Clinical and biological effects independent of cytotoxic drug efflux", "volume": "103", "author": "Henderson", "year": "2011", "journal-title": "J Natl Cancer Inst"}, {"issue": "7", "key": "10.1002/pros.23137-BIB0016|pros23137-cit-0016", "doi-asserted-by": "crossref", "first-page": "dju149", "DOI": "10.1093/jnci/dju149", "article-title": "ABCA transporter gene expression and poor outcome in epithelial ovarian cancer", "volume": "106", "author": "Hedditch", "year": "2014", "journal-title": "J Natl Cancer Inst"}, {"issue": "2", "key": "10.1002/pros.23137-BIB0017|pros23137-cit-0017", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1093/bioinformatics/19.2.295", "article-title": "Matrix2png: A utility for visualizing matrix data", "volume": "19", "author": "Pavlidis", "year": "2003", "journal-title": "Bioinformatics"}, {"issue": "10", "key": "10.1002/pros.23137-BIB0018|pros23137-cit-0018", "doi-asserted-by": "crossref", "first-page": "1119", "DOI": "10.1002/pros.20961", "article-title": "Optimizing molecular signatures for predicting prostate cancer recurrence", "volume": "69", "author": "Sun", "year": "2009", "journal-title": "Prostate"}, {"key": "10.1002/pros.23137-BIB0019|pros23137-cit-0019", "doi-asserted-by": "crossref", "first-page": "64", "DOI": "10.1186/1471-2407-7-64", "article-title": "Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process", "volume": "7", "author": "Chandran", "year": "2007", "journal-title": "BMC Cancer"}, {"issue": "14", "key": "10.1002/pros.23137-BIB0020|pros23137-cit-0020", "doi-asserted-by": "crossref", "first-page": "2790", "DOI": "10.1200/JCO.2004.05.158", "article-title": "Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy", "volume": "22", "author": "Yu", "year": "2004", "journal-title": "J Clin Oncol"}, {"issue": "2", "key": "10.1002/pros.23137-BIB0021|pros23137-cit-0021", "doi-asserted-by": "crossref", "first-page": "187", "DOI": "10.1093/mutage/ger075", "article-title": "The role of ABC transporters in progression and clinical outcome of colorectal cancer", "volume": "27", "author": "Hlavata", "year": "2012", "journal-title": "Mutagenesis"}, {"issue": "5", "key": "10.1002/pros.23137-BIB0022|pros23137-cit-0022", "doi-asserted-by": "crossref", "first-page": "794", "DOI": "10.1111/IGC.0b013e3181a835fc", "article-title": "Relationship between ABCF2 expression and response to chemotherapy or prognosis in clear cell adenocarcinoma of the ovary", "volume": "20", "author": "Tsuda", "year": "2010", "journal-title": "Int J Gynecol Cancer"}, {"issue": "5", "key": "10.1002/pros.23137-BIB0023|pros23137-cit-0023", "doi-asserted-by": "crossref", "first-page": "410", "DOI": "10.1016/j.molonc.2011.07.005", "article-title": "Functional significance of the ATP-binding cassette transporter B6 in hepatocellular carcinoma", "volume": "5", "author": "Polireddy", "year": "2011", "journal-title": "Mol Oncol"}, {"issue": "5", "key": "10.1002/pros.23137-BIB0024|pros23137-cit-0024", "doi-asserted-by": "crossref", "first-page": "1551", "DOI": "10.3892/ijo.2013.1854", "article-title": "ABCB6 mRNA and DNA methylation levels serve as useful biomarkers for prediction of early intrahepatic recurrence of hepatitis C virus-related hepatocellular carcinoma", "volume": "42", "author": "Tsunedomi", "year": "2013", "journal-title": "Int J Oncol"}, {"issue": "13", "key": "10.1002/pros.23137-BIB0025|pros23137-cit-0025", "doi-asserted-by": "crossref", "first-page": "4379", "DOI": "10.1245/s10434-011-2201-6", "article-title": "Increased expression of ABCB6 enhances protoporphyrin IX accumulation and photodynamic effect in human glioma", "volume": "20", "author": "Zhao", "year": "2013", "journal-title": "Ann Surg Oncol"}, {"issue": "8", "key": "10.1002/pros.23137-BIB0026|pros23137-cit-0026", "doi-asserted-by": "crossref", "first-page": "1611", "DOI": "10.4161/cc.20023", "article-title": "Expression of the 49 human ATP binding cassette (ABC) genes in pluripotent embryonic stem cells and in early- and late-stage multipotent mesenchymal stem cells: Possible role of ABC plasma membrane transporters in maintaining human stem cell pluripotency", "volume": "11", "author": "Barbet", "year": "2012", "journal-title": "Cell Cycle"}, {"issue": "4", "key": "10.1002/pros.23137-BIB0027|pros23137-cit-0027", "doi-asserted-by": "crossref", "first-page": "707", "DOI": "10.1097/MPA.0b013e318279b861", "article-title": "Differences in transcript levels of ABC transporters between pancreatic adenocarcinoma and nonneoplastic tissues", "volume": "42", "author": "Mohelnikova-Duchonova", "year": "2013", "journal-title": "Pancreas"}, {"issue": "4", "key": "10.1002/pros.23137-BIB0028|pros23137-cit-0028", "doi-asserted-by": "crossref", "first-page": "696", "DOI": "10.1038/bjc.2014.326", "article-title": "Abcc10 status affects mammary tumour growth, metastasis, and docetaxel treatment response", "volume": "111", "author": "Domanitskaya", "year": "2014", "journal-title": "Br J Cancer"}, {"issue": "3", "key": "10.1002/pros.23137-BIB0029|pros23137-cit-0029", "doi-asserted-by": "crossref", "first-page": "821", "DOI": "10.1002/hep.24682", "article-title": "Adenosine triphosphate-binding cassette transporter genes up-regulation in untreated hepatocellular carcinoma is mediated by cellular microRNAs", "volume": "55", "author": "Borel", "year": "2012", "journal-title": "Hepatology"}, {"issue": "9", "key": "10.1002/pros.23137-BIB0030|pros23137-cit-0030", "doi-asserted-by": "crossref", "first-page": "1829", "DOI": "10.1158/1535-7163.MCT-13-0208", "article-title": "Inhibition of ABCB1 expression overcomes acquired docetaxel resistance in prostate cancer", "volume": "12", "author": "Zhu", "year": "2013", "journal-title": "Mol Cancer Ther"}, {"issue": "2", "key": "10.1002/pros.23137-BIB0031|pros23137-cit-0031", "doi-asserted-by": "crossref", "first-page": "213", "DOI": "10.1002/path.1955", "article-title": "Expression of drug pathway proteins is independent of tumour type", "volume": "209", "author": "Zhang", "year": "2006", "journal-title": "J Pathol"}, {"issue": "Suppl 1", "key": "10.1002/pros.23137-BIB0032|pros23137-cit-0032", "doi-asserted-by": "crossref", "first-page": "S333", "DOI": "10.1007/s12032-010-9686-x", "article-title": "Effect of apoptotic and proliferative indices, P-glycoprotein and survivin expression on prognosis in laryngeal squamous cell carcinoma", "volume": "28", "author": "Li", "year": "2011", "journal-title": "Med Oncol"}, {"key": "10.1002/pros.23137-BIB0033|pros23137-cit-0033", "doi-asserted-by": "crossref", "first-page": "898", "DOI": "10.1186/1471-2164-14-898", "article-title": "Epigenetic regulation of MDR1 gene through post-translational histone modifications in prostate cancer", "volume": "14", "author": "Henrique", "year": "2013", "journal-title": "BMC Genomics"}, {"issue": "6", "key": "10.1002/pros.23137-BIB0034|pros23137-cit-0034", "doi-asserted-by": "crossref", "first-page": "1144", "DOI": "10.1248/bpb.30.1144", "article-title": "Correlation of induction of ATP binding cassette transporter A5 (ABCA5) and ABCB1 mRNAs with differentiation state of human colon tumor", "volume": "30", "author": "Ohtsuki", "year": "2007", "journal-title": "Biol Pharm Bull"}, {"issue": "16", "key": "10.1002/pros.23137-BIB0035|pros23137-cit-0035", "doi-asserted-by": "crossref", "first-page": "3067", "DOI": "10.4161/cc.21476", "article-title": "E2F1 confers anticancer drug resistance by targeting ABC transporter family members and Bcl-2 via the p73/DNp73-miR-205 circuitry", "volume": "11", "author": "Alla", "year": "2012", "journal-title": "Cell Cycle"}, {"issue": "8", "key": "10.1002/pros.23137-BIB0036|pros23137-cit-0036", "doi-asserted-by": "crossref", "first-page": "e41401", "DOI": "10.1371/journal.pone.0041401", "article-title": "Identification of CBX3 and ABCA5 as putative biomarkers for tumor stem cells in osteosarcoma", "volume": "7", "author": "Saini", "year": "2012", "journal-title": "PLoS ONE"}, {"issue": "8", "key": "10.1002/pros.23137-BIB0037|pros23137-cit-0037", "first-page": "387", "article-title": "Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia", "volume": "24", "author": "Zgheib", "year": "2014", "journal-title": "Pharmacogenet Genomics"}, {"issue": "10", "key": "10.1002/pros.23137-BIB0038|pros23137-cit-0038", "doi-asserted-by": "crossref", "first-page": "1323", "DOI": "10.2217/pgs.14.89", "article-title": "Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy", "volume": "15", "author": "Ma", "year": "2014", "journal-title": "Pharmacogenomics"}, {"issue": "6", "key": "10.1002/pros.23137-BIB0039|pros23137-cit-0039", "doi-asserted-by": "crossref", "first-page": "740", "DOI": "10.1111/j.1755-148X.2009.00630.x", "article-title": "Involvement of ABC transporters in melanogenesis and the development of multidrug resistance of melanoma", "volume": "22", "author": "Chen", "year": "2009", "journal-title": "Pigment Cell Melanoma Res"}, {"issue": "4", "key": "10.1002/pros.23137-BIB0040|pros23137-cit-0040", "first-page": "965", "article-title": "Multidrug resistance-associated protein 2 determines the efficacy of cisplatin in patients with hepatocellular carcinoma", "volume": "23", "author": "Korita", "year": "2010", "journal-title": "Oncol Rep"}, {"issue": "1", "key": "10.1002/pros.23137-BIB0041|pros23137-cit-0041", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1046/j.1365-2559.2002.01403.x", "article-title": "Expression of multidrug resistance-associated protein 2 (MRP2) in normal human tissues and carcinomas using tissue microarrays", "volume": "41", "author": "Sandusky", "year": "2002", "journal-title": "Histopathology"}, {"issue": "1-2", "key": "10.1002/pros.23137-BIB0042|pros23137-cit-0042", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1007/s11010-014-2069-4", "article-title": "NOTCH1 signaling promotes chemoresistance via regulating ABCC1 expression in prostate cancer stem cells", "volume": "393", "author": "Liu", "year": "2014", "journal-title": "Mol Cell Biochem"}, {"issue": "12", "key": "10.1002/pros.23137-BIB0043|pros23137-cit-0043", "doi-asserted-by": "crossref", "first-page": "752", "DOI": "10.1080/15216540701736285", "article-title": "Role of the MRP1/ABCC1 multidrug transporter protein in cancer", "volume": "59", "author": "Munoz", "year": "2007", "journal-title": "IUBMB Life"}, {"issue": "Database issue", "key": "10.1002/pros.23137-BIB0044|pros23137-cit-0044", "doi-asserted-by": "crossref", "first-page": "D78", "DOI": "10.1093/nar/gkt1266", "article-title": "MiRTarBase update 2014: An information resource for experimentally validated miRNA-target interactions", "volume": "42", "author": "Hsu", "year": "2014", "journal-title": "Nucleic Acids Res"}, {"issue": "5", "key": "10.1002/pros.23137-BIB0045|pros23137-cit-0045", "doi-asserted-by": "crossref", "first-page": "839", "DOI": "10.1016/j.jbi.2011.05.002", "article-title": "MiRWalk-database: Prediction of possible miRNA binding sites by \u201cwalking\u201d the genes of three genomes", "volume": "44", "author": "Dweep", "year": "2011", "journal-title": "J Biomed Inform"}, {"issue": "1", "key": "10.1002/pros.23137-BIB0046|pros23137-cit-0046", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1016/j.ccr.2010.05.026", "article-title": "Integrative genomic profiling of human prostate cancer", "volume": "18", "author": "Taylor", "year": "2010", "journal-title": "Cancer Cell"}, {"issue": "3", "key": "10.1002/pros.23137-BIB0047|pros23137-cit-0047", "doi-asserted-by": "crossref", "first-page": "811", "DOI": "10.1073/pnas.0304146101", "article-title": "Gene expression profiling identifies clinically relevant subtypes of prostate cancer", "volume": "101", "author": "Lapointe", "year": "2004", "journal-title": "Proc Natl Acad Sci USA"}, {"issue": "1", "key": "10.1002/pros.23137-BIB0048|pros23137-cit-0048", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1038/sj.bjc.6603844", "article-title": "Histone modifications as markers of cancer prognosis: A cellular view", "volume": "97", "author": "Kurdistani", "year": "2007", "journal-title": "Br J Cancer"}], "container-title": ["The Prostate"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.23137", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 9, 3]], "date-time": "2019-09-03T00:11:17Z", "timestamp": 1567469477000}, "score": 37.416344, "subtitle": ["ABC Transporters in Prostate Cancer Progression"], "issued": {"date-parts": [[2015, 12, 28]]}, "references-count": 48, "journal-issue": {"published-print": {"date-parts": [[2016, 4]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.1002/pros.23137", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0270-4137"], "issn-type": [{"value": "0270-4137", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T08:06:19Z", "timestamp": 1574755579506}, "reference-count": 38, "publisher": "Wiley", "issue": "8", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2017, 3, 6]], "date-time": "2017-03-06T00:00:00Z", "timestamp": 1488758400000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://onlinelibrary.wiley.com/termsAndConditions#am", "start": {"date-parts": [[2018, 3, 6]], "date-time": "2018-03-06T00:00:00Z", "timestamp": 1520294400000}, "delay-in-days": 365, "content-version": "am"}, {"URL": "http://onlinelibrary.wiley.com/termsAndConditions#vor", "start": {"date-parts": [[2017, 3, 6]], "date-time": "2017-03-06T00:00:00Z", "timestamp": 1488758400000}, "delay-in-days": 0, "content-version": "vor"}], "funder": [{"DOI": "10.13039/100000005", "name": "U.S. Department of Defense", "doi-asserted-by": "publisher", "award": ["DAMD17-03-2-0052"]}, {"DOI": "10.13039/100000048", "name": "American Cancer Society", "doi-asserted-by": "publisher", "award": ["RSGT-08-008-01-CPHPS"]}, {"DOI": "10.13039/100007338", "name": "Foundation for Barnes-Jewish Hospital", "doi-asserted-by": "publisher", "award": []}, {"name": "Colditz NCI", "award": ["T32190194 (Colditz)"]}, {"name": "Siteman Cancer Center", "award": []}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Prostate"], "published-print": {"date-parts": [[2017, 6]]}, "DOI": "10.1002/pros.23342", "type": "journal-article", "created": {"date-parts": [[2017, 3, 6]], "date-time": "2017-03-06T06:44:43Z", "timestamp": 1488782683000}, "page": "878-887", "source": "Crossref", "is-referenced-by-count": 4, "title": ["The Association of Diabetes and Obesity With Prostate Cancer Progression: HCaP-NC"], "prefix": "10.1002", "volume": "77", "author": [{"ORCID": "http://orcid.org/0000-0002-9024-9461", "authenticated-orcid": false, "given": "Saira", "family": "Khan", "sequence": "first", "affiliation": [{"name": "Division of Public Health Sciences, Department of Surgery; Washington University in St. Louis School of Medicine; St. Louis Missouri"}, {"name": "Department of Epidemiology; Gillings School of Global Public Health; University of North Carolina-Chapel Hill; Chapel Hill North Carolina"}]}, {"given": "Jianwen", "family": "Cai", "sequence": "additional", "affiliation": [{"name": "Department of Biostatistics, Gillings School of Global Public Health; University of North Carolina-Chapel Hill; Chapel Hill North Carolina"}]}, {"given": "Matthew E.", "family": "Nielsen", "sequence": "additional", "affiliation": [{"name": "Department of Epidemiology; Gillings School of Global Public Health; University of North Carolina-Chapel Hill; Chapel Hill North Carolina"}, {"name": "Department of Urology, School of Medicine; University of North Carolina-Chapel Hill; Chapel Hill North Carolina"}, {"name": "School of Medicine, University of North Carolina-Chapel Hill; Lineberger Comprehensive Cancer Center; Chapel Hill North Carolina"}]}, {"given": "Melissa A.", "family": "Troester", "sequence": "additional", "affiliation": [{"name": "Department of Epidemiology; Gillings School of Global Public Health; University of North Carolina-Chapel Hill; Chapel Hill North Carolina"}, {"name": "School of Medicine, University of North Carolina-Chapel Hill; Lineberger Comprehensive Cancer Center; Chapel Hill North Carolina"}]}, {"given": "James L.", "family": "Mohler", "sequence": "additional", "affiliation": [{"name": "Department of Urology, School of Medicine; University of North Carolina-Chapel Hill; Chapel Hill North Carolina"}, {"name": "School of Medicine, University of North Carolina-Chapel Hill; Lineberger Comprehensive Cancer Center; Chapel Hill North Carolina"}, {"name": "Department of Urology; Roswell Park Cancer Institute; Buffalo New York"}, {"name": "Department of Urology; University of Buffalo School of Medicine and Biotechnology; Buffalo New York"}]}, {"given": "Elizabeth T. H.", "family": "Fontham", "sequence": "additional", "affiliation": [{"name": "School of Public Health; Louisiana State University Health Science Center; New Orleans Louisiana"}]}, {"given": "Laura H.", "family": "Hendrix", "sequence": "additional", "affiliation": [{"name": "School of Medicine, University of North Carolina-Chapel Hill; Lineberger Comprehensive Cancer Center; Chapel Hill North Carolina"}]}, {"given": "Laura", "family": "Farnan", "sequence": "additional", "affiliation": [{"name": "School of Medicine, University of North Carolina-Chapel Hill; Lineberger Comprehensive Cancer Center; Chapel Hill North Carolina"}]}, {"given": "Andrew F.", "family": "Olshan", "sequence": "additional", "affiliation": [{"name": "Department of Epidemiology; Gillings School of Global Public Health; University of North Carolina-Chapel Hill; Chapel Hill North Carolina"}, {"name": "School of Medicine, University of North Carolina-Chapel Hill; Lineberger Comprehensive Cancer Center; Chapel Hill North Carolina"}]}, {"given": "Jeannette T.", "family": "Bensen", "sequence": "additional", "affiliation": [{"name": "Department of Epidemiology; Gillings School of Global Public Health; University of North Carolina-Chapel Hill; Chapel Hill North Carolina"}, {"name": "School of Medicine, University of North Carolina-Chapel Hill; Lineberger Comprehensive Cancer Center; Chapel Hill North Carolina"}]}], "member": "311", "published-online": {"date-parts": [[2017, 3, 6]]}, "reference": [{"key": "10.1002/pros.23342-BIB0001|pros23342-cit-0001", "unstructured": "http://seer.cancer.gov/statfacts/html/prost.html"}, {"key": "10.1002/pros.23342-BIB0002|pros23342-cit-0002", "unstructured": "2016"}, {"key": "10.1002/pros.23342-BIB0003|pros23342-cit-0003", "first-page": "14", "article-title": "Management of biochemically recurrent prostate cancer after local therapy: Evolving standards of care and new directions", "volume": "11", "author": "Paller", "year": "2013", "journal-title": "Clin Adv Hematol Oncol"}, {"key": "10.1002/pros.23342-BIB0004|pros23342-cit-0004", "doi-asserted-by": "crossref", "first-page": "204", "DOI": "10.1038/pcan.2013.5", "article-title": "Hyperglycemia and prostate cancer recurrence in men treated for localized prostate cancer", "volume": "16", "author": "Wright", "year": "2013", "journal-title": "Prostate Cancer Prostatic Dis"}, {"key": "10.1002/pros.23342-BIB0005|pros23342-cit-0005", "doi-asserted-by": "crossref", "first-page": "1240", "DOI": "10.1016/j.urology.2010.03.059", "article-title": "Clinical outcomes after radical prostatectomy in diabetic patients treated with metformin", "volume": "76", "author": "Patel", "year": "2010", "journal-title": "Urology"}, {"key": "10.1002/pros.23342-BIB0006|pros23342-cit-0006", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1158/1055-9965.EPI-09-0777", "article-title": "Diabetes and outcomes after radical prostatectomy: Are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database", "volume": "19", "author": "Jayachandran", "year": "2010", "journal-title": "Cancer Epidemiol Biomarkers Prev"}, {"key": "10.1002/pros.23342-BIB0007|pros23342-cit-0007", "doi-asserted-by": "crossref", "first-page": "789", "DOI": "10.1007/s10552-005-3301-z", "article-title": "History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States)", "volume": "16", "author": "Chan", "year": "2005", "journal-title": "Cancer Causes Control"}, {"key": "10.1002/pros.23342-BIB0008|pros23342-cit-0008", "doi-asserted-by": "crossref", "first-page": "486", "DOI": "10.1158/1940-6207.CAPR-10-0229", "article-title": "Body mass index, prostate cancer-specific mortality, and biochemical recurrence: A systematic review and meta-analysis", "volume": "4", "author": "Cao", "year": "2011", "journal-title": "Cancer Prev Res (Phila)"}, {"key": "10.1002/pros.23342-BIB0009|pros23342-cit-0009", "doi-asserted-by": "crossref", "first-page": "82", "DOI": "10.1007/BF02623537", "article-title": "Serum-free growth of adult human prostatic epithelial cells", "volume": "22", "author": "Peehl", "year": "1986", "journal-title": "In Vitro Cell Dev Biol"}, {"key": "10.1002/pros.23342-BIB0010|pros23342-cit-0010", "doi-asserted-by": "crossref", "first-page": "703", "DOI": "10.1007/s10552-008-9133-x", "article-title": "Hormonal profile of diabetic men and the potential link to prostate cancer", "volume": "19", "author": "Kasper", "year": "2008", "journal-title": "Cancer Causes Control"}, {"key": "10.1002/pros.23342-BIB0011|pros23342-cit-0011", "doi-asserted-by": "crossref", "first-page": "76", "DOI": "10.1001/jama.289.1.76", "article-title": "Prevalence of obesity, diabetes, and obesity-related health risk factors 2001", "volume": "289", "author": "Mokdad", "year": "2003", "journal-title": "Jama"}, {"key": "10.1002/pros.23342-BIB0012|pros23342-cit-0012", "doi-asserted-by": "crossref", "first-page": "1670", "DOI": "10.1097/01.ju.0000062674.43964.d0", "article-title": "Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy", "volume": "169", "author": "Massengill", "year": "2003", "journal-title": "J Urol"}, {"key": "10.1002/pros.23342-BIB0013|pros23342-cit-0013", "doi-asserted-by": "crossref", "first-page": "467", "DOI": "10.1007/s11934-007-0050-4", "article-title": "Testosterone, diabetes mellitus, and the metabolic syndrome", "volume": "8", "author": "Spark", "year": "2007", "journal-title": "Curr Urol Rep"}, {"key": "10.1002/pros.23342-BIB0014|pros23342-cit-0014", "doi-asserted-by": "crossref", "first-page": "115", "DOI": "10.1016/j.eururo.2013.08.015", "article-title": "A new era of testosterone and prostate cancer: From physiology to clinical implications", "volume": "65", "author": "Khera", "year": "2014", "journal-title": "Eur Urol"}, {"key": "10.1002/pros.23342-BIB0015|pros23342-cit-0015", "doi-asserted-by": "crossref", "first-page": "824", "DOI": "10.1016/S0022-5347(05)67812-3", "article-title": "Is low serum free testosterone a marker for high grade prostate cancer", "volume": "163", "author": "Hoffman", "year": "2000", "journal-title": "J Urol"}, {"key": "10.1002/pros.23342-BIB0016|pros23342-cit-0016", "doi-asserted-by": "crossref", "first-page": "52", "DOI": "10.1002/pros.1046", "article-title": "High-grade prostate cancer is associated with low serum testosterone levels", "volume": "47", "author": "Schatzl", "year": "2001", "journal-title": "Prostate"}, {"key": "10.1002/pros.23342-BIB0017|pros23342-cit-0017", "first-page": "1601", "article-title": "The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients", "volume": "20", "author": "Dell'Atti", "year": "2015", "journal-title": "J buon"}, {"key": "10.1002/pros.23342-BIB0018|pros23342-cit-0018", "doi-asserted-by": "crossref", "first-page": "1939", "DOI": "10.1016/j.juro.2007.07.021", "article-title": "Association of obesity with tumor characteristics and treatment failure of prostate cancer in African-American and European American men", "volume": "178", "author": "Spangler", "year": "2007", "journal-title": "J Urol"}, {"key": "10.1002/pros.23342-BIB0019|pros23342-cit-0019", "doi-asserted-by": "crossref", "first-page": "5263", "DOI": "10.1002/cncr.24571", "article-title": "Obesity as a predictor of adverse outcome across black and white race: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database", "volume": "115", "author": "Jayachandran", "year": "2009", "journal-title": "Cancer"}, {"key": "10.1002/pros.23342-BIB0020|pros23342-cit-0020", "doi-asserted-by": "crossref", "first-page": "637", "DOI": "10.1080/01635581.2012.676144", "article-title": "Coffee consumption and prostate cancer aggressiveness among African and Caucasian Americans in a population-based study", "volume": "64", "author": "Arab", "year": "2012", "journal-title": "Nutr Cancer"}, {"key": "10.1002/pros.23342-BIB0021|pros23342-cit-0021", "doi-asserted-by": "crossref", "first-page": "2029", "DOI": "10.1002/cncr.29309", "article-title": "Treatment decisional regret among men with prostate cancer: Racial differences and influential factors in the North Carolina health access and prostate cancer treatment project (HCaP-NC)", "volume": "121", "author": "Morris", "year": "2015", "journal-title": "Cancer"}, {"key": "10.1002/pros.23342-BIB0022|pros23342-cit-0022", "unstructured": "http://www.auanet.org/education/guidelines/prostate-specific-antigen.cfm"}, {"key": "10.1002/pros.23342-BIB0023|pros23342-cit-0023", "doi-asserted-by": "crossref", "first-page": "965", "DOI": "10.1016/j.ijrobp.2006.04.029", "article-title": "Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO phoenix consensus conference", "volume": "65", "author": "Roach", "year": "2006", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "10.1002/pros.23342-BIB0024|pros23342-cit-0024", "unstructured": "http://apps.who.int/bmi/index.jsp?introPage\u2009=\u2009intro_3.html"}, {"key": "10.1002/pros.23342-BIB0025|pros23342-cit-0025", "doi-asserted-by": "crossref", "first-page": "1162", "DOI": "10.1002/pros.20449", "article-title": "The North Carolina-Louisiana prostate cancer project (PCaP): Methods and design of a multidisciplinary population-based cohort study of racial differences in prostate cancer outcomes", "volume": "66", "author": "Schroeder", "year": "2006", "journal-title": "Prostate"}, {"key": "10.1002/pros.23342-BIB0026|pros23342-cit-0026", "doi-asserted-by": "crossref", "first-page": "863", "DOI": "10.1097/EDE.0b013e3181ba333c", "article-title": "On the distinction between interaction and effect modification", "volume": "20", "author": "VanderWeele", "year": "2009", "journal-title": "Epidemiology"}, {"key": "10.1002/pros.23342-BIB0027|pros23342-cit-0027", "doi-asserted-by": "crossref", "first-page": "999", "DOI": "10.1007/s00345-013-1171-7", "article-title": "Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer", "volume": "32", "author": "Rieken", "year": "2014", "journal-title": "World J Urol"}, {"key": "10.1002/pros.23342-BIB0028|pros23342-cit-0028", "doi-asserted-by": "crossref", "first-page": "572", "DOI": "10.1097/COC.0b013e31822dfd8a", "article-title": "The impact of diabetes mellitus on survival in men with clinically localized prostate cancer treated with permanent interstitial brachytherapy", "volume": "35", "author": "Shetti", "year": "2012", "journal-title": "Am J Clin Oncol"}, {"key": "10.1002/pros.23342-BIB0029|pros23342-cit-0029", "doi-asserted-by": "crossref", "first-page": "476", "DOI": "10.1002/jso.23677", "article-title": "The feature of metabolic syndrome is a risk factor for biochemical recurrence after radical prostatectomy", "volume": "110", "author": "Shiota", "year": "2014", "journal-title": "J Surg Oncol"}, {"key": "10.1002/pros.23342-BIB0030|pros23342-cit-0030", "doi-asserted-by": "crossref", "first-page": "121", "DOI": "10.1007/s11255-012-0306-x", "article-title": "Diabetes mellitus is associated with short prostate-specific antigen doubling time after radical prostatectomy", "volume": "45", "author": "Oh", "year": "2013", "journal-title": "Int Urol Nephrol"}, {"key": "10.1002/pros.23342-BIB0031|pros23342-cit-0031", "doi-asserted-by": "crossref", "first-page": "821", "DOI": "10.1007/s10552-015-0554-z", "article-title": "The impact of obesity on prostate cancer recurrence observed after exclusion of diabetics", "volume": "26", "author": "Agalliu", "year": "2015", "journal-title": "Cancer Causes Control"}, {"key": "10.1002/pros.23342-BIB0032|pros23342-cit-0032", "doi-asserted-by": "crossref", "first-page": "439", "DOI": "10.1200/JCO.2004.03.132", "article-title": "Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy", "volume": "22", "author": "Amling", "year": "2004", "journal-title": "J Clin Oncol"}, {"key": "10.1002/pros.23342-BIB0033|pros23342-cit-0033", "doi-asserted-by": "crossref", "first-page": "1060", "DOI": "10.1016/j.urology.2005.05.040", "article-title": "Impact of obesity on prostate cancer recurrence after radical prostatectomy: Data from CaPSURE", "volume": "66", "author": "Bassett", "year": "2005", "journal-title": "Urology"}, {"key": "10.1002/pros.23342-BIB0034|pros23342-cit-0034", "doi-asserted-by": "crossref", "first-page": "446", "DOI": "10.1200/JCO.2004.04.181", "article-title": "Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: A report by the Shared Equal Access Regional Cancer Hospital database study group", "volume": "22", "author": "Freedland", "year": "2004", "journal-title": "J Clin Oncol"}, {"key": "10.1002/pros.23342-BIB0035|pros23342-cit-0035", "author": "Rothman", "year": "2008", "edition": "3", "volume-title": "Modern Epidemiology"}, {"key": "10.1002/pros.23342-BIB0036|pros23342-cit-0036", "doi-asserted-by": "crossref", "first-page": "738", "DOI": "10.1093/aje/kws156", "article-title": "Validity and reliability of self-reported diabetes in the atherosclerosis risk in communities study", "volume": "176", "author": "Schneider", "year": "2012", "journal-title": "Am J Epidemiol"}, {"key": "10.1002/pros.23342-BIB0037|pros23342-cit-0037", "unstructured": "http://www.schs.state.nc.us/data/brfss/2014/nc/all/DIABETE3.html"}, {"key": "10.1002/pros.23342-BIB0038|pros23342-cit-0038", "doi-asserted-by": "crossref", "first-page": "1475", "DOI": "10.1007/s10552-016-0828-0", "article-title": "The association of diabetes and obesity with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study", "volume": "27", "author": "Khan", "year": "2016", "journal-title": "Cancer Causes Control"}], "container-title": ["The Prostate"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.23342", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://api.wiley.com/onlinelibrary/chorus/v1/articles/10.1002%2Fpros.23342", "content-type": "application/pdf", "content-version": "am", "intended-application": "syndication"}, {"URL": "http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.23342/fullpdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 14]], "date-time": "2018-08-14T17:21:30Z", "timestamp": 1534267290000}, "score": 36.7217, "subtitle": ["Diabetes, Obesity, and Prostate Cancer Progression"], "issued": {"date-parts": [[2017, 3, 6]]}, "references-count": 38, "journal-issue": {"published-print": {"date-parts": [[2017, 6]]}, "issue": "8"}, "URL": "http://dx.doi.org/10.1002/pros.23342", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0270-4137"], "issn-type": [{"value": "0270-4137", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T16:59:28Z", "timestamp": 1575305968490}, "reference-count": 35, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2005, 9, 1]], "date-time": "2005-09-01T00:00:00Z", "timestamp": 1125532800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Prostate Cancer"], "published-print": {"date-parts": [[2005, 9]]}, "DOI": "10.3816/cgc.2005.n.020", "type": "journal-article", "created": {"date-parts": [[2008, 9, 11]], "date-time": "2008-09-11T01:08:08Z", "timestamp": 1221095288000}, "page": "118-123", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Prostate-Specific Membrane Antigen Vaccines: Naked DNA and Protein Approaches"], "prefix": "10.3816", "volume": "4", "author": [{"given": "Susan F.", "family": "Slovin", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Clinical Prostate Cancer"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1540035211701135?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1540035211701135?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 25]], "date-time": "2018-12-25T23:22:06Z", "timestamp": 1545780126000}, "score": 36.566757, "issued": {"date-parts": [[2005, 9]]}, "references-count": 35, "journal-issue": {"published-print": {"date-parts": [[2005, 9]]}, "issue": "2"}, "alternative-id": ["S1540035211701135"], "URL": "http://dx.doi.org/10.3816/cgc.2005.n.020", "ISSN": ["1540-0352"], "issn-type": [{"value": "1540-0352", "type": "print"}], "subject": ["Urology", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T06:56:32Z", "timestamp": 1574319392241}, "publisher-location": "Dordrecht", "reference-count": 135, "publisher": "Springer Netherlands", "isbn-type": [{"value": "9781402058462", "type": "print"}, {"value": "9781402058479", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1007/978-1-4020-5847-9_5", "type": "book-chapter", "created": {"date-parts": [[2007, 9, 4]], "date-time": "2007-09-04T14:57:11Z", "timestamp": 1188917831000}, "page": "87-109", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Role of Prostaglandin Synthesis and Cyclooxygenase-2 in Prostate Cancer and Metastasis"], "prefix": "10.1007", "author": [{"given": "Alaa F.", "family": "Badawi", "sequence": "first", "affiliation": []}], "member": "297", "reference": [{"key": "5_CR1", "doi-asserted-by": "crossref", "first-page": "453", "DOI": "10.1016/S0090-6980(74)80055-9", "volume": "6", "author": "BM Jaffe", "year": "1974", "unstructured": "Jaffe BM. Prostaglandins and cancer: An update. Prostaglandins 1974, 6:453\u201361.", "journal-title": "Prostaglandins"}, {"key": "5_CR2", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1016/0161-4630(80)90086-5", "volume": "5", "author": "RA Karmali", "year": "1980", "unstructured": "Karmali RA. Prostaglandins and cancer. Review. Prostaglandins 1980, 5:11\u201328.", "journal-title": "Prostaglandins"}, {"key": "5_CR3", "first-page": "5575", "volume": "52", "author": "LJ Marnett", "year": "1992", "unstructured": "Marnett LJ. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 1992, 52:5575\u201389.", "journal-title": "Cancer Res"}, {"key": "5_CR4", "doi-asserted-by": "crossref", "first-page": "234", "DOI": "10.1096/fasebj.11.4.9068612", "volume": "11", "author": "GN Levy", "year": "1997", "unstructured": "Levy. GN. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, colon cancer. FASEB J 1997, 11:234\u201347.", "journal-title": "FASEB J"}, {"key": "5_CR5", "doi-asserted-by": "crossref", "first-page": "5", "DOI": "10.1289/ehp.90885", "volume": "88", "author": "LJ Marnett", "year": "1990", "unstructured": "Marnett LJ. Prostaglandin synthase-mediated metabolism of carcinogens and a potential role for peroxyradicals as positive intermediates. Environ Health Perspect 1990, 88:5\u201312.", "journal-title": "Environ Health Perspect"}, {"key": "5_CR6", "doi-asserted-by": "crossref", "first-page": "6", "DOI": "10.3322/canjclin.48.1.6", "volume": "48", "author": "SH Landis", "year": "1998", "unstructured": "Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin 1998, 48:6\u201329.", "journal-title": "CA Cancer J Clin"}, {"key": "5_CR7", "doi-asserted-by": "crossref", "first-page": "156", "DOI": "10.1177/146642409711700305", "volume": "117", "author": "Anonymous", "year": "1997", "unstructured": "Anonymous. Prostate cancer in the UK. J R Soc Health 1997, 117:156.", "journal-title": "J R Soc Health"}, {"key": "5_CR8", "first-page": "245", "volume": "25", "author": "WL Xie", "year": "1992", "unstructured": "Xie WL, Robertson DL, Simmons DL. Mitogen-inducible prostaglandin G/H synthase: A target for non-steroidal anti-inflammatory drugs. Drug Dev Res 1992, 25:245\u201365.", "journal-title": "Drug Dev Res"}, {"key": "5_CR9", "author": "D Simmons", "first-page": "67", "year": "1991", "unstructured": "Simmons D, Xie W, Chipman JG, Evett GE. Multiple cyclooxygenases: Cloning of a mitogen-inducible form, In: Prostaglandin, Leukotreines, Lipoxins and Paf . Bailey JM, ed., New York: Plenum Press, 1991:67\u201378.", "volume-title": "Prostaglandin, Leukotreines, Lipoxins and Paf", "DOI": "10.1007/978-1-4899-0727-1_8", "doi-asserted-by": "crossref"}, {"key": "5_CR10", "first-page": "156", "volume": "330", "author": "GP O\u2019Neill", "year": "1993", "unstructured": "O\u2019Neill GP, Ford-Hutchinson AW. Expression of mRNA for cyclooxygenase-1 and cyclooxy-genase-2 in human tissue. FEBS Lett 1993, 330:156\u201360.", "journal-title": "FEBS Lett"}, {"key": "5_CR11", "doi-asserted-by": "crossref", "first-page": "787", "DOI": "10.1006/bbrc.1993.1483", "volume": "192", "author": "CJ Smith", "year": "1993", "unstructured": "Smith CJ, Morrow JD, Roberts LJ, Marnett LJ. Differentiation of monocytoid THP-1 cells with phorbol ester induces expression of prostaglandin endoperoxide synthase-1 (COX-1). Biochem Biophys Res Commun 1993, 192:787\u201393.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "5_CR12", "doi-asserted-by": "crossref", "first-page": "8044", "DOI": "10.1074/jbc.270.14.8044", "volume": "270", "author": "JM Samet", "year": "1995", "unstructured": "Samet JM, Fasano MB, Fonteh AN, Chilton FH. Selective induction of prostaglandin G/H synthase I by stem cell factor and dexamethasone in mast cells. J Biol Chem 1995, 270:8044\u20139.", "journal-title": "J Biol Chem"}, {"key": "5_CR13", "doi-asserted-by": "crossref", "first-page": "3239", "DOI": "10.1074/jbc.270.7.3239", "volume": "270", "author": "M Murakami", "year": "1995", "unstructured": "Murakami M, Matsumoto R, Urade Y, Austen KF, Arm JP. C-kit ligand mediates increased expression of cytosolic phospholipase A2, prostaglandin endoperoxide synthase-1, and hematopoietic prostaglandin D2 synthase and increased ige-dependent prostaglandin D2 generation in immature mouse mast cells. J Biol Chem 1995, 270:3239\u201346.", "journal-title": "J Biol Chem"}, {"key": "5_CR14", "doi-asserted-by": "crossref", "first-page": "1412", "DOI": "10.1073/pnas.85.5.1412", "volume": "85", "author": "DL DeWitt", "year": "1988", "unstructured": "DeWitt DL, Smith WL. Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc Natl Acad Sci USA 1988, 85:1412\u20136.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "5_CR15", "first-page": "3550", "volume": "283", "author": "JP Merlie", "year": "1988", "unstructured": "Merlie JP, Fagan D, Mudd J, Needleman P. Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase). J Biol Chem 1988, 283:3550\u20135.", "journal-title": "J Biol Chem"}, {"key": "5_CR16", "doi-asserted-by": "crossref", "first-page": "2304", "DOI": "10.1096/fasebj.5.9.1907252", "volume": "5", "author": "CD Funk", "year": "1991", "unstructured": "Funk CD, Funk LB, Kennedy ME, Pong AS, Fitzgerald CA. Human platelet/ erythroleukemia cell prostaglandin G/H synthase: CDNA cloning, expression, and gene chromosomal assignment. FASEB J 1991, 5:2304\u201312.", "journal-title": "FASEB J"}, {"key": "5_CR17", "doi-asserted-by": "crossref", "first-page": "7384", "DOI": "10.1073/pnas.89.16.7384", "volume": "89", "author": "T Hla", "year": "1992", "unstructured": "Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 1992, 89:7384\u20138.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "5_CR18", "doi-asserted-by": "crossref", "first-page": "563", "DOI": "10.2165/00003495-199753040-00003", "volume": "53", "author": "J-Y Jouzeau", "year": "1997", "unstructured": "Jouzeau J-Y, Terlain B, Abid A, N\u00e9d\u00e9lec E, Netter P. Cyclo-oxygenase isoenzymes: How recent findings affect thinking about nonsteroidal anti-inflammatory drugs. Drugs 1997, 53:563\u201382.", "journal-title": "Drugs"}, {"key": "5_CR19", "doi-asserted-by": "crossref", "first-page": "4888", "DOI": "10.1073/pnas.89.11.4888", "volume": "89", "author": "MK O\u2019Banion", "year": "1992", "unstructured": "O\u2019Banion MK, Winn VD, Young DA. CDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci USA 1992, 89:4888\u201392.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "5_CR20", "first-page": "4338", "volume": "267", "author": "BS Fletcher", "year": "1992", "unstructured": "Fletcher BS, Kujubu DA, Perrin DM, Herschman HR. Structure of the mitogen-inducible TIS 10 gene and demonstration that the TIS 10-encoded protein is a functional prostaglandin G/H synthase. J Biol Chem 1992, 267:4338\u20134.", "journal-title": "J Biol Chem"}, {"key": "5_CR21", "doi-asserted-by": "crossref", "first-page": "493", "DOI": "10.1172/JCI116998", "volume": "93", "author": "RN DuBois", "year": "1994", "unstructured": "DuBois RN, Awad J, Morrow J, 2nd, Roberts U, Bishop PR. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester. J Clin Invest 1994, 93:493\u20138.", "journal-title": "J Clin Invest"}, {"key": "5_CR22", "doi-asserted-by": "crossref", "first-page": "50", "DOI": "10.1111/j.1749-6632.1994.tb52723.x", "volume": "744", "author": "WL Smith", "year": "1994", "unstructured": "Smith WL, Meade EA, DeWitt DL. Interactions of PGH synthase isoenzymes 1 and 2 with NSAIDs. Ann NY Acad Sci 1994, 744:50\u20137.", "journal-title": "Ann NY Acad Sci"}, {"key": "5_CR23", "doi-asserted-by": "crossref", "first-page": "1178", "DOI": "10.1073/pnas.86.4.1178", "volume": "86", "author": "DL Simmons", "year": "1989", "unstructured": "Simmons DL, Levy DB, Yannoni Y, Erikson RL. Identification of a phorbol ester-repressible v-src -inducible gene. Proc Natl Acad Sci USA 1989, 86:1178\u201382.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "5_CR24", "first-page": "10805", "volume": "265", "author": "JA Maier", "year": "1990", "unstructured": "Maier JA, Hla T, Maciag T. Cyclooxygenase is an immediate-early gene induced by interleukin-l in human endothelial cells. J Biol Chem 1990, 265:10805\u20138.", "journal-title": "J Biol Chem"}, {"key": "5_CR25", "first-page": "443", "volume": "3", "author": "RP Ryseck", "year": "1992", "unstructured": "Ryseck RP, Raynoschek C, Macdonald-Bravo H, Dorfman K, Mattei MG, Bravo R. Identification of an immediate early gene, pghs-B, whose protein product has prostaglandin synthase/cyclooxygenase activity. Cell Growth Differ 1992, 3:443\u201350.", "journal-title": "Cell Growth Differ"}, {"key": "5_CR26", "unstructured": "Needleman P, Isakson PC. Selective inhibition of cyclooxygenase 2. Sci Med 1998:26\u201335."}, {"key": "5_CR27", "doi-asserted-by": "crossref", "first-page": "9280", "DOI": "10.1074/jbc.272.14.9280", "volume": "272", "author": "E Wong", "year": "1997", "unstructured": "Wong E, Bayly C, Waterman HL, Riendeau D, Mancini JA. Conversion of prostaglandin G/H synthase-1 into an enzyme sensitive to PGHS-2-selective inhibitors by a double HIS513>arg and ILE523>val mutation. J Biol Chem 1997, 272:9280\u20136.", "journal-title": "J Biol Chem"}, {"key": "5_CR28", "first-page": "179", "volume": "15", "author": "WL Smith", "year": "1995", "unstructured": "Smith WL, DeWitt DL. Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs. Semin Nephrol 1995, 15:179\u201384.", "journal-title": "Semin Nephrol"}, {"key": "5_CR29", "first-page": "22269", "volume": "269", "author": "M Murakami", "year": "1994", "unstructured": "Murakami M, Matsumoto R, Austen KF, Arm JP. Prostaglandin endoperoxide synthase-1 and -2 couple to different transmembrane stimuli to generate prostaglandin D2 in mouse bone marrow-derived mast cells. J Biol Chem 1994, 269:22269\u201375.", "journal-title": "J Biol Chem"}, {"key": "5_CR30", "doi-asserted-by": "crossref", "first-page": "10902", "DOI": "10.1074/jbc.270.18.10902", "volume": "270", "author": "I Morita", "year": "1995", "unstructured": "Morita I, Schindler M, Regier MK, Otto JC, Hon T, DeWitt DL, Smith WL. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J Biol Chem 1995, 270:10902\u20138.", "journal-title": "J Biol Chem"}, {"key": "5_CR31", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.1016/0092-8674(95)90109-4", "volume": "83", "author": "D DeWitt", "year": "1995", "unstructured": "DeWitt D, Smith WL. Yes, but do they still get headaches. Cell 1995, 83:345\u20138.", "journal-title": "Cell"}, {"key": "5_CR32", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1016/0163-7258(92)90012-O", "volume": "53", "author": "TE Eling", "year": "1992", "unstructured": "Eling TE, Curtis JF. Xenobiotic metabolism by prostaglandin H synthase. Pharmacol Ther 1992, 53:261\u201373.", "journal-title": "Pharmacol Ther"}, {"key": "5_CR33", "doi-asserted-by": "crossref", "first-page": "651", "DOI": "10.1081/CNV-120002490", "volume": "20", "author": "AF Badawi", "year": "2002", "unstructured": "Badawi AF, Abadi AA, Habib SL, Mohammed MA, Michael MS. Influence of cigarette smoking on prostaglandin synthesis and cyclooxygenase-2 expression in human urinary bladder cancer. Cancer Invest 2002, 20:651\u2013656.", "journal-title": "Cancer Invest"}, {"key": "5_CR34", "first-page": "6610", "volume": "268", "author": "EA Meade", "year": "1993", "unstructured": "Meade EA, Smith WL, DeWitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993, 268:6610\u20134.", "journal-title": "J Biol Chem"}, {"key": "5_CR35", "first-page": "12572", "volume": "260", "author": "RJ Kulmacz", "year": "1985", "unstructured": "Kulmacz RJ, Lands WEM. Stoichiometry and kinetics of the interaction of prostaglandin H synthase with anti-inflammatory agents. J Biol Chem 1985, 260:12572\u20138.", "journal-title": "J Biol Chem"}, {"key": "5_CR36", "doi-asserted-by": "crossref", "first-page": "11693", "DOI": "10.1073/pnas.90.24.11693", "volume": "90", "author": "JA Mitchell", "year": "1994", "unstructured": "Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1994, 90:11693\u20137.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "5_CR37", "doi-asserted-by": "crossref", "first-page": "4863", "DOI": "10.1073/pnas.72.12.4863", "volume": "72", "author": "LH Rome", "year": "1975", "unstructured": "Rome LH, Lands WEM. Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by anti-inflammatory drugs. Proc Natl Acad Sci USA 1975, 72:4863\u20135.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "5_CR38", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1007/BF01630479", "volume": "44", "author": "JR Vane", "year": "1995", "unstructured": "Vane JR, Botting RM. New insights into the mode of action of anti-inflammatory drugs. Inflamm Res 1995, 44:1\u201310.", "journal-title": "Inflamm Res"}, {"key": "5_CR39", "doi-asserted-by": "crossref", "first-page": "3228", "DOI": "10.1073/pnas.91.8.3228", "volume": "91", "author": "JL Masferrer", "year": "1994", "unstructured": "Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leahy KM, Smith WG et al . Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and nonulcerogenic. Proc Natl Acad Sci USA 1994, 91:3228\u201332.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "5_CR40", "doi-asserted-by": "crossref", "first-page": "55", "DOI": "10.1016/0090-6980(94)90074-4", "volume": "47", "author": "N Futaki", "year": "1994", "unstructured": "Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S, Otoma S. NS-392, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro . Prostaglandins 1994, 47:55\u20139.", "journal-title": "Prostaglandins"}, {"key": "5_CR41", "doi-asserted-by": "crossref", "first-page": "11202", "DOI": "10.1073/pnas.91.23.11202", "volume": "94", "author": "RA Copeland", "year": "1994", "unstructured": "Copeland RA, Williams JM, Giannaras J, Nurnberg S, Covington M, Pinto D et al . Mechanisms of selective inhibition of the inducible form of prostaglandin G/H synthase. Proc Natl Acad Sci USA 1994, 94:11202\u20136.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "5_CR42", "doi-asserted-by": "crossref", "first-page": "R227", "DOI": "10.1152/ajpcell.1998.275.1.C227", "volume": "275", "author": "JA McKanna", "year": "1998", "unstructured": "McKanna JA, Zhang MZ, Wang JL, Cheng H, Harris RC. Constitutive expression of cyclooxygenase-2 in rat vas deferens . Am J Physiol 1998, 275:R227\u201333.", "journal-title": "Am J Physiol"}, {"key": "5_CR43", "doi-asserted-by": "publisher", "first-page": "223", "DOI": "10.1055/s-0029-1210391", "volume": "84", "author": "K Lyson", "year": "1984", "unstructured": "Lyson K. Indomethacin suppression of the estradiol-induced proliferative response of the seminal vesicals. Exp Clin Endocrinol 1984, 84:223\u20137.", "journal-title": "Exp Clin Endocrinol"}, {"key": "5_CR44", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.1002/j.1939-4640.1983.tb00745.x", "volume": "4", "author": "K Lyson", "year": "1983", "unstructured": "Lyson K, Pawlikowski M. Suppression of proliferative response of the seminal vesicles to testosterone by inhibitors of prostaglandin synthesis. Testosterone, indomethacin, and proliferation in seminal vesicles. J Androl 1983, 4:167\u201370.", "journal-title": "J Androl"}, {"key": "5_CR45", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1007/978-1-4899-1813-0_25", "volume": "407", "author": "RR Tjandrawinata", "year": "1997", "unstructured": "Tjandrawinata RR, Hughes-Fulford M. Up-regulation of cyclooxygenase-2 by products-prostaglandin E2. Adv Exp Med Biol 1997, 407:163\u201370.", "journal-title": "Adv Exp Med Biol"}, {"key": "5_CR46", "doi-asserted-by": "crossref", "first-page": "1111", "DOI": "10.1038/bjc.1997.192", "volume": "75", "author": "RR Tjandrawinata", "year": "1997", "unstructured": "Tjandrawinata RR, Dahiya R, Hughes-Fulford M. Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostate carcinoma cells. Br J Cancer 1997, 75:1111\u20138.", "journal-title": "Br J Cancer"}, {"key": "5_CR47", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1016/S0022-5347(01)66009-9", "volume": "156", "author": "FH Faas", "year": "1996", "unstructured": "Faas FH, Dang AQ, Pollard M, Hong XM, Fan K, Luckert PH, Schutz M. Increased phospholipid fatty acid remodeling in human and rat prostatic adenocarcinoma tissues. J Urol 1996, 156:243\u20138.", "journal-title": "J Urol"}, {"key": "5_CR48", "doi-asserted-by": "crossref", "first-page": "493", "DOI": "10.1016/0091-7435(87)90063-6", "volume": "16", "author": "RA Karmali", "year": "1987", "unstructured": "Karmali RA. Eicosanoids in neoplasia. Prev Med 1987, 16:493\u2013502.", "journal-title": "Prev Med"}, {"key": "5_CR49", "first-page": "327", "volume": "6", "author": "RJ Ablin", "year": "1986", "unstructured": "Ablin RJ, Shaw MW. Prostaglandin modulation of prostate tumor growth and metastases. Anticancer Res 1986, 6:327\u20138.", "journal-title": "Anticancer Res"}, {"key": "5_CR50", "doi-asserted-by": "publisher", "first-page": "26", "DOI": "10.1111/j.1464-410X.1982.tb13506.x", "volume": "54", "author": "O Khan", "year": "1982", "unstructured": "Khan O, Hensby CN, Williams G. Prostacyclin in prostatic cancer: A better marker than bone scan or serum acid phosphatase. Br J Urol 1982, 54:26\u201331.", "journal-title": "Br J Urol"}, {"key": "5_CR51", "doi-asserted-by": "publisher", "first-page": "171", "DOI": "10.1159/000280319", "volume": "35", "author": "U Dunzendorfer", "year": "1980", "unstructured": "Dunzendorfer U, Zahradnik HP, Grster K. 13, 14-Dihydro-15-keto-prostaglandin F\n                        2\u03b1 in patients with urogenital tumors. Urol Int 1980, 35:171\u20135.", "journal-title": "Urol Int"}, {"key": "5_CR52", "first-page": "178", "volume": "47", "author": "M Rubenstein", "year": "1987", "unstructured": "Rubenstein M, Shaw MW, McKiel CF, Ray, PS, Guinan. PD. Immunoregulatory markers in rats carrying dunning R3327 H G, or MAT-LYLU prostatic adenocarcinoma variants. Cancer Res 1987, 47:178\u201382.", "journal-title": "Cancer Res"}, {"key": "5_CR53", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1111/j.1600-0897.1985.tb00312.x", "volume": "8", "author": "MW Shaw", "year": "1985", "unstructured": "Shaw MW, Ablin RJ, Ray P, Rubenstein M, Guinan PD, McKiel CF Immunology of the Dunning R-. 3327 Rat prostate adenocarcinoma sublines: Plasma and tumor effusion prostaglandins. Am J Reprod Immunol Microbiol 1985, 8:77\u20139.", "journal-title": "Am J Reprod Immunol Microbiol"}, {"key": "5_CR54", "first-page": "359", "volume": "13", "author": "BI Smith", "year": "1983", "unstructured": "Smith BI, Wills MR, Savory J. Prostaglandins and cancer. Ann Clin Lab Sci 1983, 13:359\u201365.", "journal-title": "Ann Clin Lab Sci"}, {"key": "5_CR55", "doi-asserted-by": "crossref", "first-page": "997", "DOI": "10.1016/S0022-5347(17)54173-7", "volume": "127", "author": "RJ Ablin", "year": "1982", "unstructured": "Ablin RJ. Prostaglandins affect the tumor immune response in prostatic carcinoma. J Urol 1982, 127:997\u20138.", "journal-title": "J Urol"}, {"key": "5_CR56", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1002/pros.2990180306", "volume": "18", "author": "DP Rose", "year": "1991", "unstructured": "Rose DP, Connolly JM. Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines. Prostate 1991, 18:243\u201354.", "journal-title": "Prostate"}, {"key": "5_CR57", "first-page": "391", "volume": "4", "author": "JR Drago", "year": "1984", "unstructured": "Drago JR, AI-Mondhiry HA. The effect of prostaglandin modulators on prostate tumor growth and metastasis. Anticancer Res 1984, 4:391\u20134.", "journal-title": "Anticancer Res"}, {"key": "5_CR58", "doi-asserted-by": "crossref", "first-page": "493", "DOI": "10.1016/0092-8674(95)90127-2", "volume": "83", "author": "M Tsujii", "year": "1995", "unstructured": "Tsujii M, DuBois RN. Alteration in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995, 83:493\u2013501.", "journal-title": "Cell"}, {"key": "5_CR59", "first-page": "4424", "volume": "56", "author": "K Subbaramaiah", "year": "1996", "unstructured": "Subbaramaiah K, Telang N, Ramonetti JT, Araki R, DeVito B, Weksler BB, Dannenberg AJ. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res 1996, 56:4424\u20139.", "journal-title": "Cancer Res"}, {"key": "5_CR60", "first-page": "4245", "volume": "58", "author": "XH Liu", "year": "1998", "unstructured": "Liu XH, Yao S, Kirschenbaum A, Levine AC. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl -2 expression in LNCaP cells. Cancer Res 1998, 58:4245\u20139.", "journal-title": "Cancer Res"}, {"key": "5_CR61", "first-page": "719", "volume": "24", "author": "DK Swan", "year": "1997", "unstructured": "Swan DK, Ford B. Chemoprevention of cancer: Review of literature. Oncol Nutr Forum 1997, 24:719\u201327.", "journal-title": "Oncol Nutr Forum"}, {"key": "5_CR62", "doi-asserted-by": "crossref", "first-page": "511", "DOI": "10.1002/(SICI)1097-0215(19980812)77:4<511::AID-IJC6>3.0.CO;2-X", "volume": "77", "author": "AE Norrish", "year": "1998", "unstructured": "Norrish AE, Jackson RT, McRae CU. Non-steroidal anti-inflammatory drugs and prostate cancer progression. Int J Cancer 1998, 77:511\u20135.", "journal-title": "Int J Cancer"}, {"key": "5_CR63", "first-page": "67", "volume": "51", "author": "C Bucher", "year": "1999", "unstructured": "Bucher C, Jordan P, Nickeleit V, Torhorst J, Mihatsch MJ. Relative risk of malignant tumors in analgesic abusers: Effect of intake of aspirin. Clin Nephrol 1999, 51:67\u201372.", "journal-title": "Clin Nephrol"}, {"key": "5_CR64", "first-page": "176", "volume": "73", "author": "GA Magoha", "year": "1996", "unstructured": "Magoha GA. Ten years experience with chronic prostatitis in africans. East Afr Med J 1996, 73:176\u20138.", "journal-title": "East Afr Med J"}, {"key": "5_CR65", "first-page": "309", "volume": "394", "author": "MC Bosland", "year": "1996", "unstructured": "Bosland MC. Hormonal factors in carcinogenesis of the prostate and testis in human and in animal models. Prog Clin Biol Res 1996, 394:309\u201352.", "journal-title": "Prog Clin Biol Res"}, {"key": "5_CR66", "first-page": "193", "volume": "39", "author": "B Armstrong", "year": "1982", "unstructured": "Armstrong B. Endocrine factors in human carcinogenesis. IARC Sci Publ 1982, 39:193\u2013221.", "journal-title": "IARC Sci Publ"}, {"key": "5_CR67", "first-page": "3232", "volume": "42", "author": "BE Henderson", "year": "1982", "unstructured": "Henderson BE, Ross RK, Pike MC, Casagrande JT. Endogenous hormones as a major factor in human cancer. Cancer Res 1982, 42:3232\u20139.", "journal-title": "Cancer Res"}, {"key": "5_CR68", "first-page": "2", "volume": "18", "author": "LA Rioja", "year": "1991", "unstructured": "Rioja LA, Sanz J. Carcinomas of the prostate: General concepts. Semin Oncol 1991, 18:2\u20138.", "journal-title": "Semin Oncol"}, {"key": "5_CR69", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.1054/mehy.2001.1332", "volume": "57", "author": "AF Badawi", "year": "2001", "unstructured": "Badawi AF, El-Sohemy A. Non-steroidal anti-inflammatory drugs in chemoprevention of breast and prostate cancer. Med Hypoth 2001, 57:167\u20138.", "journal-title": "Med Hypoth"}, {"key": "5_CR70", "doi-asserted-by": "crossref", "first-page": "798", "DOI": "10.1007/BF02535853", "volume": "27", "author": "DP Rose", "year": "1992", "unstructured": "Rose DP, Connolly JM. Dietary fat, fatty acids and prostate cancer. Lipids 1992, 27:798\u2013803.", "journal-title": "Lipids"}, {"key": "5_CR71", "doi-asserted-by": "crossref", "first-page": "1538", "DOI": "10.1093/jnci/85.19.1538", "volume": "85", "author": "KJ Pienta", "year": "1993", "unstructured": "Pienta KJ, Esper PS. Is dietary fat a risk factor for prostate cancer. J Natl Cancer Inst 1993, 85:1538\u201340.", "journal-title": "J Natl Cancer Inst"}, {"key": "5_CR72", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.1016/S0090-6980(98)00049-5", "volume": "56", "author": "AF Badawi", "year": "1998", "unstructured": "Badawi AF, Archer MC. Effect of hormonal status on the expression of the cyclooxygenase 1 and 2 genes and prostaglandin synthesis in rat mammary gland. Prostaglandins Other Lipid Mediat 1998, 56:167\u201381.", "journal-title": "Prostaglandins Other Lipid Mediat"}, {"key": "5_CR73", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1007/978-1-4615-4793-8_18", "volume": "469", "author": "AF Badawi", "year": "1999", "unstructured": "Badawi AF, El-Sohemy A, Stephen LL, Archer MC. Modulation of the expression of cyclooxygenase 1 and 2 genes in the mammary gland: Role of dietary fat and hormonal status. Adv Exp Med Biol 1999, 469:119\u201324.", "journal-title": "Adv Exp Med Biol"}, {"key": "5_CR74", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1007/978-1-4757-2670-1_3", "volume": "422", "author": "MC Archer", "year": "1997", "unstructured": "Archer MC, el-Sohemy A, Stephen LL, Badawi AF. Molecular studies on the role of dietary fat and cholesterol in breast cancer induction. Adv Exp Med Biol 1997, 422:39\u201346.", "journal-title": "Adv Exp Med Biol"}, {"key": "5_CR75", "doi-asserted-by": "crossref", "first-page": "905", "DOI": "10.1093/carcin/19.5.905", "volume": "19", "author": "AF Badawi", "year": "1998", "unstructured": "Badawi AF, El-Sohemy A, Stephen LL, Ghoshal AK, Archer MC. Effects of dietary n-3 and n-6 polyunsaturated fatty acids on the expression of cyclooxygenase-1 and -2 and P21RAS in rat mammary glands. Carcinogenesis 1998, 19:905\u201310.", "journal-title": "Carcinogenesis"}, {"key": "5_CR76", "first-page": "43", "volume": "23", "author": "G Wilding", "year": "1995", "unstructured": "Wilding G. Endocrine control of prostate cancer. Cancer Surv 1995, 23:43\u201362.", "journal-title": "Cancer Surv"}, {"key": "5_CR77", "first-page": "269", "volume": "191", "author": "LA Castagnetta", "year": "1995", "unstructured": "Castagnetta LA, Carruba G. Human prostate cancer: A direct role for estrogens. Ciba Found Symp 1995, 191:269\u201389.", "journal-title": "Ciba Found Symp"}, {"key": "5_CR78", "doi-asserted-by": "crossref", "first-page": "632", "DOI": "10.1023/A:1018454632045", "volume": "8", "author": "LB Signorello", "year": "1997", "unstructured": "Signorello LB, Tzonou A, Mantzoros CS, Lipworth L, Lagiou P, Hsieh C et al . Serum steroids in relation to prostate cancer risk in case-control study (greece). Cancer Causes Control 1997, 8:632\u20136.", "journal-title": "Cancer Causes Control"}, {"key": "5_CR79", "doi-asserted-by": "crossref", "first-page": "57", "DOI": "10.1002/(SICI)1097-0045(1996)6+<57::AID-PROS11>3.0.CO;2-Q", "volume": "6", "author": "JE Montie", "year": "1996", "unstructured": "Montie JE. A glimpse at the future of some endocrine aspects of prostate cancer. Prostate Suppl 1996, 6:57\u201361.", "journal-title": "Prostate Suppl"}, {"key": "5_CR80", "doi-asserted-by": "crossref", "first-page": "780", "DOI": "10.1136/bmj.308.6931.780", "volume": "308", "author": "DP Dearnaley", "year": "1994", "unstructured": "Dearnaley DP. Cancer of the prostate. Br Med J 1994, 308:780\u20134.", "journal-title": "Br Med J"}, {"key": "5_CR81", "doi-asserted-by": "crossref", "first-page": "293", "DOI": "10.1002/jemt.1070300405", "volume": "30", "author": "G Srinivasan", "year": "1995", "unstructured": "Srinivasan G, Campbell E, Bashirelahi N. Androgen, estrogen, and progesterone receptors in normal and aging prostates. Microsc Res Techn 1995, 30:293\u2013304.", "journal-title": "Microsc Res Techn"}, {"key": "5_CR82", "doi-asserted-by": "crossref", "first-page": "467", "DOI": "10.1016/0090-6980(82)90004-1", "volume": "24", "author": "LA Klein", "year": "1982", "unstructured": "Klein LA, Stoff JS, Ellis J. Acute effects of testosterone on serum PG levels in male dogs. Prostaglandins 1982, 24:467\u201373.", "journal-title": "Prostaglandins"}, {"key": "5_CR83", "doi-asserted-by": "crossref", "first-page": "129", "DOI": "10.1210/endo-124-1-129", "volume": "124", "author": "C Gupta", "year": "1989", "unstructured": "Gupta C. The role of prostaglandins in masculine differentiation: Modulation of prostaglandin levels in the differentiating genital tract of the fetal mouse. Endocrinology 1989, 124:129\u201333.", "journal-title": "Endocrinology"}, {"key": "5_CR84", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1016/0303-7207(84)90144-8", "volume": "38", "author": "II Rui", "year": "1984", "unstructured": "Rui II, Gordeladze JO, Gutvik KM, Purvis K. Prolactin desensitizes the prostaglandin el-dependent adenylyl cyclase in the rat prostate gland. Mol Cell Endocrinol 1984, 38:53\u201360.", "journal-title": "Mol Cell Endocrinol"}, {"key": "5_CR85", "doi-asserted-by": "crossref", "first-page": "871", "DOI": "10.5980/jpnjurol1989.82.871", "volume": "82", "author": "K Takai", "year": "1991", "unstructured": "Takai K. Promotional effects of high fat diet on chemical carcinogenesis of the prostate. Japan J Urol 1991, 82:871\u20130.", "journal-title": "Japan J Urol"}, {"key": "5_CR86", "doi-asserted-by": "crossref", "first-page": "489", "DOI": "10.1093/jnci/91.6.489", "volume": "91", "author": "MC Bosland", "year": "1999", "unstructured": "Bosland MC, Oakley-Girvan I, Whittemore AS. Dietary fat, calories, and prostate cancer risk. J Natl Cancer Inst 1999, 91:489\u201391.", "journal-title": "J Natl Cancer Inst"}, {"key": "5_CR87", "doi-asserted-by": "crossref", "first-page": "176", "DOI": "10.1002/ijc.2910570208", "volume": "57", "author": "AA Chaudry", "year": "1994", "unstructured": "Chaudry AA, Wahle KW, McClinton S, Moffat LE. Arachidonic acid metabolism in benign and malignant prostatic tissue in vitro: Effects of fatty acids and cyclooxygenase inhibitors. Int J Cancer 1994, 57:176\u201380.", "journal-title": "Int J Cancer"}, {"key": "5_CR88", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1016/S0002-8223(97)00724-4", "volume": "97", "author": "LH Kuller", "year": "1997", "unstructured": "Kuller LH. Dietary fat and chronic diseases: Epidemiologic overview. J Am Diet Assoc 1997, 97:9\u201315.", "journal-title": "J Am Diet Assoc"}, {"key": "5_CR89", "doi-asserted-by": "crossref", "first-page": "501", "DOI": "10.1016/0005-2760(88)90318-9", "volume": "963", "author": "S Fischer", "year": "1988", "unstructured": "Fischer S, von Schacky C, Schweer H. Prostaglandins E3 and F\n                        3\u03b1 are excreted in human urine after ingestion of n-3 polyunsaturated fatty acids. Biochem Biophys Acta 1988, 963:501\u20138.", "journal-title": "Biochem Biophys Acta"}, {"key": "5_CR90", "first-page": "650", "volume": "33", "author": "RD Nolan", "year": "1988", "unstructured": "Nolan RD, Danilowicz RM, Eling TE. Role of arachidonic acid metabolism in the mitogenic response of balb/c 3T3 fibroblasts to epidermal growth factor. Mol Pharmacol 1988, 33:650\u20136.", "journal-title": "Mol Pharmacol"}, {"key": "5_CR91", "first-page": "21044", "volume": "266", "author": "Y Hakeda", "year": "1991", "unstructured": "Hakeda Y, Harada S, Matsumoto T, Tezuka K, Higashino K, Kodama H et al . Prostaglandin F\n                        2\u03b1 stimulates proliferation of clonal osteoplastic MC3T3-E1 cells by up-regulation of insulin-like growth factor 1 receptors. J Biol Chem 1991, 266:21044\u201350.", "journal-title": "J Biol Chem"}, {"key": "5_CR92", "doi-asserted-by": "crossref", "first-page": "246", "DOI": "10.1172/JCI112283", "volume": "77", "author": "AP Pentland", "year": "1986", "unstructured": "Pentland AP, Needleman P. Modulation of keratinocyte proliferation in vitro by endogenous prostaglandin synthesis. J Clin Invest 1986, 77:246\u201351.", "journal-title": "J Clin Invest"}, {"key": "5_CR93", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1016/0006-2952(96)00181-5", "volume": "52", "author": "R Hanif", "year": "1996", "unstructured": "Hanif R, Pittas A, Feng Y, Koutsos MI, Qiao L, Staiano-Coico L et al . Effects of non-steroidal anti-inflammatory drugs on proliferation and induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol 1996, 52:237\u201345.", "journal-title": "Biochem Pharmacol"}, {"key": "5_CR94", "doi-asserted-by": "crossref", "first-page": "1103", "DOI": "10.1016/0006-291X(78)91697-2", "volume": "84", "author": "G F\u00fcrstenberger", "year": "1987", "unstructured": "F\u00fcrstenberger G, Marks F. Indomethacin inhibition of cell proliferation induced by the phorbol ester TPA is reversed by prostaglandin E2 in mouse epidermis in vivo. Biochem Biophys Res Commun 1987, 84:1103\u20138.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "5_CR95", "unstructured": "F\u00fcrstenberger WC, Marks F. Prostaglandins, epidermal hyperplasia and skin tumor promotion. Arachidonic Acid Metabolism and Tumor Promotion 1985, 49\u201372.", "DOI": "10.1007/978-1-4613-2605-2_4", "doi-asserted-by": "crossref"}, {"key": "5_CR96", "first-page": "708", "volume": "40", "author": "AK Verma", "year": "1980", "unstructured": "Verma AK, Ashendel CL, Boutwell RK. Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 1980, 40:708\u201315.", "journal-title": "Cancer Res"}, {"key": "5_CR97", "author": "G F\u00fcrstenberger", "first-page": "100", "year": "1984", "unstructured": "F\u00fcrstenberger G, Gross M, Marks F. Involvement of prostaglandins in the process of skin tumor promotion. In: Ecosanoids and Cancer. Thaler-Dao H, Crastes de Paulet A, Paoletti R, eds, New York: Raven Press, 1984:91\u2013100.", "volume-title": "Ecosanoids and Cancer"}, {"key": "5_CR98", "doi-asserted-by": "crossref", "first-page": "138", "DOI": "10.1111/1523-1747.ep12492460", "volume": "68", "author": "A Lupulescu", "year": "1977", "unstructured": "Lupulescu A. Cytologic and metabolic effects of prostaglandins on rat skin. J Invest Dermatol 1977, 68:138\u201345.", "journal-title": "J Invest Dermatol"}, {"key": "5_CR99", "doi-asserted-by": "crossref", "first-page": "1365", "DOI": "10.1172/JCI111093", "volume": "72", "author": "PA Craven", "year": "1983", "unstructured": "Craven PA, Saito R, DeRubertis FR. Role of local prostaglandin synthesis in the modulation of proliferative activity of rat colonic epithelium. J Clin Invest 1983, 72:1365\u201375.", "journal-title": "J Clin Invest"}, {"key": "5_CR100", "doi-asserted-by": "crossref", "first-page": "1023", "DOI": "10.1016/S0028-3908(97)00096-8", "volume": "36", "author": "T Kawamura", "year": "1997", "unstructured": "Kawamura T, Akira T, Watanaba M, Kagitani Y. Prostaglandin E1 prevents apoptotic cell death in superficial dorsal horn of rat spinal cord. Neuropharmacology 1997, 36:1023\u201330.", "journal-title": "Neuropharmacology"}, {"key": "5_CR101", "doi-asserted-by": "crossref", "first-page": "1907", "DOI": "10.1046/j.1471-4159.1999.0721907.x", "volume": "72", "author": "T Kawamura", "year": "1999", "unstructured": "Kawamura T, Horie S, Maruyama T, Akira T, Imagawa T, Nakamura N. Prostaglandin E1 transported into cells blocks the apoptotic signals induced by nerve growth factor deprivation. J Neurochem 1999, 72:1907\u20134.", "journal-title": "J Neurochem"}, {"key": "5_CR102", "first-page": "895", "volume": "26", "author": "L Ottonello", "year": "1998", "unstructured": "Ottonello L, Gonella R, Dapino P, Sacchetti C, Dallegri F. Prostaglandin E2 inhibits apoptosis in human neutrophilic polymorphonuclear leukocytes: Role of intracellular cyclic AMP levels. Exp Hematol 1998, 26:895\u2013902.", "journal-title": "Exp Hematol"}, {"key": "5_CR103", "doi-asserted-by": "crossref", "first-page": "240", "DOI": "10.1006/taap.1998.8513", "volume": "152", "author": "B Kroll", "year": "1998", "unstructured": "Kroll B, Kunz S, Tu N, Schwarz LR. Inhibition of transforming growth factor-\u03b21 and UV light-induced apoptosis by prostanoids in primary cultures of rat hepatocytes. Toxicol Appl Pharmacol 1998, 152:240\u201350.", "journal-title": "Toxicol Appl Pharmacol"}, {"key": "5_CR104", "first-page": "362", "volume": "58", "author": "H Sheng", "year": "1998", "unstructured": "Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN. Modulation of apoptosis and bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 1998, 58:362\u20136.", "journal-title": "Cancer Res"}, {"key": "5_CR105", "first-page": "433", "volume": "3", "author": "L Hixson", "year": "1994", "unstructured": "Hixson L, Alberts D, Krutzsch M, Einspahr J, Brendel K, Gross PH et al. Antiproliferative effect of nonsteroidal anti-inflammatory drugs (NSAIDs) against human colon cancer cells. Cancer Epidemiol Biomarker Prev 1994, 3:433\u20138.", "journal-title": "Cancer Epidemiol Biomarker Prev"}, {"key": "5_CR106", "doi-asserted-by": "crossref", "first-page": "7961", "DOI": "10.1073/pnas.92.17.7961", "volume": "92", "author": "S Lu", "year": "1995", "unstructured": "Lu S, Xie W, Reed T, Bradshaw WS, Simmons DL. Nonsteroidal anti-inflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts. Proc Natl Acad Sci USA 1995, 92:7961\u20135.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "5_CR107", "first-page": "2273", "volume": "56", "author": "DJE Elder", "year": "1996", "unstructured": "Elder DJE, Hague A, Hicks DJ, Paraskeva C. Different growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: Enhanced apoptosis in carcinoma and in vitro -transformed adenoma relative to adenoma cell lines. Cancer Res 1996, 56:2273\u20136.", "journal-title": "Cancer Res"}, {"key": "5_CR108", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1002/anr.1780320102", "volume": "32", "author": "SB Abramson", "year": "1989", "unstructured": "Abramson SB, Weissmann G. The mechanisms of action of antiinflammatory drugs. Arthritis Rheum 1989, 32:1\u20139.", "journal-title": "Arthritis Rheum"}, {"key": "5_CR109", "first-page": "8", "volume": "201", "author": "DE Duggan", "year": "1977", "unstructured": "Duggan DE, Hooke HF, Riskley AE, Shen TY, van Arman CG. Identification of the biologically active form of sulindac. J Pharmacol Exp Ther 1977, 201:8\u201313.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "5_CR110", "doi-asserted-by": "crossref", "first-page": "491", "DOI": "10.1172/JCI118060", "volume": "96", "author": "SJ Shiff", "year": "1995", "unstructured": "Shiff SJ, Qiao L, Rigas B. Sulindac sulfide, an aspirin-like compound, inhibits cell proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J Clin Invest 1995, 96:491\u2013503.", "journal-title": "J Clin Invest"}, {"key": "5_CR111", "first-page": "2909", "volume": "57", "author": "GA Piazza", "year": "1997", "unstructured": "Piazza GA, Alberts DS, Hixson LJ, Paranka NS, Li H, Finn T et al. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res 1997, 57:2909\u201315.", "journal-title": "Cancer Res"}, {"key": "5_CR112", "first-page": "3110", "volume": "55", "author": "GA Piazza", "year": "1995", "unstructured": "Piazza GA, Kulchak-Rahm AL, Krutzsch M, Sperl G, Shipp-Puranka N, Gross PH et al. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res 1995, 55:3110\u20136.", "journal-title": "Cancer Res"}, {"key": "5_CR113", "first-page": "1259", "volume": "87", "author": "HJ Thompson", "year": "1995", "unstructured": "Thompson HJ, Briggs S, Paranka NS, Piazza GA, Brendel K, Gross PH et al. Inhibition of mammary carcinogenesis in rats by sulfone metabolite of sulindac. J Natl Cancer Inst 1995, 87:1259\u201360.", "journal-title": "J Natl Cancer Inst"}, {"key": "5_CR114", "first-page": "3579", "volume": "18", "author": "S Battu", "year": "1998", "unstructured": "Battu S, Rigaud M, Beneytout JL. Resistance to apoptosis and cyclooxygenase-2 expression in a human adenocarcinoma cell line HT29CL.19a. Anticancer Res 1998, 18:3579\u201383.", "journal-title": "Anticancer Res"}, {"key": "5_CR115", "first-page": "153", "volume": "44", "author": "O Plescia", "year": "1988", "unstructured": "Plescia O, Racis S. Prostaglandins as physiological immunoregulators. Prog Allergy 1988, 44:153\u201371.", "journal-title": "Prog Allergy"}, {"key": "5_CR116", "doi-asserted-by": "crossref", "first-page": "1719", "DOI": "10.1084/jem.146.6.1719", "volume": "146", "author": "JS Goodwin", "year": "1977", "unstructured": "Goodwin JS, Bankhurst AD, Messner RP. Suppression of human T-cell mitogenesis by prostaglandin; existence of a prostaglandin-producing suppressor cell. J Exp Med 1977, 146:1719\u201334.", "journal-title": "J Exp Med"}, {"key": "5_CR117", "first-page": "71", "volume": "95", "author": "CM Baich", "year": "1984", "unstructured": "Baich CM, Doghert PA, Cloud GA, Tilden AB. Prostaglandin E2-mediated suppression of cellular immunity in colon cancer cancer patients. Surgery 1984, 95:71\u20137.", "journal-title": "Surgery"}, {"key": "5_CR118", "first-page": "2682", "volume": "124", "author": "MJ Brunda", "year": "1980", "unstructured": "Brunda MJ, Heberman RB, Holden HT. Inhibition of murine natural killer cell activity by prostaglandins. J Immunol 1980, 124:2682\u20137.", "journal-title": "J Immunol"}, {"key": "5_CR119", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1016/S0002-9343(84)80086-8", "volume": "77", "author": "JS Goodwin", "year": "1984", "unstructured": "Goodwin JS. Immunological effects of nonsteroidal anti-inflammatory drugs. Am J Med 1984, 77:7\u201315.", "journal-title": "Am J Med"}, {"key": "5_CR120", "doi-asserted-by": "crossref", "first-page": "39", "DOI": "10.1016/0090-6980(78)90200-9", "volume": "63", "author": "WD Cantrow", "year": "1978", "unstructured": "Cantrow WD, Cheuing HT, Sundharadas G. Effects of prostaglandins on the spreading, adhesion and migration of mouse peritoneal macrophages. Prostaglandins 1978, 63:39\u201346.", "journal-title": "Prostaglandins"}, {"key": "5_CR121", "doi-asserted-by": "publisher", "first-page": "812", "DOI": "10.1172/JCI109528", "volume": "64", "author": "RS Bockman", "year": "1972", "unstructured": "Bockman RS. PGE inhibition of T-lymphocyte colony formation. J Clin Invest 1972, 64:812\u201321.", "journal-title": "J Clin Invest"}, {"key": "5_CR122", "doi-asserted-by": "crossref", "first-page": "724", "DOI": "10.1002/ijc.2910150503", "volume": "15", "author": "HR Strausser", "year": "1975", "unstructured": "Strausser HR, Humes JL. Prostaglandin synthesis inhibition: Effect on bone changes and sarcoma tumor induction in BALB/c mice. Int J Cancer 1975, 15:724\u201330.", "journal-title": "Int J Cancer"}, {"key": "5_CR123", "first-page": "117", "volume": "62", "author": "NR Lynch", "year": "1979", "unstructured": "Lynch NR, Salomon JC. Tumor growth inhibition and potentiation of immunotherapy by indomethacin in mice. J Natl Cancer Inst 1979, 62:117\u201321.", "journal-title": "J Natl Cancer Inst"}, {"key": "5_CR124", "first-page": "2973", "volume": "50", "author": "MR Young", "year": "1990", "unstructured": "Young MR, Duffie GP, Lozano Y, Young ME, Wright MA. Association of a functional prostaglandin E2-protein kinase A coupling with responsiveness of metastatic lewis lung carcinoma variants to prostaglandin E2 and to prostaglandin E2-producing nonmetastatic lewis lung carcinoma variants. Cancer Res 1990, 50:2973\u20138.", "journal-title": "Cancer Res"}, {"key": "5_CR125", "doi-asserted-by": "crossref", "first-page": "231", "DOI": "10.1080/004982599238632", "volume": "29", "author": "H Yamazaki", "year": "1999", "unstructured": "Yamazaki H, Shimada T. Effects of arachidonic acid, prostaglandins, retinol, retinoic acid and cholecalciferol on xenobiotic oxidations catalyzed by human cytochrome P450 enzymes. Xenobiotica 1999, 29:231\u201341.", "journal-title": "Xenobiotica"}, {"key": "5_CR126", "doi-asserted-by": "crossref", "first-page": "2991", "DOI": "10.1210/endo.140.7.6801", "volume": "140", "author": "Z Schwartz", "year": "1999", "unstructured": "Schwartz Z, Sylvia VL, Curry D, Luna MH, Dean DD, Boyan BD. Arachidonic acid directly mediates the rapid effects of 24,25-dihydroxyvitamin D3 via protein kinase C and indirectly through prostaglandin production in resting zone chondrocytes. Endocrinol 1999, 140:2991\u20133002.", "journal-title": "Endocrinol"}, {"key": "5_CR127", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1146/annurev.pa.30.040190.000245", "volume": "30", "author": "TE Eling", "year": "1990", "unstructured": "Eling TE, Thompson DC, Foureman GL, Curtis JF, Hughes MF. Prostaglandin H synthase and xenobiotic oxidation. Ann Rev Pharmacol Toxicol 1990, 30:1\u201345.", "journal-title": "Ann Rev Pharmacol Toxicol"}, {"key": "5_CR128", "doi-asserted-by": "crossref", "first-page": "245", "DOI": "10.1016/0009-2797(91)90108-J", "volume": "79", "author": "BJ Smith", "year": "1991", "unstructured": "Smith BJ, Curtis JF, Eling TE. Bioactivation of xenobiotics by prostaglandin H synthetase. Chem Biol Interact 1991, 79:245\u201364.", "journal-title": "Chem Biol Interact"}, {"key": "5_CR129", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1093/carcin/5.1.53", "volume": "5", "author": "G Murasaki", "year": "1984", "unstructured": "Murasaki G, Zenser TV, Davia BB, Cohen SM. Inhibition by aspirin of N-[4-(5-nitro-2-furyl-2-thiazoyl]formamide-induced bladder carcinogenesis. Carcinogenesis 1984, 5:53\u20135.", "journal-title": "Carcinogenesis"}, {"key": "5_CR130", "doi-asserted-by": "crossref", "first-page": "541", "DOI": "10.1093/carcin/8.4.541", "volume": "8", "author": "D Wild", "year": "1987", "unstructured": "Wild, D, Degan GH. Prostaglandin H synthetase-dependent mutagenic activity of heterocyclic aromatic amines of the IQ type. Carcinogenesis 1987, 8:541\u20135.", "journal-title": "Carcinogenesis"}, {"key": "5_CR131", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1002/jcb.240501221", "volume": "16H", "author": "MC Bosland", "year": "1992", "unstructured": "Bosland MC. Animal models for the study of prostate carcinogenesis. J Cell Biochem 1992, 16H:89\u201398.", "journal-title": "J Cell Biochem"}, {"key": "5_CR132", "doi-asserted-by": "crossref", "first-page": "1165", "DOI": "10.1002/1097-0142(19930201)71:3+<1165::AID-CNCR2820711440>3.0.CO;2-U", "volume": "71", "author": "TC Thomson", "year": "1993", "unstructured": "Thomson TC, Truong LD, Timme TL, Kadmon D, McCune BK, Flanders KC et al. Transgenic models for the study of prostate cancer. Cancer 1993, 71:1165\u201371.", "journal-title": "Cancer"}, {"key": "5_CR133", "doi-asserted-by": "crossref", "first-page": "406", "DOI": "10.1038/378406a0", "volume": "378", "author": "JE Dinchuk", "year": "1995", "unstructured": "Dinchuk JE, Car BD, Focht RJ, Johnston JJ, Jaffee BD, Covington MB et al. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 1995, 378:406\u20139.", "journal-title": "Nature"}, {"key": "5_CR134", "doi-asserted-by": "crossref", "first-page": "473", "DOI": "10.1016/0092-8674(95)90125-6", "volume": "83", "author": "SG Morham", "year": "1995", "unstructured": "Morham SG, Langenbach R, Loftin CD, Tiano HF, Vouloumanos N, Jennette JC et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 1995, 83:473\u201382.", "journal-title": "Cell"}, {"key": "5_CR135", "first-page": "199", "volume": "70", "author": "C Waymouth", "year": "1983", "unstructured": "Waymouth C, Coman DR, Ward-Baily PF. Spontaneous tumors of the prostate gland in inbred strains of mice. J Natl Cancer Inst 1983, 70:199\u201320.", "journal-title": "J Natl Cancer Inst"}], "container-title": ["Metastasis of Prostate Cancer", "Cancer Metastasis \u2013 Biology and Treatment"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-4020-5847-9_5", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 23]], "date-time": "2019-02-23T11:13:39Z", "timestamp": 1550920419000}, "score": 35.68549, "issued": {"date-parts": [[null]]}, "ISBN": ["9781402058462", "9781402058479"], "references-count": 135, "URL": "http://dx.doi.org/10.1007/978-1-4020-5847-9_5", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T12:07:34Z", "timestamp": 1574251654195}, "reference-count": 19, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2006, 12, 19]], "date-time": "2006-12-19T00:00:00Z", "timestamp": 1166486400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Prostate Cancer Prostatic Dis"], "published-print": {"date-parts": [[2007, 3]]}, "DOI": "10.1038/sj.pcan.4500926", "type": "journal-article", "created": {"date-parts": [[2006, 12, 19]], "date-time": "2006-12-19T05:58:43Z", "timestamp": 1166507923000}, "page": "72-76", "source": "Crossref", "is-referenced-by-count": 6, "title": ["Apical soft tissue biopsies predict biochemical failure in radical perineal prostatectomy patients with apical cancer involvement"], "prefix": "10.1038", "volume": "10", "author": [{"given": "H R", "family": "K\u00fcbler", "sequence": "first", "affiliation": []}, {"given": "S A", "family": "Szukala", "sequence": "additional", "affiliation": []}, {"given": "J F", "family": "Madden", "sequence": "additional", "affiliation": []}, {"given": "T Y", "family": "Tseng", "sequence": "additional", "affiliation": []}, {"given": "D F", "family": "Paulson", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "Vieweg", "sequence": "additional", "affiliation": []}, {"given": "P", "family": "Dahm", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2006, 12, 19]]}, "reference": [{"key": "BF4500926_CR1", "doi-asserted-by": "publisher", "first-page": "1565", "DOI": "10.1016/S0022-5347(01)67462-7", "volume": "153", "author": "VE Weldon", "year": "1995", "unstructured": "Weldon VE, Tavel FR, Neuwirth H, Cohen R . Patterns of positive specimen margins and detectable prostate specific antigen after radical perineal prostatectomy. J Urol 1995; 153: 1565\u20131569.", "journal-title": "J Urol"}, {"key": "BF4500926_CR2", "doi-asserted-by": "publisher", "first-page": "1166", "DOI": "10.1016/S0022-5347(17)40216-3", "volume": "143", "author": "TA Stamey", "year": "1990", "unstructured": "Stamey TA, Villers AA, McNeal JE, Link PC, Freiha FS . Positive surgical margins at radical prostatectomy: importance of the apical dissection. J Urol 1990; 143: 1166\u20131172; discussion 1172\u20131173.", "journal-title": "J Urol"}, {"key": "BF4500926_CR3", "doi-asserted-by": "publisher", "first-page": "299", "DOI": "10.1016/S0022-5347(01)62881-7", "volume": "160", "author": "JA Wieder", "year": "1998", "unstructured": "Wieder JA, Soloway MS . Incidence, etiology, location, prevention and treatment of positive surgical margins after radical prostatectomy for prostate cancer. J Urol 1998; 160: 299\u2013315.", "journal-title": "J Urol"}, {"key": "BF4500926_CR4", "doi-asserted-by": "publisher", "first-page": "682", "DOI": "10.1016/S0090-4295(99)00204-6", "volume": "54", "author": "C Obek", "year": "1999", "unstructured": "Obek C, Sadek S, Lai S, Civantos F, Rubinowicz D, Soloway MS . Positive surgical margins with radical retropubic prostatectomy: anatomic site-specific pathologic analysis and impact on prognosis. Urology 1999; 54: 682\u2013688.", "journal-title": "Urology"}, {"key": "BF4500926_CR5", "doi-asserted-by": "publisher", "first-page": "2176", "DOI": "10.1016/S0022-5347(01)68189-8", "volume": "158", "author": "T Fesseha", "year": "1997", "unstructured": "Fesseha T, Sakr W, Grignon D, Banerjee M, Wood Jr DP, Pontes JE . Prognostic implications of a positive apical margin in radical prostatectomy specimens. J Urol 1997; 158: 2176\u20132179.", "journal-title": "J Urol"}, {"key": "BF4500926_CR6", "doi-asserted-by": "publisher", "first-page": "1727", "DOI": "10.1016/S0022-5347(01)62394-2", "volume": "160", "author": "F Rabbani", "year": "1998", "unstructured": "Rabbani F, Bastar A, Fair WR . Site specific predictors of positive margins at radical prostatectomy: an argument for risk based modification of technique. J Urol 1998; 160: 1727\u20131733.", "journal-title": "J Urol"}, {"key": "BF4500926_CR7", "doi-asserted-by": "publisher", "first-page": "217", "DOI": "10.1016/S0090-4295(01)01167-0", "volume": "58", "author": "M Soulie", "year": "2001", "unstructured": "Soulie M, Seguin P, Benoit J, Escourrou G, Tollon C, Vazzoler N et al. Impact of a modified apical dissection during radical retropubic prostatectomy on the occurrence of positive surgical margins: a comparative study in 212 patients. Urology 2001; 58: 217\u2013221.", "journal-title": "Urology"}, {"key": "BF4500926_CR8", "doi-asserted-by": "publisher", "first-page": "629", "DOI": "10.1016/j.ucl.2004.04.021", "volume": "31", "author": "JM Holzbeierlein", "year": "2004", "unstructured": "Holzbeierlein JM, Porter II HJ, Thrasher JB . The craft of urologic surgery: modern radical perineal prostatectomy. Urol Clin North Am 2004; 31: 629\u2013641, xi\u2013xii.", "journal-title": "Urol Clin North Am"}, {"key": "BF4500926_CR9", "doi-asserted-by": "publisher", "first-page": "1863", "DOI": "10.1097/01.ju.0000161483.65619.b3", "volume": "173", "author": "DM Janoff", "year": "2005", "unstructured": "Janoff DM, Parra RO . Contemporary appraisal of radical perineal prostatectomy. J Urol 2005; 173: 1863\u20131870.", "journal-title": "J Urol"}, {"key": "BF4500926_CR10", "doi-asserted-by": "publisher", "first-page": "386", "DOI": "10.1016/S0090-4295(02)02255-0", "volume": "61", "author": "L Salomon", "year": "2003", "unstructured": "Salomon L, Anastasiadis AG, Levrel O, Katz R, Saint F, de la Taille A et al. Location of positive surgical margins after retropubic, perineal, and laparoscopic radical prostatectomy for organ-confined prostate cancer. Urology 2003; 61: 386\u2013390.", "journal-title": "Urology"}, {"key": "BF4500926_CR11", "doi-asserted-by": "publisher", "first-page": "1383", "DOI": "10.1016/S0022-5347(01)62543-6", "volume": "160", "author": "L Boccon-Gibod", "year": "1998", "unstructured": "Boccon-Gibod L, Ravery V, Vordos D, Toublanc M, Delmas V, Boccon-Gibod L . Radical prostatectomy for prostate cancer: the perineal approach increases the risk of surgically induced positive margins and capsular incisions. J Urol 1998; 160: 1383\u20131385.", "journal-title": "J Urol"}, {"key": "BF4500926_CR12", "first-page": "847", "volume": "7", "author": "DF Paulson", "year": "1980", "unstructured": "Paulson DF . Radical perineal prostatectomy. Urol Clin North Am 1980; 7: 847\u2013853.", "journal-title": "Urol Clin North Am"}, {"key": "BF4500926_CR13", "author": "DG Bostwick", "first-page": "172", "year": "1998", "unstructured": "Bostwick DG, Foster CS . Examination of radical prostatectomy specimens:therapeutic and prognostic significance. In: Bostwick FA (ed). Pathology of the Prostate. W.B. Saunders: Philadelphia, 1998, pp 172\u2013189.", "volume-title": "Pathology of the Prostate"}, {"key": "BF4500926_CR14", "doi-asserted-by": "publisher", "first-page": "1803", "DOI": "10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9", "volume": "80", "author": "LH Sobin", "year": "1997", "unstructured": "Sobin LH, Fleming ID . TNM classification of malignant tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997; 80: 1803\u20131804.", "journal-title": "Cancer"}, {"key": "BF4500926_CR15", "doi-asserted-by": "publisher", "first-page": "1146", "DOI": "10.1016/S0022-5347(05)66452-X", "volume": "165", "author": "CL Amling", "year": "2001", "unstructured": "Amling CL, Bergstralh EJ, Blute ML, Slezak JM, Zincke H . Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point? J Urol 2001; 165: 1146\u20131151.", "journal-title": "J Urol"}, {"key": "BF4500926_CR16", "doi-asserted-by": "publisher", "first-page": "457", "DOI": "10.1080/01621459.1958.10501452", "volume": "53", "author": "EL Kaplan", "year": "1958", "unstructured": "Kaplan EL, Meier P . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457\u2013481.", "journal-title": "J Am Stat Assoc"}, {"key": "BF4500926_CR17", "first-page": "187", "volume": "34", "author": "DR Cox", "year": "1972", "unstructured": "Cox DR . Regression models and life tables. J Roy Stat Soc 1972; 34: 187\u2013220.", "journal-title": "J Roy Stat Soc"}, {"issue": "6 Part 1", "key": "BF4500926_CR18", "doi-asserted-by": "publisher", "first-page": "1943", "DOI": "10.1016/S0022-5347(05)66247-7", "volume": "165", "author": "O Shah", "year": "2001", "unstructured": "Shah O, Melamed J, Lepor H . Analysis of apical soft tissue margins during radical retropubic prostatectomy. J Urol 2001; 165 (6 Part 1): 1943\u20131948; discussion 1948\u20131949.", "journal-title": "J Urol"}, {"key": "BF4500926_CR19", "doi-asserted-by": "publisher", "first-page": "500", "DOI": "10.1016/S0022-5347(01)61935-9", "volume": "161", "author": "M Ohori", "year": "1999", "unstructured": "Ohori M, Abbas F, Wheeler TM, Kattan MW, Scardino PT, Lerner SP . Pathological features and prognostic significance of prostate cancer in the apical section determined by whole mount histology. J Urol 1999; 161: 500\u2013504.", "journal-title": "J Urol"}], "container-title": ["Prostate Cancer and Prostatic Diseases"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/4500926.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/4500926", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/4500926.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 17]], "date-time": "2019-03-17T09:16:30Z", "timestamp": 1552814190000}, "score": 35.666073, "issued": {"date-parts": [[2006, 12, 19]]}, "references-count": 19, "journal-issue": {"published-print": {"date-parts": [[2007, 3]]}, "issue": "1"}, "alternative-id": ["BF4500926"], "URL": "http://dx.doi.org/10.1038/sj.pcan.4500926", "relation": {"cites": []}, "ISSN": ["1365-7852", "1476-5608"], "issn-type": [{"value": "1365-7852", "type": "print"}, {"value": "1476-5608", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T19:08:42Z", "timestamp": 1574276922147}, "publisher-location": "Totowa, NJ", "reference-count": 200, "publisher": "Humana Press", "isbn-type": [{"value": "9781603272803", "type": "print"}, {"value": "9781603272810", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2009]]}, "DOI": "10.1007/978-1-60327-281-0_10", "type": "book-chapter", "created": {"date-parts": [[2009, 1, 23]], "date-time": "2009-01-23T14:35:11Z", "timestamp": 1232721311000}, "page": "117-180", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Nomograms for Prostate Cancer"], "prefix": "10.1007", "author": [{"given": "Shahrokh F.", "family": "Shariat", "sequence": "first", "affiliation": []}, {"given": "Michael W.", "family": "Kattan", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"issue": "2", "key": "10_CR1", "first-page": "74", "volume": "55", "author": "DM Parkin", "year": "2005", "unstructured": "Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA: a cancer. J Clin 2005;55(2):74\u2013108.", "journal-title": "J Clin"}, {"issue": "1", "key": "10_CR2", "first-page": "43", "volume": "57", "author": "A Jemal", "year": "2007", "unstructured": "Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA: a cancer. J Clin 2007;57(1):43\u201366.", "journal-title": "J Clin"}, {"issue": "1", "key": "10_CR3", "doi-asserted-by": "crossref", "first-page": "169", "DOI": "10.1016/S0090-4295(98)00456-7", "volume": "53", "author": "BJ Miles", "year": "1999", "unstructured": "Miles BJ, Giesler B, Kattan MW. Recall and attitudes in patients with prostate cancer. Urology 1999;53(1):169\u201374.", "journal-title": "Urology"}, {"issue": "1", "key": "10_CR4", "doi-asserted-by": "crossref", "first-page": "72", "DOI": "10.1200/JCO.2001.19.1.72", "volume": "19", "author": "JA Clark", "year": "2001", "unstructured": "Clark JA, Wray NP, Ashton CM. Living with treatment decisions: regrets and quality of life among men treated for metastatic prostate cancer. J Clin Oncol 2001;19(1):72\u201380.", "journal-title": "J Clin Oncol"}, {"issue": "7", "key": "10_CR5", "doi-asserted-by": "crossref", "first-page": "791", "DOI": "10.1097/00001888-199907000-00012", "volume": "74", "author": "AS Elstein", "year": "1999", "unstructured": "Elstein AS. Heuristics and biases: selected errors in clinical reasoning. Acad Med 1999;74(7):791\u20134.", "journal-title": "Acad Med"}, {"issue": "1", "key": "10_CR6", "first-page": "131", "volume": "32", "author": "I Vlaev", "year": "2006", "unstructured": "Vlaev I, Chater N. Game relativity: how context influences strategic decision making. J Exp Psychol 2006;32(1):131\u201349.", "journal-title": "J Exp Psychol"}, {"key": "10_CR7", "author": "M Kattan", "first-page": "5135", "year": "2001", "unstructured": "Kattan M. Expert systems in medicine. In Smelser NJ, Baltes PB eds. International Encyclopedia of the Social and Behavioral Sciences Oxford: Pergamon 2001:5135\u20139.", "volume-title": "International Encyclopedia of the Social and Behavioral Sciences", "DOI": "10.1016/B0-08-043076-7/00556-8", "doi-asserted-by": "crossref"}, {"issue": "3", "key": "10_CR8", "doi-asserted-by": "crossref", "first-page": "733", "DOI": "10.1037/0033-295X.114.3.733", "volume": "114", "author": "RM Hogarth", "year": "2007", "unstructured": "Hogarth RM, Karelaia N. Heuristic and linear models of judgment: matching rules and environments. Psychol Rev 2007;114(3):733\u201358.", "journal-title": "Psychol Rev"}, {"issue": "2", "key": "10_CR9", "first-page": "79", "volume": "20", "author": "MW Kattan", "year": "2002", "unstructured": "Kattan MW. Nomograms. Introduction. Semin Urol Oncol 2002;20(2):79\u201381.", "journal-title": "Semin Urol Oncol"}, {"issue": "6", "key": "10_CR10", "doi-asserted-by": "crossref", "first-page": "1929", "DOI": "10.1016/S0022-5347(05)66921-2", "volume": "164", "author": "F Rabbani", "year": "2000", "unstructured": "Rabbani F, Stapleton AM, Kattan MW, Wheeler TM, Scardino PT. Factors predicting recovery of erections after radical prostatectomy. J Urol 2000;164(6):1929\u201334.", "journal-title": "J Urol"}, {"issue": "2", "key": "10_CR11", "doi-asserted-by": "crossref", "first-page": "82", "DOI": "10.1053/suro.2002.32490", "volume": "20", "author": "PL Ross", "year": "2002", "unstructured": "Ross PL, Gerigk C, Gonen M, et al. Comparisons of nomograms and urologists\u2019 predictions in prostate cancer. Semin Urol Oncol 2002;20(2):82\u20138.", "journal-title": "Semin Urol Oncol"}, {"issue": "5", "key": "10_CR12", "doi-asserted-by": "crossref", "first-page": "1562", "DOI": "10.1016/S0022-5347(05)66349-5", "volume": "165", "author": "PL Ross", "year": "2001", "unstructured": "Ross PL, Scardino PT, Kattan MW. A catalog of prostate cancer nomograms. J Urol 2001;165(5):1562\u20138.", "journal-title": "J Urol"}, {"issue": "5", "key": "10_CR13", "doi-asserted-by": "crossref", "first-page": "1499", "DOI": "10.1200/JCO.1999.17.5.1499", "volume": "17", "author": "MW Kattan", "year": "1999", "unstructured": "Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 1999;17(5):1499\u2013507.", "journal-title": "J Clin Oncol"}, {"issue": "10", "key": "10_CR14", "doi-asserted-by": "crossref", "first-page": "766", "DOI": "10.1093/jnci/90.10.766", "volume": "90", "author": "MW Kattan", "year": "1998", "unstructured": "Kattan MW, Eastham JA, Stapleton AM, Wheeler TM, Scardino PT. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 1998;90(10):766\u201371.", "journal-title": "J Natl Cancer Inst"}, {"issue": "6 Pt 1", "key": "10_CR15", "doi-asserted-by": "crossref", "first-page": "2096", "DOI": "10.1016/S0022-5347(01)62251-1", "volume": "160", "author": "AV D\u2019Amico", "year": "1998", "unstructured": "D\u2019Amico AV, Whittington R, Malkowicz SB, et al. The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancer. J Urol 1998;160(6 Pt 1):2096\u2013101.", "journal-title": "J Urol"}, {"issue": "3", "key": "10_CR16", "doi-asserted-by": "crossref", "first-page": "581", "DOI": "10.1016/S0360-3016(02)02797-9", "volume": "53", "author": "AV D\u2019Amico", "year": "2002", "unstructured": "D\u2019Amico AV, Keshaviah A, Manola J, et al. Clinical utility of the percentage of positive prostate biopsies in predicting prostate cancer-specific and overall survival after radiotherapy for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 2002;53(3):581\u20137.", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"issue": "1", "key": "10_CR17", "doi-asserted-by": "crossref", "first-page": "168", "DOI": "10.1200/JCO.1999.17.1.168", "volume": "17", "author": "AV D\u2019Amico", "year": "1999", "unstructured": "D\u2019Amico AV, Whittington R, Malkowicz SB, et al. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. J Clin Oncol 1999;17(1):168\u201372.", "journal-title": "J Clin Oncol"}, {"issue": "4", "key": "10_CR18", "doi-asserted-by": "crossref", "first-page": "572", "DOI": "10.1016/S0090-4295(99)00479-3", "volume": "55", "author": "AV D\u2019Amico", "year": "2000", "unstructured": "D\u2019Amico AV, Whittington R, Malkowicz SB, et al. Combination of the preoperative PSA level, biopsy Gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer. Urology 2000;55(4):572\u20137.", "journal-title": "Urology"}, {"issue": "5 Pt 2", "key": "10_CR19", "doi-asserted-by": "crossref", "first-page": "1923", "DOI": "10.1016/S0022-5347(17)32416-3", "volume": "152", "author": "PB Snow", "year": "1994", "unstructured": "Snow PB, Smith DS, Catalona WJ. Artificial neural networks in the diagnosis and prognosis of prostate cancer: a pilot study. J Urol 1994;152(5 Pt 2):1923\u20136.", "journal-title": "J Urol"}, {"issue": "2", "key": "10_CR20", "first-page": "118", "volume": "9", "author": "AW Partin", "year": "1997", "unstructured": "Partin AW, Kattan MW, Subong EN, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update [see comments] [published erratum appears in JAMA 1997 Jul 9;278(2):118]. Jama 1997;277(18):1445\u201351.", "journal-title": "Jama"}, {"issue": "6", "key": "10_CR21", "doi-asserted-by": "crossref", "first-page": "1095", "DOI": "10.1016/j.urology.2007.03.042", "volume": "69", "author": "DV Makarov", "year": "2007", "unstructured": "Makarov DV, Trock BJ, Humphreys EB, et al. Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005. Urology 2007;69(6):1095\u2013101.", "journal-title": "Urology"}, {"issue": "2 Pt 1", "key": "10_CR22", "doi-asserted-by": "crossref", "first-page": "521", "DOI": "10.1016/S0022-5347(01)69077-3", "volume": "167", "author": "S Conrad", "year": "2002", "unstructured": "Conrad S, Graefen M, Pichlmeier U, et al. Prospective validation of an algorithm with systematic sextant biopsy to predict pelvic lymph node metastasis in patients with clinically localized prostatic carcinoma. J Urol 2002;167(2 Pt 1):521\u20135.", "journal-title": "J Urol"}, {"issue": "3", "key": "10_CR23", "doi-asserted-by": "crossref", "first-page": "857", "DOI": "10.1016/S0022-5347(05)66544-5", "volume": "165", "author": "M Graefen", "year": "2001", "unstructured": "Graefen M, Haese A, Pichlmeier U, et al. A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy. J Urol 2001;165(3):857\u201363.", "journal-title": "J Urol"}, {"key": "10_CR24", "unstructured": "Bradley EaT, R.J. Monographs on statistics and applied probability: an introduction to the bootstrap: Champman and Hall/CRC; 1993."}, {"issue": "6 Pt 2", "key": "10_CR25", "first-page": "S6", "volume": "170", "author": "MW Kattan", "year": "2003", "unstructured": "Kattan MW. Comparison of Cox regression with other methods for determining prediction models and nomograms. J Urol 2003;170(6 Pt 2):S6\u20139; discussion S10.", "journal-title": "J Urol"}, {"issue": "5", "key": "10_CR26", "doi-asserted-by": "crossref", "first-page": "441", "DOI": "10.1016/S0895-4356(03)00047-7", "volume": "56", "author": "EW Steyerberg", "year": "2003", "unstructured": "Steyerberg EW, Bleeker SE, Moll HA, Grobbee DE, Moons KG. Internal and external validation of predictive models: a simulation study of bias and precision in small samples. J Clin Epidemiol 2003;56(5):441\u20137.", "journal-title": "J Clin Epidemiol"}, {"issue": "8", "key": "10_CR27", "doi-asserted-by": "crossref", "first-page": "774", "DOI": "10.1016/S0895-4356(01)00341-9", "volume": "54", "author": "EW Steyerberg", "year": "2001", "unstructured": "Steyerberg EW, Harrell FE, Jr., Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001;54(8):774\u201381.", "journal-title": "J Clin Epidemiol"}, {"issue": "3", "key": "10_CR28", "doi-asserted-by": "crossref", "first-page": "349", "DOI": "10.1177/0272989X9801800314", "volume": "18", "author": "EW Steyerberg", "year": "1998", "unstructured": "Steyerberg EW, Harrell FE, Jr., Goodman PH. Neural networks, logistic regression, and calibration. Med Decis Making 1998;18(3):349\u201350.", "journal-title": "Med Decis Making"}, {"issue": "1", "key": "10_CR29", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1016/j.juro.2006.08.068", "volume": "177", "author": "EW Steyerberg", "year": "2007", "unstructured": "Steyerberg EW, Roobol MJ, Kattan MW, van der Kwast TH, de Koning HJ, Schroder FH. Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram. J Urol 2007;177(1):107\u201312; discussion 12.", "journal-title": "J Urol"}, {"issue": "3", "key": "10_CR30", "doi-asserted-by": "crossref", "first-page": "528", "DOI": "10.1111/j.1464-410X.2007.07005.x", "volume": "100", "author": "A Briganti", "year": "2007", "unstructured": "Briganti A, Shariat SF, Chun FK, et al. Differences in the rate of lymph node invasion in men with clinically localized prostate cancer might be related to the continent of origin. BJU Int 2007;100(3):528\u201332.", "journal-title": "BJU Int"}, {"issue": "12", "key": "10_CR31", "doi-asserted-by": "crossref", "first-page": "2155", "DOI": "10.1001/archinte.1987.00370120091016", "volume": "147", "author": "ME Charlson", "year": "1987", "unstructured": "Charlson ME, Ales KL, Simon R, MacKenzie CR. Why predictive indexes perform less well in validation studies. Is it magic or methods? Arch Intern Med 1987;147(12):2155\u201361.", "journal-title": "Arch Intern Med"}, {"issue": "4", "key": "10_CR32", "doi-asserted-by": "crossref", "first-page": "361", "DOI": "10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4", "volume": "15", "author": "FE Harrell Jr", "year": "1996", "unstructured": "Harrell FE, Jr., Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15(4):361\u201387.", "journal-title": "Stat Med"}, {"issue": "6", "key": "10_CR33", "doi-asserted-by": "crossref", "first-page": "515", "DOI": "10.7326/0003-4819-130-6-199903160-00016", "volume": "130", "author": "AC Justice", "year": "1999", "unstructured": "Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Ann Intern Med 1999;130(6):515\u201324.", "journal-title": "Ann Intern Med"}, {"issue": "4", "key": "10_CR34", "doi-asserted-by": "crossref", "first-page": "783", "DOI": "10.1111/j.1464-410X.2006.06388.x", "volume": "98", "author": "BV Yanke", "year": "2006", "unstructured": "Yanke BV, Carver BS, Bianco FJ, Jr., et al. African-American race is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram. BJU Int 2006;98(4):783\u20137.", "journal-title": "BJU Int"}, {"issue": "1", "key": "10_CR35", "doi-asserted-by": "crossref", "first-page": "131", "DOI": "10.1016/j.urology.2005.07.040", "volume": "67", "author": "H Suzuki", "year": "2006", "unstructured": "Suzuki H, Komiya A, Kamiya N, et al. Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients. Urology 2006;67(1):131\u20136.", "journal-title": "Urology"}, {"issue": "4", "key": "10_CR36", "doi-asserted-by": "crossref", "first-page": "709", "DOI": "10.1016/S0090-4295(99)00213-7", "volume": "54", "author": "JA Eastham", "year": "1999", "unstructured": "Eastham JA, May R, Robertson JL, Sartor O, Kattan MW. Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4\u00a0ng/mL. Urology 1999;54(4):709\u201313.", "journal-title": "Urology"}, {"issue": "7", "key": "10_CR37", "doi-asserted-by": "crossref", "first-page": "1417", "DOI": "10.1002/cncr.11668", "volume": "98", "author": "M Garzotto", "year": "2003", "unstructured": "Garzotto M, Hudson RG, Peters L, et al. Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels < or = 10\u00a0ng/mL. Cancer 2003;98(7):1417\u201322.", "journal-title": "Cancer"}, {"issue": "5", "key": "10_CR38", "doi-asserted-by": "crossref", "first-page": "831", "DOI": "10.1016/S0090-4295(02)01882-4", "volume": "60", "author": "CR Porter", "year": "2002", "unstructured": "Porter CR, O\u2019Donnell C, Crawford ED, et al. Predicting the outcome of prostate biopsy in a racially diverse population: a prospective study. Urology 2002;60(5):831\u20135.", "journal-title": "Urology"}, {"issue": "2", "key": "10_CR39", "first-page": "60", "volume": "6", "author": "EJ Gamito", "year": "2000", "unstructured": "Gamito EJ, Stone NN, Batuello JT, Crawford ED. Use of artificial neural networks in the clinical staging of prostate cancer: implications for prostate brachytherapy. Tech urol 2000;6(2):60\u20133.", "journal-title": "Tech urol"}, {"issue": "4", "key": "10_CR40", "doi-asserted-by": "crossref", "first-page": "1513", "DOI": "10.1097/01.ju.0000117975.40782.95", "volume": "171", "author": "A Tewari", "year": "2004", "unstructured": "Tewari A, Johnson CC, Divine G, et al. Long-term survival probability in men with clinically localized prostate cancer: a case-control, propensity modeling study stratified by race, age, treatment and comorbidities. J Urol 2004;171(4):1513\u20139.", "journal-title": "J Urol"}, {"issue": "5", "key": "10_CR41", "doi-asserted-by": "crossref", "first-page": "952", "DOI": "10.1002/(SICI)1097-0142(19970301)79:5<952::AID-CNCR12>3.0.CO;2-1", "volume": "79", "author": "JJ Bauer", "year": "1997", "unstructured": "Bauer JJ, Connelly RR, Sesterhenn IA, et al. Biostatistical modeling using traditional variables and genetic biomarkers for predicting the risk of prostate carcinoma recurrence after radical prostatectomy. Cancer 1997;79(5):952\u201362.", "journal-title": "Cancer"}, {"issue": "4", "key": "10_CR42", "doi-asserted-by": "crossref", "first-page": "951", "DOI": "10.1200/JCO.2002.20.4.951", "volume": "20", "author": "M Graefen", "year": "2002", "unstructured": "Graefen M, Karakiewicz PI, Cagiannos I, et al. Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer. J Clin Oncol 2002;20(4):951\u20136.", "journal-title": "J Clin Oncol"}, {"issue": "15", "key": "10_CR43", "doi-asserted-by": "crossref", "first-page": "3206", "DOI": "10.1200/JCO.2002.12.019", "volume": "20", "author": "M Graefen", "year": "2002", "unstructured": "Graefen M, Karakiewicz PI, Cagiannos I, et al. International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. J Clin Oncol 2002;20(15):3206\u201312.", "journal-title": "J Clin Oncol"}, {"issue": "4", "key": "10_CR44", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1016/S1078-1439(02)00177-1", "volume": "7", "author": "M Graefen", "year": "2002", "unstructured": "Graefen M, Karakiewicz PI, Cagiannos I, et al. A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men. Urol Oncol 2002;7(4):141\u20136.", "journal-title": "Urol Oncol"}, {"issue": "22", "key": "10_CR45", "doi-asserted-by": "crossref", "first-page": "6663", "DOI": "10.1158/1078-0432.CCR-06-0372", "volume": "12", "author": "SF Shariat", "year": "2006", "unstructured": "Shariat SF, Karakiewicz PI, Palapattu GS, et al. Nomograms provide improved accuracy for predicting survival after radical cystectomy. Clin Cancer Res 2006;12(22):6663\u201376.", "journal-title": "Clin Cancer Res"}, {"issue": "2", "key": "10_CR46", "doi-asserted-by": "crossref", "first-page": "111", "DOI": "10.1097/00042307-200303000-00005", "volume": "13", "author": "MW Kattan", "year": "2003", "unstructured": "Kattan MW. Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer. Curr Opin Urol 2003;13(2):111\u20136.", "journal-title": "Curr Opin Urol"}, {"issue": "19", "key": "10_CR47", "doi-asserted-by": "crossref", "first-page": "3573", "DOI": "10.1200/JCO.2003.12.037", "volume": "21", "author": "MW Kattan", "year": "2003", "unstructured": "Kattan MW, Shariat SF, Andrews B, et al. The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer. J Clin Oncol 2003;21(19):3573\u20139.", "journal-title": "J Clin Oncol"}, {"issue": "5", "key": "10_CR48", "doi-asserted-by": "crossref", "first-page": "1236", "DOI": "10.1016/j.eururo.2006.07.021", "volume": "51", "author": "FK Chun", "year": "2007", "unstructured": "Chun FK, Graefen M, Briganti A, et al. Initial biopsy outcome prediction \u2013 head-to-head comparison of a logistic regression-based nomogram versus artificial neural network. Eur Urol 2007;51(5):1236\u201340; discussion 41\u20133.", "journal-title": "Eur Urol"}, {"issue": "4", "key": "10_CR49", "doi-asserted-by": "crossref", "first-page": "794", "DOI": "10.1111/j.1464-410X.2006.06694.x", "volume": "99", "author": "FK Chun", "year": "2007", "unstructured": "Chun FK, Karakiewicz PI, Briganti A, et al. A critical appraisal of logistic regression-based nomograms, artificial neural networks, classification and regression-tree models, look-up tables and risk-group stratification models for prostate cancer. BJU Int 2007;99(4):794\u2013800.", "journal-title": "BJU Int"}, {"issue": "15", "key": "10_CR50", "doi-asserted-by": "crossref", "first-page": "1138", "DOI": "10.1056/NEJMsa011788", "volume": "346", "author": "CB Begg", "year": "2002", "unstructured": "Begg CB, Riedel ER, Bach PB, et al. Variations in morbidity after radical prostatectomy. N Engl J Med 2002;346(15):1138\u201344.", "journal-title": "N Engl J Med"}, {"issue": "6", "key": "10_CR51", "doi-asserted-by": "crossref", "first-page": "2099", "DOI": "10.1097/01.ju.0000158163.21079.66", "volume": "173", "author": "FJ Bianco Jr", "year": "2005", "unstructured": "Bianco FJ, Jr., Riedel ER, Begg CB, Kattan MW, Scardino PT. Variations among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters. J Urol 2005;173(6):2099\u2013103.", "journal-title": "J Urol"}, {"issue": "6 Pt 1", "key": "10_CR52", "doi-asserted-by": "crossref", "first-page": "2292", "DOI": "10.1097/01.ju.0000091100.83725.51", "volume": "170", "author": "JA Eastham", "year": "2003", "unstructured": "Eastham JA, Kattan MW, Riedel E, et al. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J Urol 2003;170(6 Pt 1):2292\u20135.", "journal-title": "J Urol"}, {"issue": "3", "key": "10_CR53", "doi-asserted-by": "crossref", "first-page": "401", "DOI": "10.1200/JCO.2003.05.169", "volume": "21", "author": "JC Hu", "year": "2003", "unstructured": "Hu JC, Gold KF, Pashos CL, Mehta SS, Litwin MS. Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol 2003;21(3):401\u20135.", "journal-title": "J Clin Oncol"}, {"issue": "2", "key": "10_CR54", "first-page": "58", "volume": "6", "author": "SF Shariat", "year": "2004", "unstructured": "Shariat SF, Canto EI, Kattan MW, Slawin KM. Beyond prostate-specific antigen: new serologic biomarkers for improved diagnosis and management of prostate cancer. Rev Urol 2004;6(2):58\u201372.", "journal-title": "Rev Urol"}, {"issue": "1", "key": "10_CR55", "doi-asserted-by": "crossref", "first-page": "103", "DOI": "10.1016/S0022-5347(05)65392-X", "volume": "167", "author": "TA Stamey", "year": "2002", "unstructured": "Stamey TA, Johnstone IM, McNeal JE, Lu AY, Yemoto CM. Preoperative serum prostate specific antigen levels between 2 and 22\u00a0ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9\u00a0ng./ml. J Urol 2002;167(1):103\u201311.", "journal-title": "J Urol"}, {"issue": "5", "key": "10_CR56", "doi-asserted-by": "crossref", "first-page": "1596", "DOI": "10.1016/S0022-5347(05)67036-X", "volume": "164", "author": "M Noguchi", "year": "2000", "unstructured": "Noguchi M, Stamey TA, McNeal JE, Yemoto CM. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers. J Urol 2000;164(5):1596\u2013600.", "journal-title": "J Urol"}, {"issue": "2", "key": "10_CR57", "doi-asserted-by": "crossref", "first-page": "293", "DOI": "10.1016/j.eururo.2005.10.027", "volume": "49", "author": "SF Shariat", "year": "2006", "unstructured": "Shariat SF, Abdel-Aziz KF, Roehrborn CG, Lotan Y. Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10\u00a0ng/ml. Eur Urol 2006;49(2):293\u2013302.", "journal-title": "Eur Urol"}, {"issue": "3", "key": "10_CR58", "doi-asserted-by": "crossref", "first-page": "581", "DOI": "10.1016/S0090-4295(98)00655-4", "volume": "53", "author": "CG Roehrborn", "year": "1999", "unstructured": "Roehrborn CG, Boyle P, Gould AL, Waldstreicher J. Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology 1999;53(3):581\u20139.", "journal-title": "Urology"}, {"issue": "1", "key": "10_CR59", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1016/S0022-5347(05)67962-1", "volume": "163", "author": "CG Roehrborn", "year": "2000", "unstructured": "Roehrborn CG, McConnell J, Bonilla J, et al. Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study. J Urol 2000;163(1):13\u201320.", "journal-title": "J Urol"}, {"issue": "3", "key": "10_CR60", "doi-asserted-by": "crossref", "first-page": "473", "DOI": "10.1016/S0090-4295(98)00654-2", "volume": "53", "author": "CG Roehrborn", "year": "1999", "unstructured": "Roehrborn CG, McConnell JD, Lieber M, et al. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group. Urology 1999;53(3):473\u201380.", "journal-title": "Urology"}, {"issue": "4", "key": "10_CR61", "doi-asserted-by": "crossref", "first-page": "449", "DOI": "10.2217/14796694.3.4.449", "volume": "3", "author": "SF Shariat", "year": "2007", "unstructured": "Shariat SF, Karam JA, Roehrborn CG. Blood biomarkers for prostate cancer detection and prognosis. Future Oncol 2007;3(4):449\u201361.", "journal-title": "Future Oncol"}, {"issue": "5", "key": "10_CR62", "doi-asserted-by": "crossref", "first-page": "1605", "DOI": "10.1016/S0022-5347(05)00957-2", "volume": "175", "author": "K Eichler", "year": "2006", "unstructured": "Eichler K, Hempel S, Wilby J, Myers L, Bachmann LM, Kleijnen J. Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review. J Urol 2006;175(5):1605\u201312.", "journal-title": "J Urol"}, {"issue": "11", "key": "10_CR63", "doi-asserted-by": "crossref", "first-page": "975", "DOI": "10.1001/jama.280.11.975", "volume": "280", "author": "PC Albertsen", "year": "1998", "unstructured": "Albertsen PC, Hanley JA, Gleason DF, Barry MJ. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 1998;280(11):975\u201380.", "journal-title": "JAMA"}, {"issue": "11", "key": "10_CR64", "doi-asserted-by": "crossref", "first-page": "2509", "DOI": "10.1002/cncr.20635", "volume": "101", "author": "MW Kattan", "year": "2004", "unstructured": "Kattan MW, Giri D, Panageas KS, et al. A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy. Cancer 2004;101(11):2509\u201315.", "journal-title": "Cancer"}, {"issue": "22", "key": "10_CR65", "doi-asserted-by": "crossref", "first-page": "3515", "DOI": "10.1002/sim.1574", "volume": "22", "author": "MW Kattan", "year": "2003", "unstructured": "Kattan MW, Heller G, Brennan MF. A competing-risks nomogram for sarcoma-specific death following local recurrence. Stat Med 2003;22(22):3515\u201325.", "journal-title": "Stat Med"}, {"issue": "1", "key": "10_CR66", "doi-asserted-by": "crossref", "first-page": "182", "DOI": "10.1148/radiol.2421051254", "volume": "242", "author": "L Wang", "year": "2007", "unstructured": "Wang L, Hricak H, Kattan MW, et al. Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram. Radiology 2007;242(1):182\u20138.", "journal-title": "Radiology"}, {"issue": "3", "key": "10_CR67", "doi-asserted-by": "crossref", "first-page": "743", "DOI": "10.2214/AJR.04.1682", "volume": "186", "author": "L Wang", "year": "2006", "unstructured": "Wang L, Hricak H, Kattan MW, et al. Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer. Ajr 2006;186(3):743\u20138.", "journal-title": "Ajr"}, {"issue": "1", "key": "10_CR68", "doi-asserted-by": "crossref", "first-page": "42", "DOI": "10.1111/j.1464-410X.2004.04898.x", "volume": "94", "author": "SM Khoddami", "year": "2004", "unstructured": "Khoddami SM, Shariat SF, Lotan Y, et al. Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomy. BJU Int 2004;94(1):42\u20136.", "journal-title": "BJU Int"}, {"issue": "15", "key": "10_CR69", "doi-asserted-by": "crossref", "first-page": "1997", "DOI": "10.1002/1097-0258(20000815)19:15<1997::AID-SIM511>3.0.CO;2-C", "volume": "19", "author": "CB Begg", "year": "2000", "unstructured": "Begg CB, Cramer LD, Venkatraman ES, Rosai J. Comparing tumour staging and grading systems: a case study and a review of the issues, using thymoma as a model. Stat Med 2000;19(15):1997\u20132014.", "journal-title": "Stat Med"}, {"issue": "23", "key": "10_CR70", "doi-asserted-by": "crossref", "first-page": "4567", "DOI": "10.1200/JCO.2002.03.061", "volume": "20", "author": "AV D\u2019Amico", "year": "2002", "unstructured": "D\u2019Amico AV, Cote K, Loffredo M, Renshaw AA, Schultz D. Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer. J Clin Oncol 2002;20(23):4567\u201373.", "journal-title": "J Clin Oncol"}, {"issue": "6 Pt 2", "key": "10_CR71", "first-page": "S42", "volume": "170", "author": "AV D\u2019Amico", "year": "2003", "unstructured": "D\u2019Amico AV, Cote K, Loffredo M, Renshaw AA, Schultz D. Determinants of prostate cancer specific survival following radiation therapy during the prostate specific antigen era. J Urol 2003;170(6 Pt 2):S42\u20136; discussion S6\u20137.", "journal-title": "J Urol"}, {"issue": "2", "key": "10_CR72", "doi-asserted-by": "crossref", "first-page": "281", "DOI": "10.1002/cncr.10657", "volume": "95", "author": "AV D\u2019Amico", "year": "2002", "unstructured": "D\u2019Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era. Cancer 2002;95(2):281\u20136.", "journal-title": "Cancer"}, {"issue": "11", "key": "10_CR73", "doi-asserted-by": "crossref", "first-page": "969", "DOI": "10.1001/jama.280.11.969", "volume": "280", "author": "AV D\u2019Amico", "year": "1998", "unstructured": "D\u2019Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998;280(11):969\u201374.", "journal-title": "JAMA"}, {"issue": "11", "key": "10_CR74", "doi-asserted-by": "crossref", "first-page": "2163", "DOI": "10.1200/JCO.2003.01.075", "volume": "21", "author": "AV D\u2019Amico", "year": "2003", "unstructured": "D\u2019Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. J Clin Oncol 2003;21(11):2163\u201372.", "journal-title": "J Clin Oncol"}, {"issue": "4 Pt 1", "key": "10_CR75", "doi-asserted-by": "crossref", "first-page": "1354", "DOI": "10.1016/j.juro.2006.06.025", "volume": "176", "author": "PI Karakiewicz", "year": "2006", "unstructured": "Karakiewicz PI, Shariat SF, Palapattu GS, et al. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. J Urol 2006;176(4 Pt 1):1354\u201361; discussion 61\u20132.", "journal-title": "J Urol"}, {"issue": "19", "key": "10_CR76", "doi-asserted-by": "crossref", "first-page": "3647", "DOI": "10.1200/JCO.2003.01.240", "volume": "21", "author": "MW Kattan", "year": "2003", "unstructured": "Kattan MW, Karpeh MS, Mazumdar M, Brennan MF. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol 2003;21(19):3647\u201350.", "journal-title": "J Clin Oncol"}, {"issue": "3", "key": "10_CR77", "doi-asserted-by": "crossref", "first-page": "791", "DOI": "10.1200/JCO.2002.20.3.791", "volume": "20", "author": "MW Kattan", "year": "2002", "unstructured": "Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol 2002;20(3):791\u20136.", "journal-title": "J Clin Oncol"}, {"issue": "1", "key": "10_CR78", "doi-asserted-by": "crossref", "first-page": "63", "DOI": "10.1016/S0022-5347(05)66077-6", "volume": "166", "author": "MW Kattan", "year": "2001", "unstructured": "Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P. A postoperative prognostic nomogram for renal cell carcinoma. J Urol 2001;166(1):63\u20137.", "journal-title": "J Urol"}, {"issue": "24", "key": "10_CR79", "doi-asserted-by": "crossref", "first-page": "4568", "DOI": "10.1200/JCO.2003.05.046", "volume": "21", "author": "MW Kattan", "year": "2003", "unstructured": "Kattan MW, Zelefsky MJ, Kupelian PA, et al. Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer. J Clin Oncol 2003;21(24):4568\u201371.", "journal-title": "J Clin Oncol"}, {"issue": "4", "key": "10_CR80", "doi-asserted-by": "crossref", "first-page": "1126", "DOI": "10.1097/01.ju.0000155535.25971.de", "volume": "173", "author": "JA Mitchell", "year": "2005", "unstructured": "Mitchell JA, Cooperberg MR, Elkin EP, et al. Ability of 2 pretreatment risk assessment methods to predict prostate cancer recurrence after radical prostatectomy: data from CaPSURE. J Urol 2005;173(4):1126\u201331.", "journal-title": "J Urol"}, {"issue": "3", "key": "10_CR81", "doi-asserted-by": "crossref", "first-page": "370", "DOI": "10.1207/s15327752jpa5003_6", "volume": "50", "author": "PE Meehl", "year": "1986", "unstructured": "Meehl PE. Causes and effects of my disturbing little book. J Pers Assess 1986;50(3):370\u20135.", "journal-title": "J Pers Assess"}, {"issue": "7", "key": "10_CR82", "doi-asserted-by": "crossref", "first-page": "835", "DOI": "10.1001/jama.284.7.835", "volume": "284", "author": "EM Antman", "year": "2000", "unstructured": "Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA 2000;284(7):835\u201342.", "journal-title": "JAMA"}, {"issue": "10", "key": "10_CR83", "doi-asserted-by": "crossref", "first-page": "2384", "DOI": "10.1002/cncr.22262", "volume": "107", "author": "MR Cooperberg", "year": "2006", "unstructured": "Cooperberg MR, Freedland SJ, Pasta DJ, et al. Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy. Cancer 2006;107(10):2384\u201391.", "journal-title": "Cancer"}, {"issue": "6", "key": "10_CR84", "doi-asserted-by": "crossref", "first-page": "1938", "DOI": "10.1097/01.ju.0000158155.33890.e7", "volume": "173", "author": "MR Cooperberg", "year": "2005", "unstructured": "Cooperberg MR, Pasta DJ, Elkin EP, et al. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol 2005;173(6):1938\u201342.", "journal-title": "J Urol"}, {"issue": "1", "key": "10_CR85", "doi-asserted-by": "crossref", "first-page": "110", "DOI": "10.1016/S0022-5347(17)35410-1", "volume": "150", "author": "AW Partin", "year": "1993", "unstructured": "Partin AW, Yoo J, Carter HB, et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer [see comments]. J Urol 1993;150(1):110\u20134.", "journal-title": "J Urol"}, {"issue": "5", "key": "10_CR86", "doi-asserted-by": "crossref", "first-page": "1798", "DOI": "10.1097/01.ju.0000091805.98960.13", "volume": "170", "author": "I Cagiannos", "year": "2003", "unstructured": "Cagiannos I, Karakiewicz P, Eastham JA, et al. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. J Urol 2003;170(5):1798\u2013803.", "journal-title": "J Urol"}, {"issue": "5", "key": "10_CR87", "doi-asserted-by": "crossref", "first-page": "1792", "DOI": "10.1097/01.ju.0000091806.70171.41", "volume": "170", "author": "MW Kattan", "year": "2003", "unstructured": "Kattan MW, Eastham JA, Wheeler TM, et al. Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. J Urol 2003;170(5):1792\u20137.", "journal-title": "J Urol"}, {"issue": "4 Pt 1", "key": "10_CR88", "doi-asserted-by": "crossref", "first-page": "1203", "DOI": "10.1097/01.ju.0000085074.62960.7b", "volume": "170", "author": "H Koh", "year": "2003", "unstructured": "Koh H, Kattan MW, Scardino PT, et al. A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results. J Urol 2003;170(4 Pt 1):1203\u20138.", "journal-title": "J Urol"}, {"issue": "4", "key": "10_CR89", "doi-asserted-by": "crossref", "first-page": "788", "DOI": "10.1111/j.1464-410X.2006.06318.x", "volume": "98", "author": "A Briganti", "year": "2006", "unstructured": "Briganti A, Chun FK, Salonia A, et al. Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer. BJU Int 2006;98(4):788\u201393.", "journal-title": "BJU Int"}, {"issue": "1", "key": "10_CR90", "doi-asserted-by": "crossref", "first-page": "98", "DOI": "10.1016/j.eururo.2007.01.060", "volume": "52", "author": "A Gallina", "year": "2007", "unstructured": "Gallina A, Chun FK, Briganti A, et al. Development and split-sample validation of a nomogram predicting the probability of seminal vesicle invasion at radical prostatectomy. Eur Urol 2007;52(1):98\u2013105.", "journal-title": "Eur Urol"}, {"issue": "5", "key": "10_CR91", "doi-asserted-by": "crossref", "first-page": "820", "DOI": "10.1016/j.eururo.2005.11.007", "volume": "49", "author": "FK Chun", "year": "2006", "unstructured": "Chun FK, Steuber T, Erbersdobler A, et al. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. Eur Urol 2006;49(5):820\u20136.", "journal-title": "Eur Urol"}, {"issue": "4", "key": "10_CR92", "doi-asserted-by": "crossref", "first-page": "841", "DOI": "10.1016/S0360-3016(99)00260-6", "volume": "45", "author": "AV D\u2019Amico", "year": "1999", "unstructured": "D\u2019Amico AV, Renshaw AA, Arsenault L, Schultz D, Richie JP. Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patient selection for radiation and androgen suppression therapy. Int J Radiat Oncol Biol Phys 1999;45(4):841\u20136.", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"issue": "11", "key": "10_CR93", "doi-asserted-by": "crossref", "first-page": "1325", "DOI": "10.1001/jama.291.11.1325", "volume": "291", "author": "AJ Stephenson", "year": "2004", "unstructured": "Stephenson AJ, Shariat SF, Zelefsky MJ, et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 2004;291(11):1325\u201332.", "journal-title": "JAMA"}, {"key": "10_CR94", "doi-asserted-by": "crossref", "first-page": "501", "DOI": "10.1016/S0305-0483(00)00015-3", "volume": "28", "author": "MW Kattan", "year": "2000", "unstructured": "Kattan MW, Cooper RB. A simulation of factors affecting machine learning techniques: an examination of partitioning and class proportions. Onmega Int J Mgmt Sci 2000;28:501.", "journal-title": "Onmega Int J Mgmt Sci"}, {"issue": "6", "key": "10_CR95", "doi-asserted-by": "crossref", "first-page": "603", "DOI": "10.1016/S0895-4356(00)00344-9", "volume": "54", "author": "RJ Marshall", "year": "2001", "unstructured": "Marshall RJ. The use of classification and regression trees in clinical epidemiology. J Clin Epidemiol 2001;54(6):603\u20139.", "journal-title": "J Clin Epidemiol"}, {"issue": "5", "key": "10_CR96", "doi-asserted-by": "crossref", "first-page": "1844", "DOI": "10.1097/01.ju.0000121693.05077.3d", "volume": "171", "author": "M Ohori", "year": "2004", "unstructured": "Ohori M, Kattan MW, Koh H, et al. Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer. J Urol 2004;171(5):1844\u20139; discussion 9.", "journal-title": "J Urol"}, {"issue": "3 Pt 1", "key": "10_CR97", "doi-asserted-by": "crossref", "first-page": "939", "DOI": "10.1016/S0022-5347(05)00342-3", "volume": "175", "author": "T Steuber", "year": "2006", "unstructured": "Steuber T, Graefen M, Haese A, et al. Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy. J Urol 2006;175(3 Pt 1):939\u201344; discussion 44.", "journal-title": "J Urol"}, {"issue": "8 Suppl", "key": "10_CR98", "doi-asserted-by": "crossref", "first-page": "1615", "DOI": "10.1002/1097-0142(20010415)91:8+<1615::AID-CNCR1175>3.0.CO;2-L", "volume": "91", "author": "JE Dayhoff", "year": "2001", "unstructured": "Dayhoff JE, DeLeo JM. Artificial neural networks: opening the black box. Cancer 2001;91(8 Suppl):1615\u201335.", "journal-title": "Cancer"}, {"issue": "8 Suppl", "key": "10_CR99", "doi-asserted-by": "crossref", "first-page": "1636", "DOI": "10.1002/1097-0142(20010415)91:8+<1636::AID-CNCR1176>3.0.CO;2-D", "volume": "91", "author": "DJ Sargent", "year": "2001", "unstructured": "Sargent DJ. Comparison of artificial neural networks with other statistical approaches: results from medical data sets. Cancer 2001;91(8 Suppl):1636\u201342.", "journal-title": "Cancer"}, {"issue": "2", "key": "10_CR100", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1053/suro.2002.32492", "volume": "20", "author": "G Schwarzer", "year": "2002", "unstructured": "Schwarzer G, Schumacher M. Artificial neural networks for diagnosis and prognosis in prostate cancer. Semin Urol Oncol 2002;20(2):89\u201395.", "journal-title": "Semin Urol Oncol"}, {"issue": "8", "key": "10_CR101", "doi-asserted-by": "crossref", "first-page": "721", "DOI": "10.1016/S0895-4356(03)00120-3", "volume": "56", "author": "N Terrin", "year": "2003", "unstructured": "Terrin N, Schmid CH, Griffith JL, D\u2019Agostino RB, Selker HP. External validity of predictive models: a comparison of logistic regression, classification trees, and neural networks. J Clin Epidemiol 2003;56(8):721\u20139.", "journal-title": "J Clin Epidemiol"}, {"issue": "8", "key": "10_CR102", "first-page": "1279", "volume": "48", "author": "C Stephan", "year": "2002", "unstructured": "Stephan C, Cammann H, Semjonow A, et al. Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsies. Clin Chem 2002;48(8):1279\u201387.", "journal-title": "Clin Chem"}, {"issue": "6", "key": "10_CR103", "doi-asserted-by": "crossref", "first-page": "1930", "DOI": "10.1097/01.ju.0000158039.94467.5d", "volume": "173", "author": "PI Karakiewicz", "year": "2005", "unstructured": "Karakiewicz PI, Benayoun S, Kattan MW, et al. Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen. J Urol 2005;173(6):1930\u20134.", "journal-title": "J Urol"}, {"issue": "2", "key": "10_CR104", "doi-asserted-by": "crossref", "first-page": "436", "DOI": "10.1016/j.eururo.2006.08.039", "volume": "52", "author": "FK Chun", "year": "2007", "unstructured": "Chun FK, Briganti A, Graefen M, et al. Development and external validation of an extended 10-core biopsy nomogram. Eur Urol 2007;52(2):436\u201345.", "journal-title": "Eur Urol"}, {"issue": "2", "key": "10_CR105", "doi-asserted-by": "crossref", "first-page": "510", "DOI": "10.1016/j.juro.2006.09.025", "volume": "177", "author": "FK Chun", "year": "2007", "unstructured": "Chun FK, Briganti A, Graefen M, et al. Development and external validation of an extended repeat biopsy nomogram. J Urol 2007;177(2):510\u20135.", "journal-title": "J Urol"}, {"issue": "4", "key": "10_CR106", "doi-asserted-by": "crossref", "first-page": "553", "DOI": "10.1016/S0090-4295(00)00447-7", "volume": "55", "author": "G J O\u2019Dowd", "year": "2000", "unstructured": "O\u2019Dowd G J, Miller MC, Orozco R, Veltri RW. Analysis of repeated biopsy results within 1 year after a noncancer diagnosis. Urology 2000;55(4):553\u20139.", "journal-title": "Urology"}, {"issue": "4 Pt 1", "key": "10_CR107", "doi-asserted-by": "crossref", "first-page": "1184", "DOI": "10.1097/01.ju.0000087451.64657.fa", "volume": "170", "author": "E Lopez-Corona", "year": "2003", "unstructured": "Lopez-Corona E, Ohori M, Scardino PT, Reuter VE, Gonen M, Kattan MW. A nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session. J Urol 2003;170(4 Pt 1):1184\u20138; discussion 8.", "journal-title": "J Urol"}, {"issue": "2", "key": "10_CR108", "doi-asserted-by": "crossref", "first-page": "421", "DOI": "10.1097/01.ju.0000150522.82760.00", "volume": "173", "author": "BV Yanke", "year": "2005", "unstructured": "Yanke BV, Gonen M, Scardino PT, Kattan MW. Validation of a nomogram for predicting positive repeat biopsy for prostate cancer. J Urol 2005;173(2):421\u20134.", "journal-title": "J Urol"}, {"issue": "4", "key": "10_CR109", "doi-asserted-by": "crossref", "first-page": "1653", "DOI": "10.1016/S0022-5347(05)65172-5", "volume": "167", "author": "DF Penson", "year": "2002", "unstructured": "Penson DF, Grossfeld GD, Li YP, Henning JM, Lubeck DP, Carroll PR. How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population? Results of the cancer of the prostate strategic urological research endeavor. J Urol 2002;167(4):1653\u20137; discussion 7\u20138.", "journal-title": "J Urol"}, {"issue": "1", "key": "10_CR110", "doi-asserted-by": "crossref", "first-page": "177", "DOI": "10.1097/01.ju.0000099827.77355.a7", "volume": "171", "author": "H Augustin", "year": "2004", "unstructured": "Augustin H, Eggert T, Wenske S, et al. Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathological stage in clinically localized prostate cancer. J Urol 2004;171(1):177\u201381.", "journal-title": "J Urol"}, {"issue": "6", "key": "10_CR111", "doi-asserted-by": "crossref", "first-page": "843", "DOI": "10.1016/S0090-4295(01)01441-8", "volume": "58", "author": "AW Partin", "year": "2001", "unstructured": "Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 2001;58(6):843\u20138.", "journal-title": "Urology"}, {"issue": "4", "key": "10_CR112", "doi-asserted-by": "crossref", "first-page": "1681", "DOI": "10.1016/S0022-5347(05)65177-4", "volume": "167", "author": "A Heidenreich", "year": "2002", "unstructured": "Heidenreich A, Varga Z, Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 2002;167(4):1681\u20136.", "journal-title": "J Urol"}, {"issue": "2", "key": "10_CR113", "doi-asserted-by": "crossref", "first-page": "514", "DOI": "10.1016/S0022-5347(05)64670-8", "volume": "168", "author": "P Bader", "year": "2002", "unstructured": "Bader P, Burkhard FC, Markwalder R, Studer UE. Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol 2002;168(2):514\u20138; discussion 8.", "journal-title": "J Urol"}, {"issue": "6", "key": "10_CR114", "doi-asserted-by": "crossref", "first-page": "1019", "DOI": "10.1016/j.eururo.2006.01.043", "volume": "49", "author": "A Briganti", "year": "2006", "unstructured": "Briganti A, Chun FK, Salonia A, et al. Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy. Eur Urol 2006;49(6):1019\u201326; discussion 26\u20137.", "journal-title": "Eur Urol"}, {"issue": "1", "key": "10_CR115", "doi-asserted-by": "crossref", "first-page": "112", "DOI": "10.1016/j.eururo.2006.05.045", "volume": "51", "author": "A Briganti", "year": "2007", "unstructured": "Briganti A, Chun FK, Salonia A, et al. A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer. Eur Urol 2007;51(1):112\u20139; discussion 9\u201320.", "journal-title": "Eur Urol"}, {"issue": "22", "key": "10_CR116", "doi-asserted-by": "crossref", "first-page": "2713", "DOI": "10.1001/jama.291.22.2713", "volume": "291", "author": "JE Johansson", "year": "2004", "unstructured": "Johansson JE, Andren O, Andersson SO, et al. Natural history of early, localized prostate cancer. JAMA 2004;291(22):2713\u20139.", "journal-title": "JAMA"}, {"issue": "6875", "key": "10_CR117", "doi-asserted-by": "crossref", "first-page": "407", "DOI": "10.1136/bmj.306.6875.407", "volume": "306", "author": "FH Schroder", "year": "1993", "unstructured": "Schroder FH. Prostate cancer: to screen or not to screen? BMJ (Clinical research ed) 1993;306(6875):407\u20138.", "journal-title": "BMJ (Clinical research ed)"}, {"issue": "6", "key": "10_CR118", "doi-asserted-by": "crossref", "first-page": "1295", "DOI": "10.1016/j.urology.2006.08.1066", "volume": "68", "author": "T Steuber", "year": "2006", "unstructured": "Steuber T, Chun FK, Erbersdobler A, et al. Development and internal validation of preoperative transition zone prostate cancer nomogram. Urology 2006;68(6):1295\u2013300.", "journal-title": "Urology"}, {"issue": "28", "key": "10_CR119", "doi-asserted-by": "crossref", "first-page": "7005", "DOI": "10.1200/JCO.2005.01.867", "volume": "23", "author": "AJ Stephenson", "year": "2005", "unstructured": "Stephenson AJ, Scardino PT, Eastham JA, et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 2005;23(28):7005\u201312.", "journal-title": "J Clin Oncol"}, {"issue": "10", "key": "10_CR120", "doi-asserted-by": "crossref", "first-page": "715", "DOI": "10.1093/jnci/djj190", "volume": "98", "author": "AJ Stephenson", "year": "2006", "unstructured": "Stephenson AJ, Scardino PT, Eastham JA, et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst 2006;98(10):715\u20137.", "journal-title": "J Natl Cancer Inst"}, {"issue": "2 Pt 1", "key": "10_CR121", "doi-asserted-by": "crossref", "first-page": "528", "DOI": "10.1016/S0022-5347(01)69079-7", "volume": "167", "author": "GW Hull", "year": "2002", "unstructured": "Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 2002;167(2 Pt 1):528\u201334.", "journal-title": "J Urol"}, {"key": "10_CR122", "first-page": "S4", "volume": "16", "author": "J Blumberg", "year": "2004", "unstructured": "Blumberg J. PDA applications for physicians. ASCO News 2004 2004;16:S4\u20136.", "journal-title": "ASCO News 2004"}, {"issue": "1", "key": "10_CR123", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1097/01.ju.0000068037.57553.54", "volume": "170", "author": "FJ Bianco Jr", "year": "2003", "unstructured": "Bianco FJ, Jr., Kattan MW, Scardino PT, Powell IJ, Pontes JE, Wood DP, Jr. Radical prostatectomy nomograms in black American men: accuracy and applicability. J Urol 2003;170(1):73\u20136; discussion 6\u20137.", "journal-title": "J Urol"}, {"issue": "17", "key": "10_CR124", "doi-asserted-by": "crossref", "first-page": "1591", "DOI": "10.1001/jama.281.17.1591", "volume": "281", "author": "CR Pound", "year": "1999", "unstructured": "Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy [see comments]. JAMA 1999;281(17):1591\u20137.", "journal-title": "JAMA"}, {"issue": "4", "key": "10_CR125", "doi-asserted-by": "crossref", "first-page": "433", "DOI": "10.1001/jama.294.4.433", "volume": "294", "author": "SJ Freedland", "year": "2005", "unstructured": "Freedland SJ, Humphreys EB, Mangold LA, et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA 2005;294(4):433\u20139.", "journal-title": "JAMA"}, {"issue": "2 Pt 1", "key": "10_CR126", "doi-asserted-by": "crossref", "first-page": "692", "DOI": "10.1097/01.ju.0000107260.98031.0e", "volume": "171", "author": "I Cagiannos", "year": "2004", "unstructured": "Cagiannos I, Karakiewicz P, Graefen M, et al. Is year of radical prostatectomy a predictor of outcome in prostate cancer? J Urol 2004;171(2 Pt 1):692\u20136.", "journal-title": "J Urol"}, {"issue": "19", "key": "10_CR127", "doi-asserted-by": "crossref", "first-page": "3352", "DOI": "10.1200/JCO.2000.18.19.3352", "volume": "18", "author": "MW Kattan", "year": "2000", "unstructured": "Kattan MW, Zelefsky MJ, Kupelian PA, Scardino PT, Fuks Z, Leibel SA. Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. J Clin Oncol 2000;18(19):3352\u20139.", "journal-title": "J Clin Oncol"}, {"issue": "3", "key": "10_CR128", "doi-asserted-by": "crossref", "first-page": "393", "DOI": "10.1016/S0090-4295(01)01233-X", "volume": "58", "author": "MW Kattan", "year": "2001", "unstructured": "Kattan MW, Potters L, Blasko JC, et al. Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer. Urology 2001;58(3):393\u20139.", "journal-title": "Urology"}, {"issue": "17", "key": "10_CR129", "doi-asserted-by": "crossref", "first-page": "1591", "DOI": "10.1001/jama.281.17.1591", "volume": "281", "author": "CR Pound", "year": "1999", "unstructured": "Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999;281(17):1591\u20137.", "journal-title": "JAMA"}, {"issue": "4", "key": "10_CR130", "doi-asserted-by": "crossref", "first-page": "1030", "DOI": "10.1200/JCO.2001.19.4.1030", "volume": "19", "author": "AK Leventis", "year": "2001", "unstructured": "Leventis AK, Shariat SF, Kattan MW, Butler EB, Wheeler TM, Slawin KM. Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy. J Clin Oncol 2001;19(4):1030\u20139.", "journal-title": "J Clin Oncol"}, {"issue": "32", "key": "10_CR131", "doi-asserted-by": "crossref", "first-page": "8192", "DOI": "10.1200/JCO.2005.03.0007", "volume": "23", "author": "AK Lee", "year": "2005", "unstructured": "Lee AK, D\u2019Amico AV. Utility of prostate-specific antigen kinetics in addition to clinical factors in the selection of patients for salvage local therapy. J Clin Oncol 2005;23(32):8192\u20137.", "journal-title": "J Clin Oncol"}, {"issue": "9", "key": "10_CR132", "doi-asserted-by": "crossref", "first-page": "1962", "DOI": "10.1200/JCO.2005.06.058", "volume": "23", "author": "ZA Dotan", "year": "2005", "unstructured": "Dotan ZA, Bianco FJ, Jr., Rabbani F, et al. Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy. J Clin Oncol 2005;23(9):1962\u20138.", "journal-title": "J Clin Oncol"}, {"issue": "24 Pt 1", "key": "10_CR133", "doi-asserted-by": "crossref", "first-page": "8669", "DOI": "10.1158/1078-0432.CCR-05-1668", "volume": "11", "author": "SF Slovin", "year": "2005", "unstructured": "Slovin SF, Wilton AS, Heller G, Scher HI. Time to detectable metastatic disease in patients with rising prostate-specific antigen values following surgery or radiation therapy. Clin Cancer Res 2005;11(24 Pt 1):8669\u201373.", "journal-title": "Clin Cancer Res"}, {"issue": "19", "key": "10_CR134", "doi-asserted-by": "crossref", "first-page": "3972", "DOI": "10.1200/JCO.2002.11.021", "volume": "20", "author": "O Smaletz", "year": "2002", "unstructured": "Smaletz O, Scher HI, Small EJ, et al. Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration. J Clin Oncol 2002;20(19):3972\u201382.", "journal-title": "J Clin Oncol"}, {"issue": "7", "key": "10_CR135", "doi-asserted-by": "crossref", "first-page": "1232", "DOI": "10.1200/JCO.2003.06.100", "volume": "21", "author": "S Halabi", "year": "2003", "unstructured": "Halabi S, Small EJ, Kantoff PW, et al. Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer. J Clin Oncol 2003;21(7):1232\u20137.", "journal-title": "J Clin Oncol"}, {"issue": "2", "key": "10_CR136", "doi-asserted-by": "crossref", "first-page": "446", "DOI": "10.1016/j.eururo.2006.11.027", "volume": "52", "author": "CR Porter", "year": "2007", "unstructured": "Porter CR, Gallina A, Kodama K, et al. Prostate cancer-specific survival in men treated with hormonal therapy after failure of radical prostatectomy. Eur Urol 2007;52(2):446\u201354.", "journal-title": "Eur Urol"}, {"issue": "1", "key": "10_CR137", "doi-asserted-by": "crossref", "first-page": "99", "DOI": "10.1016/S0022-5347(05)00018-2", "volume": "175", "author": "ME Cowen", "year": "2006", "unstructured": "Cowen ME, Halasyamani LK, Kattan MW. Predicting life expectancy in men with clinically localized prostate cancer. J Urol 2006;175(1):99\u2013103.", "journal-title": "J Urol"}, {"issue": "3", "key": "10_CR138", "doi-asserted-by": "crossref", "first-page": "536", "DOI": "10.1016/j.ejca.2006.10.018", "volume": "43", "author": "FK Chun", "year": "2007", "unstructured": "Chun FK, Briganti A, Jeldres C, et al. Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy. Eur J Cancer 2007;43(3):536\u201343.", "journal-title": "Eur J Cancer"}, {"issue": "2", "key": "10_CR139", "doi-asserted-by": "crossref", "first-page": "290", "DOI": "10.1002/cncr.21157", "volume": "104", "author": "AJ Stephenson", "year": "2005", "unstructured": "Stephenson AJ, Smith A, Kattan MW, et al. Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy. Cancer 2005;104(2):290\u20138.", "journal-title": "Cancer"}, {"issue": "1", "key": "10_CR140", "doi-asserted-by": "crossref", "first-page": "28", "DOI": "10.1148/radiol.2431030580", "volume": "243", "author": "H Hricak", "year": "2007", "unstructured": "Hricak H, Choyke PL, Eberhardt SC, Leibel SA, Scardino PT. Imaging prostate cancer: a multidisciplinary perspective. Radiology 2007;243(1):28\u201353.", "journal-title": "Radiology"}, {"issue": "12", "key": "10_CR141", "doi-asserted-by": "crossref", "first-page": "2655", "DOI": "10.1002/cncr.20319", "volume": "100", "author": "H Hricak", "year": "2004", "unstructured": "Hricak H, Wang L, Wei DC, et al. The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy. Cancer 2004;100(12):2655\u201363.", "journal-title": "Cancer"}, {"issue": "3", "key": "10_CR142", "doi-asserted-by": "crossref", "first-page": "804", "DOI": "10.1148/radiol.2343040363", "volume": "234", "author": "KL Zakian", "year": "2005", "unstructured": "Zakian KL, Sircar K, Hricak H, et al. Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 2005;234(3):804\u201314.", "journal-title": "Radiology"}, {"issue": "6", "key": "10_CR143", "doi-asserted-by": "crossref", "first-page": "1165", "DOI": "10.1016/j.urology.2004.06.030", "volume": "64", "author": "V Poulakis", "year": "2004", "unstructured": "Poulakis V, Witzsch U, de Vries R, et al. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and Gleason score for predicting prostate cancer biochemical recurrence after radical prostatectomy. Urology 2004;64(6):1165\u201370.", "journal-title": "Urology"}, {"issue": "4", "key": "10_CR144", "doi-asserted-by": "crossref", "first-page": "786", "DOI": "10.1111/j.1464-410X.2007.06689.x", "volume": "99", "author": "A Shukla-Dave", "year": "2007", "unstructured": "Shukla-Dave A, Hricak H, Kattan MW, et al. The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis. BJU Int 2007;99(4):786\u201393.", "journal-title": "BJU Int"}, {"issue": "1", "key": "10_CR145", "doi-asserted-by": "crossref", "first-page": "132", "DOI": "10.1016/S0090-4295(97)00574-8", "volume": "51", "author": "RJ Babaian", "year": "1998", "unstructured": "Babaian RJ, Fritsche HA, Zhang Z, Zhang KH, Madyastha KR, Barnhill SD. Evaluation of prostasure index in the detection of prostate cancer: a preliminary report. Urology 1998;51(1):132\u20136.", "journal-title": "Urology"}, {"issue": "7", "key": "10_CR146", "first-page": "987", "volume": "45", "author": "A Virtanen", "year": "1999", "unstructured": "Virtanen A, Gomari M, Kranse R, Stenman UH. Estimation of prostate cancer probability by logistic regression: free and total prostate-specific antigen, digital rectal examination, and heredity are significant variables. Clin Chem 1999;45(7):987\u201394.", "journal-title": "Clin Chem"}, {"issue": "3", "key": "10_CR147", "doi-asserted-by": "crossref", "first-page": "418", "DOI": "10.1016/S0090-4295(00)00672-5", "volume": "56", "author": "P Finne", "year": "2000", "unstructured": "Finne P, Finne R, Auvinen A, et al. Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network. Urology 2000;56(3):418\u201322.", "journal-title": "Urology"}, {"issue": "8 Suppl", "key": "10_CR148", "doi-asserted-by": "crossref", "first-page": "1667", "DOI": "10.1002/1097-0142(20010415)91:8+<1667::AID-CNCR1181>3.0.CO;2-L", "volume": "91", "author": "W Horninger", "year": "2001", "unstructured": "Horninger W, Bartsch G, Snow PB, Brandt JM, Partin AW. The problem of cutoff levels in a screened population: appropriateness of informing screenees about their risk of having prostate carcinoma. Cancer 2001;91(8 Suppl):1667\u201372.", "journal-title": "Cancer"}, {"issue": "9", "key": "10_CR149", "doi-asserted-by": "crossref", "first-page": "1849", "DOI": "10.1002/cncr.11748", "volume": "98", "author": "P Kalra", "year": "2003", "unstructured": "Kalra P, Togami J, Bansal BSG, et al. A neurocomputational model for prostate carcinoma detection. Cancer 2003;98(9):1849\u201354.", "journal-title": "Cancer"}, {"issue": "2", "key": "10_CR150", "doi-asserted-by": "crossref", "first-page": "310", "DOI": "10.1002/ijc.20250", "volume": "111", "author": "P Finne", "year": "2004", "unstructured": "Finne P, Finne R, Bangma C, et al. Algorithms based on prostate-specific antigen (PSA), free PSA, digital rectal examination and prostate volume reduce false-positive PSA results in prostate cancer screening. Int J Cancer 2004;111(2):310\u20135.", "journal-title": "Int J Cancer"}, {"issue": "5", "key": "10_CR151", "doi-asserted-by": "crossref", "first-page": "937", "DOI": "10.1016/j.urology.2004.11.049", "volume": "65", "author": "CR Porter", "year": "2005", "unstructured": "Porter CR, Gamito EJ, Crawford ED, et al. Model to predict prostate biopsy outcome in large screening population with independent validation in referral setting. Urology 2005;65(5):937\u201341.", "journal-title": "Urology"}, {"issue": "3", "key": "10_CR152", "doi-asserted-by": "crossref", "first-page": "456", "DOI": "10.1016/S0090-4295(03)00409-6", "volume": "62", "author": "M Remzi", "year": "2003", "unstructured": "Remzi M, Anagnostou T, Ravery V, et al. An artificial neural network to predict the outcome of repeat prostate biopsies. Urology 2003;62(3):456\u201360.", "journal-title": "Urology"}, {"issue": "3", "key": "10_CR153", "doi-asserted-by": "crossref", "first-page": "498", "DOI": "10.1016/j.eururo.2006.03.026", "volume": "50", "author": "J Walz", "year": "2006", "unstructured": "Walz J, Graefen M, Chun FK, et al. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur Urol 2006;50(3):498\u2013505.", "journal-title": "Eur Urol"}, {"issue": "3", "key": "10_CR154", "doi-asserted-by": "crossref", "first-page": "455", "DOI": "10.1016/S0090-4295(98)00205-2", "volume": "52", "author": "GD Carlson", "year": "1998", "unstructured": "Carlson GD, Calvanese CB, Partin AW. An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer: results on 4298 cases. Urology 1998;52(3):455\u201361.", "journal-title": "Urology"}, {"issue": "4", "key": "10_CR155", "doi-asserted-by": "crossref", "first-page": "921", "DOI": "10.1200/JCO.2002.20.4.921", "volume": "20", "author": "B Djavan", "year": "2002", "unstructured": "Djavan B, Remzi M, Zlotta A, Seitz C, Snow P, Marberger M. Novel artificial neural network for early detection of prostate cancer. J Clin Oncol 2002;20(4):921\u20139.", "journal-title": "J Clin Oncol"}, {"issue": "10", "key": "10_CR156", "doi-asserted-by": "crossref", "first-page": "602", "DOI": "10.1093/jjco/hyh112", "volume": "34", "author": "Y Matsui", "year": "2004", "unstructured": "Matsui Y, Utsunomiya N, Ichioka K, et al. The use of artificial neural network analysis to improve the predictive accuracy of prostate biopsy in the Japanese population. Jpn J Clin Oncol 2004;34(10):602\u20137.", "journal-title": "Jpn J Clin Oncol"}, {"issue": "2", "key": "10_CR157", "doi-asserted-by": "crossref", "first-page": "357", "DOI": "10.1016/j.urology.2006.03.003", "volume": "68", "author": "L Benecchi", "year": "2006", "unstructured": "Benecchi L. Neuro-fuzzy system for prostate cancer diagnosis. Urology 2006;68(2):357\u201361.", "journal-title": "Urology"}, {"issue": "3", "key": "10_CR158", "doi-asserted-by": "crossref", "first-page": "528", "DOI": "10.1002/(SICI)1097-0142(19970201)79:3<528::AID-CNCR15>3.0.CO;2-5", "volume": "79", "author": "MW Kattan", "year": "1997", "unstructured": "Kattan MW, Stapleton AM, Wheeler TM, Scardino PT. Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma. Cancer 1997;79(3):528\u201337.", "journal-title": "Cancer"}, {"issue": "2", "key": "10_CR159", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1016/S0090-4295(99)80195-2", "volume": "46", "author": "P Narayan", "year": "1995", "unstructured": "Narayan P, Gajendran V, Taylor SP, et al. The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer. Urology 1995;46(2):205\u201312.", "journal-title": "Urology"}, {"issue": "5", "key": "10_CR160", "doi-asserted-by": "crossref", "first-page": "1591", "DOI": "10.1016/S0022-5347(05)67035-8", "volume": "164", "author": "ML Blute", "year": "2000", "unstructured": "Blute ML, Bergstralh EJ, Partin AW, et al. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. J Urol 2000;164(5):1591\u20135.", "journal-title": "J Urol"}, {"issue": "5", "key": "10_CR161", "doi-asserted-by": "crossref", "first-page": "368", "DOI": "10.1001/jama.1994.03510290050036", "volume": "271", "author": "JI Epstein", "year": "1994", "unstructured": "Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994;271(5):368\u201374.", "journal-title": "JAMA"}, {"issue": "6", "key": "10_CR162", "doi-asserted-by": "crossref", "first-page": "359", "DOI": "10.1007/BF01300183", "volume": "15", "author": "HB Carter", "year": "1997", "unstructured": "Carter HB, Epstein JI. Prediction of significant cancer in men with stage T1c adenocarcinoma of the prostate. World J Urol 1997;15(6):359\u201363.", "journal-title": "World J Urol"}, {"issue": "3", "key": "10_CR163", "doi-asserted-by": "crossref", "first-page": "1059", "DOI": "10.1016/S0022-5347(01)65702-1", "volume": "156", "author": "Y Goto", "year": "1996", "unstructured": "Goto Y, Ohori M, Arakawa A, Kattan MW, Wheeler TM, Scardino PT. Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies. J Urol 1996;156(3):1059\u201363.", "journal-title": "J Urol"}, {"issue": "2", "key": "10_CR164", "doi-asserted-by": "crossref", "first-page": "329", "DOI": "10.1111/j.1464-410X.2006.06262.x", "volume": "98", "author": "FK Chun", "year": "2006", "unstructured": "Chun FK, Briganti A, Shariat SF, et al. Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation. BJU Int 2006;98(2):329\u201334.", "journal-title": "BJU Int"}, {"issue": "2", "key": "10_CR165", "doi-asserted-by": "crossref", "first-page": "530", "DOI": "10.1002/1097-0142(19950115)75:2<530::AID-CNCR2820750216>3.0.CO;2-Y", "volume": "75", "author": "PA Peller", "year": "1995", "unstructured": "Peller PA, Young DC, Marmaduke DP, Marsh WL, Badalament RA. Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens. Cancer 1995;75(2):530\u20138.", "journal-title": "Cancer"}, {"issue": "6", "key": "10_CR166", "doi-asserted-by": "crossref", "first-page": "1845", "DOI": "10.1016/S0022-5347(17)35912-8", "volume": "150", "author": "DA Ackerman", "year": "1993", "unstructured": "Ackerman DA, Barry JM, Wicklund RA, Olson N, Lowe BA. Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy. J Urol 1993;150(6):1845\u201350.", "journal-title": "J Urol"}, {"issue": "5", "key": "10_CR167", "doi-asserted-by": "crossref", "first-page": "1727", "DOI": "10.1016/S0022-5347(01)62394-2", "volume": "160", "author": "F Rabbani", "year": "1998", "unstructured": "Rabbani F, Bastar A, Fair WR. Site specific predictors of positive margins at radical prostatectomy: an argument for risk based modification of technique. J Urol 1998;160(5):1727\u201333.", "journal-title": "J Urol"}, {"issue": "4", "key": "10_CR168", "doi-asserted-by": "crossref", "first-page": "1361", "DOI": "10.1016/S0022-5347(01)66267-0", "volume": "155", "author": "DG Bostwick", "year": "1996", "unstructured": "Bostwick DG, Qian J, Bergstralh E, et al. Prediction of capsular perforation and seminal vesicle invasion in prostate cancer. J Urol 1996;155(4):1361\u20137.", "journal-title": "J Urol"}, {"issue": "4", "key": "10_CR169", "doi-asserted-by": "crossref", "first-page": "1341", "DOI": "10.1016/S0022-5347(05)68281-X", "volume": "162", "author": "FD Gilliland", "year": "1999", "unstructured": "Gilliland FD, Hoffman RM, Hamilton A, et al. Predicting extracapsular extension of prostate cancer in men treated with radical prostatectomy: results from the population based prostate cancer outcomes study. J Urol 1999;162(4):1341\u20135.", "journal-title": "J Urol"}, {"issue": "4", "key": "10_CR170", "doi-asserted-by": "crossref", "first-page": "1375", "DOI": "10.1016/S0022-5347(01)65590-3", "volume": "156", "author": "RA Badalament", "year": "1996", "unstructured": "Badalament RA, Miller MC, Peller PA, et al. An algorithm for predicting nonorgan confined prostate cancer using the results obtained from sextant core biopsies with prostate specific antigen level. J Urol 1996;156(4):1375\u201380.", "journal-title": "J Urol"}, {"issue": "3", "key": "10_CR171", "doi-asserted-by": "crossref", "first-page": "585", "DOI": "10.1016/S0360-3016(96)00359-8", "volume": "36", "author": "TM Pisansky", "year": "1996", "unstructured": "Pisansky TM, Blute ML, Suman VJ, Bostwick DG, Earle JD, Zincke H. Correlation of pretherapy prostate cancer characteristics with seminal vesicle invasion in radical prostatectomy specimens. Int J Radiat Oncol Biol Phys 1996;36(3):585\u201391.", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"issue": "3", "key": "10_CR172", "doi-asserted-by": "crossref", "first-page": "536", "DOI": "10.1016/j.urology.2006.12.013", "volume": "69", "author": "A Baccala Jr", "year": "2007", "unstructured": "Baccala A, Jr., Reuther AM, Bianco FJ, Jr., Scardino PT, Kattan MW, Klein EA. Complete resection of seminal vesicles at radical prostatectomy results in substantial long-term disease-free survival: multi-institutional study of 6740 patients. Urology 2007;69(3):536\u201340.", "journal-title": "Urology"}, {"issue": "5", "key": "10_CR173", "doi-asserted-by": "crossref", "first-page": "1315", "DOI": "10.1016/S0022-5347(17)35239-4", "volume": "151", "author": "DL Bluestein", "year": "1994", "unstructured": "Bluestein DL, Bostwick DG, Bergstralh EJ, Oesterling JE. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer. J Urol 1994;151(5):1315\u201320.", "journal-title": "J Urol"}, {"issue": "1", "key": "10_CR174", "doi-asserted-by": "crossref", "first-page": "33", "DOI": "10.1016/0360-3016(94)90138-4", "volume": "28", "author": "M Roach 3rd", "year": "1994", "unstructured": "Roach M, 3rd, Marquez C, Yuo HS, et al. Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1994;28(1):33\u20137.", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"issue": "3", "key": "10_CR175", "doi-asserted-by": "crossref", "first-page": "481", "DOI": "10.1016/S0090-4295(00)01039-6", "volume": "57", "author": "JT Batuello", "year": "2001", "unstructured": "Batuello JT, Gamito EJ, Crawford ED, et al. Artificial neural network model for the assessment of lymph node spread in patients with clinically localized prostate cancer. Urology 2001;57(3):481\u20135.", "journal-title": "Urology"}, {"issue": "6", "key": "10_CR176", "doi-asserted-by": "crossref", "first-page": "1573", "DOI": "10.1016/j.eururo.2007.01.108", "volume": "51", "author": "A Briganti", "year": "2007", "unstructured": "Briganti A, Karakiewicz PI, Chun FK, et al. Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection. Eur Urol 2007;51(6):1573\u201381.", "journal-title": "Eur Urol"}, {"issue": "6 Pt 1", "key": "10_CR177", "doi-asserted-by": "crossref", "first-page": "2255", "DOI": "10.1097/01.ju.0000127733.01845.57", "volume": "171", "author": "KL Greene", "year": "2004", "unstructured": "Greene KL, Meng MV, Elkin EP, et al. Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure). J Urol 2004;171(6 Pt 1):2255\u20139.", "journal-title": "J Urol"}, {"issue": "5", "key": "10_CR178", "doi-asserted-by": "crossref", "first-page": "685", "DOI": "10.1007/s00120-002-0251-x", "volume": "42", "author": "M Graefen", "year": "2003", "unstructured": "Graefen M, Augustin H, Karakiewicz PI, et al. [Can nomograms derived in the U.S. applied to German patients? A study about the validation of preoperative nomograms predicting the risk of recurrence after radical prostatectomy]. Urologe A 2003;42(5):685\u201392.", "journal-title": "Urologe A"}, {"issue": "1", "key": "10_CR179", "doi-asserted-by": "crossref", "first-page": "21", "DOI": "10.1159/000019922", "volume": "36", "author": "M Graefen", "year": "1999", "unstructured": "Graefen M, Noldus J, Pichlmeier U, et al. Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics. Eur Urol 1999;36(1):21\u201330.", "journal-title": "Eur Urol"}, {"issue": "4", "key": "10_CR180", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1089/10915360152745849", "volume": "5", "author": "A Tewari", "year": "2001", "unstructured": "Tewari A, Issa M, El-Galley R, et al. Genetic adaptive neural network to predict biochemical failure after radical prostatectomy: a multi-institutional study. Mol urol 2001;5(4):163\u20139.", "journal-title": "Mol urol"}, {"issue": "3", "key": "10_CR181", "doi-asserted-by": "crossref", "first-page": "929", "DOI": "10.1016/S0022-5347(01)63773-X", "volume": "159", "author": "JJ Bauer", "year": "1998", "unstructured": "Bauer JJ, Connelly RR, Seterhenn IA, et al. Biostatistical modeling using traditional preoperative and pathological prognostic variables in the selection of men at high risk for disease recurrence after radical prostatectomy for prostate cancer. J Urol 1998;159(3):929\u201333.", "journal-title": "J Urol"}, {"issue": "4", "key": "10_CR182", "doi-asserted-by": "crossref", "first-page": "1322", "DOI": "10.1016/S0022-5347(05)65761-8", "volume": "166", "author": "JW Moul", "year": "2001", "unstructured": "Moul JW, Connelly RR, Lubeck DP, et al. Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases. J Urol 2001;166(4):1322\u20137.", "journal-title": "J Urol"}, {"issue": "5", "key": "10_CR183", "doi-asserted-by": "crossref", "first-page": "791", "DOI": "10.1016/S0090-4295(99)00328-3", "volume": "54", "author": "SR Potter", "year": "1999", "unstructured": "Potter SR, Miller MC, Mangold LA, et al. Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy. Urology 1999;54(5):791\u20135.", "journal-title": "Urology"}, {"issue": "7", "key": "10_CR184", "doi-asserted-by": "crossref", "first-page": "961", "DOI": "10.1111/j.1464-410X.2003.04760.x", "volume": "93", "author": "AR Ramsden", "year": "2004", "unstructured": "Ramsden AR, Chodak G. An analysis of risk factors for biochemical progression in patients with seminal vesicle invasion: validation of Kattan\u2019s nomogram in a pathological subgroup. BJU Int 2004;93(7):961\u20134.", "journal-title": "BJU Int"}, {"issue": "4", "key": "10_CR185", "doi-asserted-by": "crossref", "first-page": "1155", "DOI": "10.1016/S0022-5347(05)67713-0", "volume": "163", "author": "TA Stamey", "year": "2000", "unstructured": "Stamey TA, Yemoto CM, McNeal JE, Sigal BM, Johnstone IM. Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens. J Urol 2000;163(4):1155\u201360.", "journal-title": "J Urol"}, {"issue": "5", "key": "10_CR186", "doi-asserted-by": "crossref", "first-page": "311", "DOI": "10.1016/j.urolonc.2004.12.013", "volume": "23", "author": "SJ McAleer", "year": "2005", "unstructured": "McAleer SJ, Schultz D, Whittington R, et al. PSA outcome following radical prostatectomy for patients with localized prostate cancer stratified by prostatectomy findings and the preoperative PSA level. Urol Oncol 2005;23(5):311\u20137.", "journal-title": "Urol Oncol"}, {"issue": "1", "key": "10_CR187", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1016/0167-8140(95)01645-7", "volume": "38", "author": "GM Duchesne", "year": "1996", "unstructured": "Duchesne GM, Bloomfield D, Wall P. Identification of intermediate-risk prostate cancer patients treated with radiotherapy suitable for neoadjuvant hormone studies. Radiother Oncol 1996;38(1):7\u201312.", "journal-title": "Radiother Oncol"}, {"issue": "11", "key": "10_CR188", "doi-asserted-by": "crossref", "first-page": "2154", "DOI": "10.1002/(SICI)1097-0142(19970601)79:11<2154::AID-CNCR13>3.0.CO;2-V", "volume": "79", "author": "TM Pisansky", "year": "1997", "unstructured": "Pisansky TM, Kahn MJ, Bostwick DG. An enhanced prognostic system for clinically localized carcinoma of the prostate. Cancer 1997;79(11):2154\u201361.", "journal-title": "Cancer"}, {"issue": "7", "key": "10_CR189", "doi-asserted-by": "crossref", "first-page": "1370", "DOI": "10.1002/(SICI)1097-0142(19970401)79:7<1370::AID-CNCR15>3.0.CO;2-X", "volume": "79", "author": "GK Zagars", "year": "1997", "unstructured": "Zagars GK, Pollack A, von Eschenbach AC. Prognostic factors for clinically localized prostate carcinoma: analysis of 938 patients irradiated in the prostate specific antigen era. Cancer 1997;79(7):1370\u201380.", "journal-title": "Cancer"}, {"issue": "17", "key": "10_CR190", "doi-asserted-by": "crossref", "first-page": "1598", "DOI": "10.1001/jama.281.17.1598", "volume": "281", "author": "WU Shipley", "year": "1999", "unstructured": "Shipley WU, Thames HD, Sandler HM, et al. Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA 1999;281(17):1598\u2013604.", "journal-title": "JAMA"}, {"issue": "5", "key": "10_CR191", "doi-asserted-by": "crossref", "first-page": "1562", "DOI": "10.1097/01.ju.0000154633.73092.8e", "volume": "173", "author": "L Potters", "year": "2005", "unstructured": "Potters L, Morgenstern C, Calugaru E, et al. 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J Urol 2005;173(5):1562\u20136.", "journal-title": "J Urol"}, {"issue": "5", "key": "10_CR192", "doi-asserted-by": "crossref", "first-page": "989", "DOI": "10.1002/(SICI)1097-0142(19980901)83:5<989::AID-CNCR26>3.0.CO;2-Q", "volume": "83", "author": "H Ragde", "year": "1998", "unstructured": "Ragde H, Elgamal AA, Snow PB, et al. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma. Cancer 1998;83(5):989\u20131001.", "journal-title": "Cancer"}, {"issue": "15", "key": "10_CR193", "doi-asserted-by": "crossref", "first-page": "2035", "DOI": "10.1200/JCO.2006.08.9607", "volume": "25", "author": "AJ Stephenson", "year": "2007", "unstructured": "Stephenson AJ, Scardino PT, Kattan MW, et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 2007;25(15):2035\u201341.", "journal-title": "J Clin Oncol"}, {"issue": "5", "key": "10_CR194", "doi-asserted-by": "crossref", "first-page": "649", "DOI": "10.1016/0090-4295(94)90180-5", "volume": "43", "author": "AW Partin", "year": "1994", "unstructured": "Partin AW, Pearson JD, Landis PK, et al. Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. Urology 1994;43(5):649\u201359.", "journal-title": "Urology"}, {"issue": "28", "key": "10_CR195", "doi-asserted-by": "crossref", "first-page": "6992", "DOI": "10.1200/JCO.2005.01.2906", "volume": "23", "author": "P Zhou", "year": "2005", "unstructured": "Zhou P, Chen MH, McLeod D, Carroll PR, Moul JW, D\u2019Amico AV. Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Clin Oncol 2005;23(28):6992\u20138.", "journal-title": "J Clin Oncol"}, {"issue": "4", "key": "10_CR196", "doi-asserted-by": "crossref", "first-page": "666", "DOI": "10.1016/j.eururo.2005.11.032", "volume": "49", "author": "R Svatek", "year": "2006", "unstructured": "Svatek R, Karakiewicz PI, Shulman M, Karam J, Perrotte P, Benaim E. Pre-treatment nomogram for disease-specific survival of patients with chemotherapy-naive androgen independent prostate cancer. Eur Urol 2006;49(4):666\u201374.", "journal-title": "Eur Urol"}, {"issue": "1", "key": "10_CR197", "doi-asserted-by": "crossref", "first-page": "127", "DOI": "10.1016/S0022-5347(01)65964-0", "volume": "156", "author": "PC Albertsen", "year": "1996", "unstructured": "Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. The impact of co-morbidity on life expectancy among men with localized prostate cancer. J Urol 1996;156(1):127\u201332.", "journal-title": "J Urol"}, {"issue": "24", "key": "10_CR198", "doi-asserted-by": "crossref", "first-page": "3576", "DOI": "10.1200/JCO.2006.10.3820", "volume": "25", "author": "J Walz", "year": "2007", "unstructured": "Walz J, Gallina A, Saad F, et al. A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. J Clin Oncol 2007;25(24):3576\u201381.", "journal-title": "J Clin Oncol"}, {"issue": "9", "key": "10_CR199", "doi-asserted-by": "crossref", "first-page": "1526", "DOI": "10.1200/JCO.2007.12.4669", "volume": "26", "author": "SF Shariat", "year": "2008", "unstructured": "Shariat SF, Walz J, Roehrborn CG, et al. External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy. J Clin Oncol 2008;26(9):1526\u201331.", "journal-title": "J Clin Oncol"}, {"issue": "4 Pt 1", "key": "10_CR200", "doi-asserted-by": "crossref", "first-page": "1229", "DOI": "10.1016/j.juro.2007.05.161", "volume": "178", "author": "SF Shariat", "year": "2007", "unstructured": "Shariat SF, Park S, Trinh QD, Roehrborn CG, Slawin KM, Karakiewicz PI. Plasminogen activation inhibitor-1 improves the predictive accuracy of prostate cancer nomograms. J Urol 2007;178(4 Pt 1):1229\u201336; discussion 36\u20137.", "journal-title": "J Urol"}], "container-title": ["Prostate Cancer Screening"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-60327-281-0_10", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 4]], "date-time": "2019-03-04T23:18:41Z", "timestamp": 1551741521000}, "score": 35.65439, "issued": {"date-parts": [[2009]]}, "ISBN": ["9781603272803", "9781603272810"], "references-count": 200, "URL": "http://dx.doi.org/10.1007/978-1-60327-281-0_10", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T15:45:20Z", "timestamp": 1575215120419}, "reference-count": 55, "publisher": "Wiley", "issue": "11", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 858, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Prostate"], "published-print": {"date-parts": [[2013, 8]]}, "DOI": "10.1002/pros.22669", "type": "journal-article", "created": {"date-parts": [[2013, 4, 26]], "date-time": "2013-04-26T09:39:23Z", "timestamp": 1366969163000}, "page": "1202-1213", "source": "Crossref", "is-referenced-by-count": 17, "title": ["A New Proposed Rodent Model of Chemically Induced Prostate Carcinogenesis: Distinct Time-Course Prostate Cancer Progression in the Dorsolateral and Ventral Lobes"], "prefix": "10.1002", "volume": "73", "author": [{"given": "Bianca F.", "family": "Gon\u00e7alves", "sequence": "first", "affiliation": [{"name": "Department of Cell Biology; Institute of Biology, State University of Campinas (UNICAMP); Campinas; Brazil"}]}, {"given": "Silvana G.P.", "family": "de Campos", "sequence": "additional", "affiliation": [{"name": "Department of Biology, Laboratory of Microscopy and Microanalysis; Institute of Biosciences, Humanities and Exact Sciences (IBILCE), S\u00e3o Paulo State University (UNESP); S\u00e3o Jos\u00e9 do Rio Preto; Brazil"}]}, {"given": "Cristiani", "family": "Zanetoni", "sequence": "additional", "affiliation": [{"name": "Department of Biology, Laboratory of Microscopy and Microanalysis; Institute of Biosciences, Humanities and Exact Sciences (IBILCE), S\u00e3o Paulo State University (UNESP); S\u00e3o Jos\u00e9 do Rio Preto; Brazil"}]}, {"given": "Wellerson R.", "family": "Scarano", "sequence": "additional", "affiliation": [{"name": "Department of Morphology; Institute of Biosciences, S\u00e3o Paulo State University (UNESP); Botucatu; Brazil"}]}, {"suffix": "Jr", "given": "Luiz R.", "family": "Falleiros", "sequence": "additional", "affiliation": [{"name": "Department of Biology, Laboratory of Microscopy and Microanalysis; Institute of Biosciences, Humanities and Exact Sciences (IBILCE), S\u00e3o Paulo State University (UNESP); S\u00e3o Jos\u00e9 do Rio Preto; Brazil"}]}, {"given": "Rene\u00e9 L.", "family": "Amorim", "sequence": "additional", "affiliation": [{"name": "Department of Veterinary Clinical Science; College of Veterinary Medicine and Animal Science (FMVZ), S\u00e3o Paulo State University (UNESP); Botucatu; Brazil"}]}, {"given": "Rejane M.", "family": "G\u00f3es", "sequence": "additional", "affiliation": [{"name": "Department of Biology, Laboratory of Microscopy and Microanalysis; Institute of Biosciences, Humanities and Exact Sciences (IBILCE), S\u00e3o Paulo State University (UNESP); S\u00e3o Jos\u00e9 do Rio Preto; Brazil"}]}, {"given": "Sebasti\u00e3o R.", "family": "Taboga", "sequence": "additional", "affiliation": [{"name": "Department of Biology, Laboratory of Microscopy and Microanalysis; Institute of Biosciences, Humanities and Exact Sciences (IBILCE), S\u00e3o Paulo State University (UNESP); S\u00e3o Jos\u00e9 do Rio Preto; Brazil"}]}], "member": "311", "published-online": {"date-parts": [[2013, 4, 26]]}, "reference": [{"issue": "1", "key": "10.1002/pros.22669-BIB0001|pros22669-cit-0001", "first-page": "3866", "article-title": "The worldwide epidemiology of prostate cancer: Perspectives from autopsy studies", "volume": "15", "author": "Haas", "year": "2008", "journal-title": "Can J Urol"}, {"issue": "4", "key": "10.1002/pros.22669-BIB0002|pros22669-cit-0002", "doi-asserted-by": "crossref", "first-page": "293", "DOI": "10.1210/er.2009-0002", "article-title": "Endocrine-disrupting chemicals: An endocrine society scientific statement", "volume": "30", "author": "Diamanti-Kandarakis", "year": "2009", "journal-title": "Endocr Rev"}, {"key": "10.1002/pros.22669-BIB0003|pros22669-cit-0003", "first-page": "109", "article-title": "Multistage prostate carcinogenesis: The role of hormones", "volume": "22", "author": "Bosland", "year": "1991", "journal-title": "Princess Takamatsu Symp"}, {"issue": "1", "key": "10.1002/pros.22669-BIB0004|pros22669-cit-0004", "doi-asserted-by": "crossref", "first-page": "65", "DOI": "10.1007/s11934-000-0037-x", "article-title": "Prostatic intraepithelial neoplasia", "volume": "1", "author": "Bostwick", "year": "2000", "journal-title": "Curr Urol Rep"}, {"key": "10.1002/pros.22669-BIB0005|pros22669-cit-0005", "doi-asserted-by": "crossref", "first-page": "2270", "DOI": "10.1158/0008-5472.CAN-03-0946", "article-title": "Prostate pathology of genetically engineered mice: Definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee", "volume": "64", "author": "Shappell", "year": "2004", "journal-title": "Cancer Res"}, {"key": "10.1002/pros.22669-BIB0006|pros22669-cit-0006", "doi-asserted-by": "crossref", "first-page": "15382", "DOI": "10.1073/pnas.95.26.15382", "article-title": "A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells", "volume": "95", "author": "Garabedian", "year": "1998", "journal-title": "Proc Natl Acad Sci"}, {"issue": "1", "key": "10.1002/pros.22669-BIB0007|pros22669-cit-0007", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1007/s00428-008-0707-5", "article-title": "Precursor lesions to prostatic adenocarcinoma", "volume": "454", "author": "Epstein", "year": "2009", "journal-title": "Virchows Arch"}, {"key": "10.1002/pros.22669-BIB0008|pros22669-cit-0008", "doi-asserted-by": "crossref", "first-page": "123", "DOI": "10.1007/s10555-010-9212-9", "article-title": "Modeling prostate cancer: A perspective on transgenic mouse models", "volume": "29", "author": "Jeet", "year": "2010", "journal-title": "Cancer Metastasis Rev"}, {"key": "10.1002/pros.22669-BIB0009|pros22669-cit-0009", "first-page": "240", "article-title": "Quantitative determination of prostatic epithelial and stromal hyperplasia by a new technique: Biomorphometrics", "volume": "16", "author": "DeKlerk", "year": "1978", "journal-title": "Invest Urol"}, {"key": "10.1002/pros.22669-BIB0010|pros22669-cit-0010", "doi-asserted-by": "crossref", "first-page": "961", "DOI": "10.1095/biolreprod34.5.961", "article-title": "Morphogenesis of ductal networks in the mouse prostate", "volume": "34", "author": "Sugimura", "year": "1986", "journal-title": "Biol Reprod"}, {"key": "10.1002/pros.22669-BIB0011|pros22669-cit-0011", "doi-asserted-by": "crossref", "first-page": "308", "DOI": "10.1095/biolreprod45.2.308", "article-title": "Morphological and fuctional hetereogeneity in the rat prostatic gland", "volume": "45", "author": "Hayashi", "year": "1991", "journal-title": "Biol Reprod"}, {"key": "10.1002/pros.22669-BIB0012|pros22669-cit-0012", "doi-asserted-by": "crossref", "first-page": "675", "DOI": "10.1095/biolreprod51.4.675", "article-title": "Age and lobe-specific responses of Brown Norway rat prostate to androgen", "volume": "51", "author": "Banerjee", "year": "1994", "journal-title": "Biol Reprod"}, {"key": "10.1002/pros.22669-BIB0013|pros22669-cit-0013", "doi-asserted-by": "crossref", "first-page": "58", "DOI": "10.1002/(SICI)1097-0045(199601)28:1<58::AID-PROS8>3.0.CO;2-K", "article-title": "Ductal heterogeneity in rat dorsolateral prostate", "volume": "28", "author": "Kinbara", "year": "1996", "journal-title": "Prostate"}, {"key": "10.1002/pros.22669-BIB0014|pros22669-cit-0014", "doi-asserted-by": "crossref", "first-page": "219", "DOI": "10.1016/S1383-5742(00)00039-9", "article-title": "Experimental prostate carcinogenesis-Rodent models", "volume": "462", "author": "Shirai", "year": "2000", "journal-title": "Mutat Res"}, {"key": "10.1002/pros.22669-BIB0015|pros22669-cit-0015", "doi-asserted-by": "crossref", "first-page": "219", "DOI": "10.1002/pros.2990110303", "article-title": "Autochthonous prostate adenocarcinomas in Lobund-Wistar rats: A model system", "volume": "11", "author": "Pollard", "year": "1987", "journal-title": "Prostate"}, {"key": "10.1002/pros.22669-BIB0016|pros22669-cit-0016", "first-page": "3282", "article-title": "Influence of N-methyl-N-nitrosourea, testosterone, and N-(4-hydroxyphenyl)-all-trans-retinamide on prostate cancer induction in Wistar-Unilever rats", "volume": "58", "author": "McCormick", "year": "1998", "journal-title": "Cancer Res"}, {"key": "10.1002/pros.22669-BIB0017|pros22669-cit-0017", "doi-asserted-by": "crossref", "first-page": "1701", "DOI": "10.1093/carcin/23.10.1701", "article-title": "Interrelationships among angiogenesis, proliferation, and apoptosis in the tumor microenvironment during N-methyl-N-nitrosourea androgen-induced prostate carcinogenesis in rats", "volume": "23", "author": "Liao", "year": "2002", "journal-title": "Carcinogenesis"}, {"key": "10.1002/pros.22669-BIB0018|pros22669-cit-0018", "doi-asserted-by": "crossref", "first-page": "1578", "DOI": "10.1093/jnci/djg081", "article-title": "Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets", "volume": "95", "author": "Boileau", "year": "2003", "journal-title": "J Natl Cancer Inst"}, {"key": "10.1002/pros.22669-BIB0019|pros22669-cit-0019", "doi-asserted-by": "crossref", "first-page": "375", "DOI": "10.1248/bpb.29.375", "article-title": "Chemoprevention of rat prostate carcinogenesis by diallyl disulfide, an organosulfur compound of garlic", "volume": "29", "author": "Arunkumar", "year": "2006", "journal-title": "Biol Pharm Bull"}, {"issue": "1", "key": "10.1002/pros.22669-BIB0020|pros22669-cit-0020", "first-page": "11", "article-title": "Review: Animal models of N-Methyl-N-nitrosourea-induced mammary cancer and retinal degeneration with special emphasis on therapeutic trials", "volume": "25", "author": "Tsubura", "year": "2011", "journal-title": "In Vivo"}, {"key": "10.1002/pros.22669-BIB0021|pros22669-cit-0021", "doi-asserted-by": "crossref", "first-page": "11", "DOI": "10.1016/0027-5107(90)90173-2", "article-title": "Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents", "volume": "231", "author": "Beranek", "year": "1990", "journal-title": "Mutat Res"}, {"issue": "1-2", "key": "10.1002/pros.22669-BIB0022|pros22669-cit-0022", "doi-asserted-by": "crossref", "first-page": "131", "DOI": "10.1016/j.mrfmmm.2007.12.011", "article-title": "Reduced methylation-induced mutagenesis in rat splenocytes in vivo by sub-chronic low dose exposure to N-metyl-N-nitrosourea", "volume": "640", "author": "van Zeeland", "year": "2008", "journal-title": "Mutat Res"}, {"key": "10.1002/pros.22669-BIB0023|pros22669-cit-0023", "doi-asserted-by": "crossref", "first-page": "1079", "DOI": "10.1016/j.dnarep.2007.03.008", "article-title": "MGMT: Key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents", "volume": "6", "author": "Kaina", "year": "2007", "journal-title": "DNA Repair"}, {"key": "10.1002/pros.22669-BIB0024|pros22669-cit-0024", "first-page": "1848", "article-title": "Variability in DNA repair and individual susceptibility to genotoxins", "volume": "41", "author": "Kyrtopoulos", "year": "1995", "journal-title": "Clin Chem"}, {"key": "10.1002/pros.22669-BIB0025|pros22669-cit-0025", "doi-asserted-by": "crossref", "first-page": "168", "DOI": "10.1196/annals.1386.040", "article-title": "Sex steroids and prostate carcinogenesis: Integrated, multifactorial working hypothesis", "volume": "1089", "author": "Bosland", "year": "2006", "journal-title": "Ann N Y Acad Sci"}, {"key": "10.1002/pros.22669-BIB0026|pros22669-cit-0026", "doi-asserted-by": "crossref", "first-page": "1190", "DOI": "10.1002/ar.a.20391", "article-title": "Tissue evidence of the testosterone role on the abnormal growth and aging effects reversion in the gerbil (Meriones unguiculatus) prostate", "volume": "288", "author": "Scarano", "year": "2006", "journal-title": "Anat Rec A Discov Mol Cell Evol Biol"}, {"key": "10.1002/pros.22669-BIB0027|pros22669-cit-0027", "doi-asserted-by": "crossref", "first-page": "25", "DOI": "10.1111/j.1365-2613.2007.00559.x", "article-title": "Oestrogen supplementation following castration promotes stromal remodelling and histopathological alterations in the Mongolian gerbil ventral prostate", "volume": "89", "author": "Scarano", "year": "2008", "journal-title": "Int J Exp Pathol"}, {"key": "10.1002/pros.22669-BIB0028|pros22669-cit-0028", "doi-asserted-by": "crossref", "first-page": "723", "DOI": "10.1002/ar.a.20347", "article-title": "Biological behavior of the gerbil ventral prostate in three phases of postnatal development", "volume": "288", "author": "Pegorin deCampos", "year": "2006", "journal-title": "Anat Rec A Discov Mol Cell Evol Biol"}, {"key": "10.1002/pros.22669-BIB0029|pros22669-cit-0029", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1111/j.1365-2613.2007.00550.x", "article-title": "Age-related histopathological lesions in the Mongolian gerbil ventral prostate as a good model for studies of spontaneous hormone-related disorders", "volume": "89", "author": "Campos", "year": "2008", "journal-title": "Int J Exp Pathol"}, {"key": "10.1002/pros.22669-BIB0030|pros22669-cit-0030", "doi-asserted-by": "crossref", "first-page": "394", "DOI": "10.1111/j.1365-2613.2010.00706.x", "article-title": "Tissue changes in senescent gerbil prostate after hormone deprivation leads to acquisition of androgen insensitivity", "volume": "91", "author": "Campos", "year": "2010", "journal-title": "Int J Exp Pathol"}, {"key": "10.1002/pros.22669-BIB0031|pros22669-cit-0031", "doi-asserted-by": "crossref", "first-page": "97", "DOI": "10.1016/j.biomag.2011.05.001", "article-title": "Prostatic stromal cells of old gerbils respond to steroidal blockades creating a microenvironment similar to reactive stroma", "volume": "1", "author": "Campos", "year": "2011", "journal-title": "Biomed Aging Pathol"}, {"key": "10.1002/pros.22669-BIB0032|pros22669-cit-0032", "doi-asserted-by": "crossref", "first-page": "96", "DOI": "10.1016/j.yexmp.2009.09.017", "article-title": "Prostate carcinogenesis induced by N-methyl-N-nitrosourea (MNU) in gerbils: Histopathological diagnosis and potential invasiveness mediated by extracellular matrix components", "volume": "88", "author": "Gon\u00e7alves", "year": "2010", "journal-title": "Exp Mol Pathol"}, {"key": "10.1002/pros.22669-BIB0033|pros22669-cit-0033", "doi-asserted-by": "crossref", "first-page": "939", "DOI": "10.1002/jemt.20740", "article-title": "Increased androgen receptor and remodeling in the prostatic stroma after the inhibition of 5-alpha reductase and aromatase in gerbil ventral prostate", "volume": "72", "author": "Corradi", "year": "2009", "journal-title": "Microsc Res Tech"}, {"key": "10.1002/pros.22669-BIB0034|pros22669-cit-0034", "first-page": "461", "article-title": "Dietary prevention of hormone refractory prostate cancer in Lobund-Wistar rats: A review of studies in a relevant animal model", "volume": "56", "author": "Pollard", "year": "2006", "journal-title": "Comp Med"}, {"key": "10.1002/pros.22669-BIB0035|pros22669-cit-0035", "first-page": "583", "article-title": "Production of autochthonous prostate cancer in Lobund-Wistar rats by treatments with n-nitroso-n-methylurea and testosterone", "volume": "7", "author": "Pollard", "year": "1986", "journal-title": "J Natl Cancer Inst"}, {"issue": "3", "key": "10.1002/pros.22669-BIB0036|pros22669-cit-0036", "first-page": "700", "article-title": "Characterization of adenocarcinomas of the dorsolateral prostate induced in Wistar rats by N-methyl-N-nitrosourea, 7,12-dimethylbenz(a)anthracene, and 3,2'-dimethyl-4-aminobiphenyl, following sequential treatment with cyproterone acetate and testosterone propionate", "volume": "50", "author": "Bosland", "year": "1990", "journal-title": "Cancer Res"}, {"issue": "4", "key": "10.1002/pros.22669-BIB0037|pros22669-cit-0037", "doi-asserted-by": "crossref", "first-page": "256", "DOI": "10.1038/nrc2090", "article-title": "Inflammation in prostate carcinogenesis", "volume": "7", "author": "De Marzo", "year": "2007", "journal-title": "Nat Rev Cancer"}, {"issue": "7", "key": "10.1002/pros.22669-BIB0038|pros22669-cit-0038", "doi-asserted-by": "crossref", "first-page": "728", "DOI": "10.1002/pros.20719", "article-title": "Histopathological evidence for an association of inflammation with ductal Pin-like lesions but not with ductal adenocarcinoma in the prostate of the noble rat", "volume": "68", "author": "Bernoulli", "year": "2008", "journal-title": "Prostate"}, {"key": "10.1002/pros.22669-BIB0039|pros22669-cit-0039", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1097/00042307-200301000-00002", "article-title": "Aetiology and pathogenesis of benign prostatic hyperplasia", "volume": "13", "author": "Eaton", "year": "2003", "journal-title": "Curr Opin Urol"}, {"key": "10.1002/pros.22669-BIB0040|pros22669-cit-0040", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1016/j.ucl.2007.09.012", "article-title": "Inflammation benign prostatic hyperplasia", "volume": "35", "author": "Nickel", "year": "2008", "journal-title": "Urol Clin North Am"}, {"key": "10.1002/pros.22669-BIB0041|pros22669-cit-0041", "doi-asserted-by": "crossref", "first-page": "1021", "DOI": "10.1016/j.mehy.2007.08.022", "article-title": "Chronic inflammation in benign prostatic hyperplasia: Implications for therapy", "volume": "70", "author": "Wang", "year": "2008", "journal-title": "Med Hypotheses"}, {"key": "10.1002/pros.22669-BIB0042|pros22669-cit-0042", "doi-asserted-by": "crossref", "first-page": "117", "DOI": "10.1016/j.ucl.2007.09.006", "article-title": "Inflammation and prostate cancer: A future target for prevention and therapy", "volume": "35", "author": "Stock", "year": "2008", "journal-title": "Urol Clin North Am"}, {"issue": "3", "key": "10.1002/pros.22669-BIB0043|pros22669-cit-0043", "first-page": "S4", "article-title": "The role of estrogens in prostate carcinogenesis: A rationale for chemoprevention", "volume": "7", "author": "Bosland", "year": "2005", "journal-title": "Rev Urol"}, {"key": "10.1002/pros.22669-BIB0044|pros22669-cit-0044", "doi-asserted-by": "crossref", "first-page": "S30", "DOI": "10.1097/01.ju.0000108142.53241.47", "article-title": "Inflammation as a target for prostate cancer chemoprevention: Pathological and laboratory rationale", "volume": "171", "author": "Lucia", "year": "2004", "journal-title": "J Urol"}, {"issue": "8", "key": "10.1002/pros.22669-BIB0045|pros22669-cit-0045", "doi-asserted-by": "crossref", "first-page": "1505", "DOI": "10.1093/carcin/18.8.1505", "article-title": "Suppression of testosterone and estradiol-17beta-induced dysplasia in the dorsolateral prostate of Noble rats by bromocriptine", "volume": "18", "author": "Lane", "year": "1997", "journal-title": "Carcinogenesis"}, {"key": "10.1002/pros.22669-BIB0046|pros22669-cit-0046", "doi-asserted-by": "crossref", "first-page": "167", "DOI": "10.1016/S0079-6603(08)60879-X", "article-title": "Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase", "volume": "51", "author": "Pegg", "year": "1995", "journal-title": "Prog Nucleic Acid Res Mol Biol"}, {"key": "10.1002/pros.22669-BIB0047|pros22669-cit-0047", "first-page": "6471", "article-title": "Expression of the endogenous O6-methylguanine-DNA-methyltransferase protects Chinese hamster ovary cells from spontaneous G: C to A:T transitions", "volume": "52", "author": "Aquilina", "year": "1992", "journal-title": "Cancer Res"}, {"issue": "1-2", "key": "10.1002/pros.22669-BIB0048|pros22669-cit-0048", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1016/S0027-5107(00)00021-X", "article-title": "Role of DNA repair in carcinogen-induced ras mutation", "volume": "450", "author": "Engelbergs", "year": "2000", "journal-title": "Mutat Res"}, {"issue": "4", "key": "10.1002/pros.22669-BIB0049|pros22669-cit-0049", "doi-asserted-by": "crossref", "first-page": "252", "DOI": "10.3109/07357909809039774", "article-title": "The morphogenetic role of cadherin cell adhesion molecules in human cancer: A thematic review", "volume": "16", "author": "Yap", "year": "1998", "journal-title": "Cancer Invest"}, {"issue": "55", "key": "10.1002/pros.22669-BIB0050|pros22669-cit-0050", "doi-asserted-by": "crossref", "first-page": "6920", "DOI": "10.1038/onc.2008.343", "article-title": "Cadherins and cancer: How does cadherin dysfunction promote tumor progression", "volume": "27", "author": "Jeanes", "year": "2008", "journal-title": "Oncogene"}, {"key": "10.1002/pros.22669-BIB0051|pros22669-cit-0051", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1155/2011/567305", "article-title": "E-cadherin/\u03b2-catenin complex and the epithelial barrier", "volume": "2011", "author": "Tian", "year": "2011", "journal-title": "J Biomed Biotechnol"}, {"key": "10.1002/pros.22669-BIB0052|pros22669-cit-0052", "doi-asserted-by": "crossref", "first-page": "1115", "DOI": "10.1002/ar.20728", "article-title": "Anatomy of smooth muscle cells in nonmalignant and malignant human prostate tissue", "volume": "291", "author": "Taboga", "year": "2008", "journal-title": "Anat Rec (Hoboken)"}, {"key": "10.1002/pros.22669-BIB0053|pros22669-cit-0053", "doi-asserted-by": "crossref", "first-page": "276", "DOI": "10.7150/ijbs.5.276", "article-title": "Correlated alterations in prostate basal cell layer and basement membrane", "volume": "5", "author": "Liu", "year": "2009", "journal-title": "Int J Biol Sci"}, {"key": "10.1002/pros.22669-BIB0054|pros22669-cit-0054", "doi-asserted-by": "crossref", "first-page": "748", "DOI": "10.1002/pros.21291", "article-title": "Elevated expression of cancer-associated proliferating cell nuclear antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer", "volume": "71", "author": "Wang", "year": "2011", "journal-title": "Prostate"}, {"issue": "4", "key": "10.1002/pros.22669-BIB0055|pros22669-cit-0055", "doi-asserted-by": "crossref", "first-page": "677", "DOI": "10.1007/s00432-010-0926-4", "article-title": "Chemopreventive effects of zinc on prostate carcinogenesis induced by N-methyl-N-nitrosourea and testosterone in adult male Sprague-Dawley rats", "volume": "137", "author": "Banudevi", "year": "2011", "journal-title": "J Cancer Res Clin Oncol"}], "container-title": ["The Prostate"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.22669", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 21]], "date-time": "2017-06-21T12:02:03Z", "timestamp": 1498046523000}, "score": 35.52097, "subtitle": ["A New Model for Induced Prostate Cancer"], "issued": {"date-parts": [[2013, 4, 26]]}, "references-count": 55, "journal-issue": {"published-print": {"date-parts": [[2013, 8]]}, "issue": "11"}, "URL": "http://dx.doi.org/10.1002/pros.22669", "relation": {"cites": []}, "ISSN": ["0270-4137"], "issn-type": [{"value": "0270-4137", "type": "print"}], "subject": ["Urology", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T14:13:54Z", "timestamp": 1574518434938}, "reference-count": 61, "publisher": "Hindawi Limited", "license": [{"URL": "http://creativecommons.org/licenses/by/3.0/", "start": {"date-parts": [[2011, 1, 1]], "date-time": "2011-01-01T00:00:00Z", "timestamp": 1293840000000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Prostate Cancer"], "published-print": {"date-parts": [[2011]]}, "abstract": "<jats:p>Prostate cancer is one of the most common cancers in Western countries and is associated with a considerable risk of mortality. Biochemical recurrence following radical prostatectomy is a relatively common finding, affecting approximately 25% of cases. The aim of our paper was to identify factors that can predict the occurrence of biochemical recurrence, so the patient can be properly counselled pre- and postoperatively. Medline review of the literatures was done followed by a group discussion on the chosen publications and their valuable influence. Preoperative serum total PSA and clinical stage, together with prostatectomy Gleason grade, tumour volume, and perineural and vascular invasions, were the most important variables found to influence outcome.</jats:p>", "DOI": "10.1155/2011/485189", "type": "journal-article", "created": {"date-parts": [[2011, 6, 15]], "date-time": "2011-06-15T19:34:51Z", "timestamp": 1308166491000}, "page": "1-6", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Prognostic Factors for the Development of Biochemical Recurrence after Radical Prostatectomy"], "prefix": "10.1155", "volume": "2011", "author": [{"given": "Ahmed F.", "family": "Kotb", "sequence": "first", "affiliation": [{"name": "Urology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt"}]}, {"given": "Ahmed A.", "family": "Elabbady", "sequence": "additional", "affiliation": [{"name": "Urology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt"}]}], "member": "98", "reference": [{"key": "1", "volume": "3", "issue": "3, supplement 2", "first-page": "S102", "year": "2009", "journal-title": "Journal of the Canadian Urological Association"}, {"key": "2", "DOI": "10.3322/caac.20006", "doi-asserted-by": "publisher"}, {"key": "3", "volume": "152", "issue": "5", "first-page": "1831", "year": "1994", "journal-title": "Journal of Urology"}, {"key": "4", "volume": "149", "issue": "3", "first-page": "516", "year": "1993", "journal-title": "Journal of Urology", "DOI": "10.1016/S0022-5347(17)36132-3", "doi-asserted-by": "crossref"}, {"key": "5", "volume": "145", "issue": "5", "first-page": "907", "year": "1991", "journal-title": "Journal of Urology", "DOI": "10.1016/S0022-5347(17)38491-4", "doi-asserted-by": "crossref"}, {"key": "6", "DOI": "10.1016/j.juro.2006.10.097", "doi-asserted-by": "publisher"}, {"key": "7", "DOI": "10.1016/j.eururo.2005.06.001", "doi-asserted-by": "publisher"}, {"key": "8", "DOI": "10.1016/S0090-4295(02)02268-9", "doi-asserted-by": "publisher"}, {"key": "9", "DOI": "10.1200/JCO.2005.04.0756", "doi-asserted-by": "publisher"}, {"key": "10", "DOI": "10.1016/S0022-5347(05)00998-5", "doi-asserted-by": "publisher"}, {"key": "11", "DOI": "10.1016/j.juro.2009.11.027", "doi-asserted-by": "publisher"}, {"key": "12", "year": "2002"}, {"key": "13", "DOI": "10.1001/jama.280.11.969", "doi-asserted-by": "publisher"}, {"key": "14", "volume": "32", "issue": "2", "first-page": "165", "year": "2006", "journal-title": "International Brazilian Journal of Urology", "DOI": "10.1590/S1677-55382006000200006", "doi-asserted-by": "crossref"}, {"key": "15", "DOI": "10.1002/cncr.20145", "doi-asserted-by": "publisher"}, {"key": "16", "DOI": "10.1097/01.ju.0000158155.33890.e7", "doi-asserted-by": "publisher"}, {"key": "17", "DOI": "10.1111/j.1464-410X.2005.05713.x", "doi-asserted-by": "publisher"}, {"key": "18", "DOI": "10.1016/j.juro.2010.03.025", "doi-asserted-by": "publisher"}, {"key": "19", "DOI": "10.1093/jnci/djj190", "doi-asserted-by": "publisher"}, {"key": "20", "DOI": "10.1093/jjco/hym135", "doi-asserted-by": "publisher"}, {"key": "21", "volume": "31", "issue": "2", "first-page": "74", "year": "2001", "journal-title": "Japanese Journal of Clinical Oncology", "DOI": "10.1093/jjco/hye018", "doi-asserted-by": "crossref"}, {"key": "22", "DOI": "10.1111/j.1464-410X.2009.09134.x", "doi-asserted-by": "publisher"}, {"key": "23", "DOI": "10.1016/j.urology.2007.01.087", "doi-asserted-by": "publisher"}, {"key": "24", "volume": "168", "issue": "1", "first-page": "110", "year": "2002", "journal-title": "Journal of Urology", "DOI": "10.1016/S0022-5347(05)64841-0", "doi-asserted-by": "crossref"}, {"key": "25", "DOI": "10.1097/01.ju.0000051400.85694.bb", "doi-asserted-by": "publisher"}, {"key": "26", "DOI": "10.1016/j.urology.2005.06.106", "doi-asserted-by": "publisher"}, {"key": "27", "volume": "90", "issue": "6", "first-page": "305", "year": "2000", "journal-title": "International Journal of Cancer", "DOI": "10.1002/1097-0215(20001220)90:6<305::AID-IJC1>3.0.CO;2-U", "doi-asserted-by": "crossref"}, {"key": "28", "volume": "166", "issue": "5", "first-page": "1692", "year": "2001", "journal-title": "Journal of Urology", "DOI": "10.1016/S0022-5347(05)65655-8", "doi-asserted-by": "crossref"}, {"key": "29", "DOI": "10.1016/S0090-4295(00)00791-3", "doi-asserted-by": "publisher"}, {"key": "30", "volume": "164", "issue": "5", "first-page": "1596", "year": "2000", "journal-title": "Journal of Urology", "DOI": "10.1016/S0022-5347(05)67036-X", "doi-asserted-by": "crossref"}, {"key": "31", "DOI": "10.1200/JCO.2005.03.018", "doi-asserted-by": "publisher"}, {"key": "32", "DOI": "10.1016/S0090-4295(00)00753-6", "doi-asserted-by": "publisher"}, {"key": "33", "DOI": "10.1111/j.1464-410X.2010.09539.x", "doi-asserted-by": "publisher"}, {"key": "34", "DOI": "10.1097/01.ju.0000156885.49788.92", "doi-asserted-by": "publisher"}, {"key": "35", "DOI": "10.1016/S0022-5347(01)66792-2", "doi-asserted-by": "publisher"}, {"key": "36", "DOI": "10.1016/S0090-4295(96)00092-1", "doi-asserted-by": "publisher"}, {"key": "37", "DOI": "10.1016/j.juro.2007.01.009", "doi-asserted-by": "publisher"}, {"key": "38", "DOI": "10.1001/jama.281.15.1395", "doi-asserted-by": "publisher"}, {"key": "39", "DOI": "10.1111/j.1464-410X.2006.06148.x", "doi-asserted-by": "publisher"}, {"key": "40", "DOI": "10.1038/pcan.2010.17", "doi-asserted-by": "publisher"}, {"key": "41", "DOI": "10.1016/j.urolonc.2009.06.017", "doi-asserted-by": "publisher"}, {"key": "42", "volume": "165", "issue": "1", "first-page": "119", "year": "2001", "journal-title": "Journal of Urology", "DOI": "10.1097/00005392-200101000-00030", "doi-asserted-by": "crossref"}, {"key": "43", "DOI": "10.1093/jjco/hym135", "doi-asserted-by": "publisher"}, {"key": "44", "DOI": "10.1080/00365590802299585", "doi-asserted-by": "publisher"}, {"key": "45", "DOI": "10.1016/j.urology.2009.08.088", "doi-asserted-by": "publisher"}, {"key": "46", "DOI": "10.1016/j.urology.2007.08.042", "doi-asserted-by": "publisher"}, {"key": "47", "DOI": "10.1159/000315491", "doi-asserted-by": "publisher"}, {"key": "48", "DOI": "10.1038/modpathol.2008.81", "doi-asserted-by": "publisher"}, {"key": "49", "volume": "51", "issue": "4", "first-page": "241", "year": "2005", "journal-title": "Acta Urologica Japonica"}, {"key": "50", "DOI": "10.1046/j.1464-410X.2000.00518.x", "doi-asserted-by": "publisher"}, {"key": "51", "DOI": "10.1016/S0360-3016(03)01433-0", "doi-asserted-by": "publisher"}, {"key": "52", "DOI": "10.1016/S0090-4295(01)01486-8", "doi-asserted-by": "publisher"}, {"key": "53", "DOI": "10.1159/000030197", "doi-asserted-by": "publisher"}, {"key": "54", "volume": "38", "issue": "1", "first-page": "79", "year": "2000", "journal-title": "European Urology", "DOI": "10.1159/000020256", "doi-asserted-by": "crossref"}, {"key": "55", "DOI": "10.1016/j.urology.2004.04.070", "doi-asserted-by": "publisher"}, {"key": "56", "volume": "118", "issue": "8", "first-page": "779", "year": "1994", "journal-title": "Archives of Pathology and Laboratory Medicine"}, {"key": "57", "DOI": "10.1016/j.urology.2005.12.009", "doi-asserted-by": "publisher"}, {"key": "58", "DOI": "10.1016/S0046-8177(96)90398-6", "doi-asserted-by": "publisher"}, {"key": "59", "DOI": "10.1080/00365590701224445", "doi-asserted-by": "publisher"}, {"key": "60", "DOI": "10.1016/S0090-4295(00)00838-4", "doi-asserted-by": "publisher"}, {"key": "61", "volume": "27", "issue": "5b", "first-page": "3651", "year": "2007", "journal-title": "Anticancer Research"}], "container-title": ["Prostate Cancer"], "language": "en", "link": [{"URL": "http://downloads.hindawi.com/journals/pc/2011/485189.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://downloads.hindawi.com/journals/pc/2011/485189.xml", "content-type": "application/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://downloads.hindawi.com/journals/pc/2011/485189.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 11]], "date-time": "2019-06-11T19:49:43Z", "timestamp": 1560282583000}, "score": 35.50812, "issued": {"date-parts": [[2011]]}, "references-count": 61, "alternative-id": ["485189", "485189"], "URL": "http://dx.doi.org/10.1155/2011/485189", "relation": {"cites": []}, "ISSN": ["2090-3111", "2090-312X"], "issn-type": [{"value": "2090-3111", "type": "print"}, {"value": "2090-312X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T21:43:31Z", "timestamp": 1574372611607}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "11", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Cancer Research"], "published-print": {"date-parts": [[2008, 6, 1]]}, "DOI": "10.1158/1078-0432.ccr-07-5119", "type": "journal-article", "created": {"date-parts": [[2008, 6, 2]], "date-time": "2008-06-02T19:46:02Z", "timestamp": 1212435962000}, "page": "3367-3371", "source": "Crossref", "is-referenced-by-count": 33, "title": ["Genetic Polymorphism in EGF Is Associated with Prostate Cancer Aggressiveness and Progression-Free Interval in Androgen Blockade-Treated Patients"], "prefix": "10.1158", "volume": "14", "author": [{"given": "A. L.", "family": "Teixeira", "sequence": "first", "affiliation": []}, {"given": "R.", "family": "Ribeiro", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Cardoso", "sequence": "additional", "affiliation": []}, {"given": "D.", "family": "Pinto", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Lobo", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Fraga", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Pina", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Calais-da-Silva", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Medeiros", "sequence": "additional", "affiliation": []}], "member": "1086", "container-title": ["Clinical Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1078-0432.CCR-07-5119", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T04:50:15Z", "timestamp": 1482468615000}, "score": 35.281548, "issued": {"date-parts": [[2008, 6, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2008, 6, 1]]}, "issue": "11"}, "URL": "http://dx.doi.org/10.1158/1078-0432.ccr-07-5119", "ISSN": ["1078-0432", "1557-3265"], "issn-type": [{"value": "1078-0432", "type": "print"}, {"value": "1557-3265", "type": "electronic"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}